<SEC-DOCUMENT>0001493152-26-005110.txt : 20260204
<SEC-HEADER>0001493152-26-005110.hdr.sgml : 20260204
<ACCEPTANCE-DATETIME>20260204163031
ACCESSION NUMBER:		0001493152-26-005110
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		17
CONFORMED PERIOD OF REPORT:	20260202
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20260204
DATE AS OF CHANGE:		20260204

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			WRAP TECHNOLOGIES, INC.
		CENTRAL INDEX KEY:			0001702924
		STANDARD INDUSTRIAL CLASSIFICATION:	ORDNANCE & ACCESSORIES, (NO VEHICLES/GUIDED MISSILES) [3480]
		ORGANIZATION NAME:           	04 Manufacturing
		EIN:				980551945
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38750
		FILM NUMBER:		26598717

	BUSINESS ADDRESS:	
		STREET 1:		3480 MAIN HWY, SUITE 202
		CITY:			MIAMI
		STATE:			FL
		ZIP:			33133
		BUSINESS PHONE:		800-583-2652

	MAIL ADDRESS:	
		STREET 1:		3480 MAIN HWY, SUITE 202
		CITY:			MIAMI
		STATE:			FL
		ZIP:			33133
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>form8-k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:us-roles="http://fasb.org/us-roles/2025" xmlns:country="http://xbrl.sec.gov/country/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:WRAP="http://wrap.com/20260202">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02E_US%2DGAAP%2D2025 -->
<!-- Field: Set; Name: xdx; ID: xdx_033_WRAP_wrap.com_20260202 -->
<!-- Field: Set; Name: xdx; ID: xdx_04F_20260202_20260202 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_050_edei%2D%2DEntityCentralIndexKey_0001702924 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2026-02-02" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2026-02-02" id="Fact000004" name="dei:EntityCentralIndexKey">0001702924</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="wrap-20260202.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2026-02-02">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001702924</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2026-02-02</xbrli:startDate>
        <xbrli:endDate>2026-02-02</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 4pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>UNITED
STATES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>SECURITIES
AND EXCHANGE COMMISSION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt"><b>Washington,
DC 20549</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin: 0pt auto; width: 30%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>FORM
<span id="xdx_90F_edei--DocumentType_c20260202__20260202_zrPzFyPe9Yu8"><ix:nonNumeric contextRef="AsOf2026-02-02" id="Fact000009" name="dei:DocumentType">8-K</ix:nonNumeric></span> </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<!-- Field: Rule-Page --><div style="margin: 0pt auto; width: 30%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CURRENT
REPORT</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Pursuant
to Section 13 or 15(d) of the</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Securities
Exchange Act of 1934</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date
of Report (Date of earliest event reported): <span id="xdx_90C_edei--DocumentPeriodEndDate_c20260202__20260202_zKjEkZFf0Cc4"><ix:nonNumeric contextRef="AsOf2026-02-02" format="ixt:datemonthdayyearen" id="Fact000010" name="dei:DocumentPeriodEndDate">February 2, 2026</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin: 0pt auto; width: 30%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b><span id="xdx_902_edei--EntityRegistrantName_c20260202__20260202_zhuxUhornVk6"><ix:nonNumeric contextRef="AsOf2026-02-02" id="Fact000011" name="dei:EntityRegistrantName">WRAP
TECHNOLOGIES, INC.</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Exact
name of Registrant as specified in its Charter)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin: 0pt auto; width: 30%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top; text-align: left">
  <td style="text-align: center; width: 32%"><span style="text-decoration: underline"><span id="xdx_902_edei--EntityIncorporationStateCountryCode_c20260202__20260202_zjuDrk8WUw64"><ix:nonNumeric contextRef="AsOf2026-02-02" format="ixt-sec:stateprovnameen" id="Fact000012" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></span></td>
    <td style="width: 2%">&#160;</td>
  <td style="text-align: center; width: 32%"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="text-decoration: underline"><span id="xdx_90A_edei--EntityFileNumber_c20260202__20260202_zJwkACKogGsd"><ix:nonNumeric contextRef="AsOf2026-02-02" id="Fact000013" name="dei:EntityFileNumber">001-38750</ix:nonNumeric></span></span></p></td>
    <td style="width: 2%">&#160;</td>
  <td style="text-align: center; width: 32%"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="text-decoration: underline"><span id="xdx_90B_edei--EntityTaxIdentificationNumber_c20260202__20260202_zplLYIkdaZGk"><ix:nonNumeric contextRef="AsOf2026-02-02" id="Fact000014" name="dei:EntityTaxIdentificationNumber">98-0551945</ix:nonNumeric></span></span></p></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td style="text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">(State or other jurisdiction</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0">of incorporation)</p></td>
    <td>&#160;</td>
  <td style="text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0">(Commission File No.)</p></td>
    <td>&#160;</td>
  <td style="text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">(IRS Employer</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0">Identification No.)</p></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_90D_edei--EntityAddressAddressLine1_c20260202__20260202_zU5hc1nria2b"><ix:nonNumeric contextRef="AsOf2026-02-02" id="Fact000015" name="dei:EntityAddressAddressLine1">3480
Main Hwy</ix:nonNumeric></span>, <span id="xdx_90C_edei--EntityAddressAddressLine2_c20260202__20260202_zIdwH0h4P0N"><ix:nonNumeric contextRef="AsOf2026-02-02" id="Fact000016" name="dei:EntityAddressAddressLine2">Suite 202</ix:nonNumeric></span>, <span id="xdx_905_edei--EntityAddressCityOrTown_c20260202__20260202_zH5VsvLm6xAl"><ix:nonNumeric contextRef="AsOf2026-02-02" id="Fact000017" name="dei:EntityAddressCityOrTown">Miami</ix:nonNumeric></span>, <span id="xdx_902_edei--EntityAddressStateOrProvince_c20260202__20260202_zcqvONUaEHH2"><ix:nonNumeric contextRef="AsOf2026-02-02" format="ixt-sec:stateprovnameen" id="Fact000018" name="dei:EntityAddressStateOrProvince">Florida</ix:nonNumeric></span> <span id="xdx_90F_edei--EntityAddressPostalZipCode_c20260202__20260202_zUxFqC3y6E6"><ix:nonNumeric contextRef="AsOf2026-02-02" id="Fact000019" name="dei:EntityAddressPostalZipCode">33133</ix:nonNumeric></span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address of principal executive offices) (Zip code) &#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_901_edei--CityAreaCode_c20260202__20260202_zjguRhTiaPkk"><ix:nonNumeric contextRef="AsOf2026-02-02" id="Fact000020" name="dei:CityAreaCode">(800)</ix:nonNumeric></span>
<span id="xdx_909_edei--LocalPhoneNumber_c20260202__20260202_zaOaDXBhvBK8"><ix:nonNumeric contextRef="AsOf2026-02-02" id="Fact000021" name="dei:LocalPhoneNumber">583-2652</ix:nonNumeric></span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Registrant&#8217;s Telephone
Number) </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span>Not
Applicable</span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Former name or address, if changed since last report)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p>

<!-- Field: Rule-Page --><div style="margin: 0pt auto; width: 30%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Check the appropriate box below if the Form
8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General
Instruction A.2. below):&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_edei--WrittenCommunications_c20260202__20260202_zh4pXjFGdJol"><ix:nonNumeric contextRef="AsOf2026-02-02" format="ixt:booleanfalse" id="Fact000022" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td>
</tr>
<tr style="vertical-align: top; text-align: justify">
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_edei--SolicitingMaterial_c20260202__20260202_zpl1n2mKwQdg"><ix:nonNumeric contextRef="AsOf2026-02-02" format="ixt:booleanfalse" id="Fact000023" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td>
</tr>
<tr style="vertical-align: top; text-align: justify">
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_edei--PreCommencementTenderOffer_c20260202__20260202_zJeV8QBZzyPb"><ix:nonNumeric contextRef="AsOf2026-02-02" format="ixt:booleanfalse" id="Fact000024" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td>
</tr>
<tr style="vertical-align: top; text-align: justify">
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_edei--PreCommencementIssuerTenderOffer_c20260202__20260202_zogAxAxf10rf"><ix:nonNumeric contextRef="AsOf2026-02-02" format="ixt:booleanfalse" id="Fact000025" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities registered pursuant to Section 12(b) of the Act:&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top; text-align: left">
  <td style="border-bottom: Black 1pt solid; text-align: center; width: 38%">Title of each class</td>
    <td style="padding-bottom: 1pt; width: 2%">&#160;</td>
  <td style="border-bottom: Black 1pt solid; text-align: center; width: 20%"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0">Trading Symbol(s)</p></td>
    <td style="padding-bottom: 1pt; width: 2%">&#160;</td>
  <td style="border-bottom: Black 1pt solid; text-align: center; width: 38%"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0">Name of each exchange on which registered</p></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td style="text-align: center"><span id="xdx_90F_edei--Security12bTitle_c20260202__20260202_zRY3e2ERl5U6"><ix:nonNumeric contextRef="AsOf2026-02-02" id="Fact000026" name="dei:Security12bTitle">Common Stock, par value $0.0001 per share</ix:nonNumeric></span></td>
    <td>&#160;</td>
  <td style="text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span id="xdx_90A_edei--TradingSymbol_c20260202__20260202_zGqMOuePIHg8"><ix:nonNumeric contextRef="AsOf2026-02-02" id="Fact000027" name="dei:TradingSymbol">WRAP</ix:nonNumeric></span></p></td>
    <td>&#160;</td>
  <td style="text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span id="xdx_90B_edei--SecurityExchangeName_c20260202__20260202_zZF7wwAwNdM5"><ix:nonNumeric contextRef="AsOf2026-02-02" format="ixt-sec:exchnameen" id="Fact000028" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span> Capital Market</p></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR 230.405)
or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR 240.12b-2) <span id="xdx_90A_edei--EntityEmergingGrowthCompany_c20260202__20260202_zP51eBawn3B5"><ix:nonNumeric contextRef="AsOf2026-02-02" format="ixt:booleanfalse" id="Fact000029" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 4pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
1.01. Entry into a Material Definitive Agreement.&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On February 2, 2026, Wrap Technologies, Inc. (the &#8220;Company&#8221;) entered into a securities purchase agreement
(the &#8220;Purchase Agreement&#8221;) with certain accredited investors (collectively, the &#8220;Purchasers&#8221;) for the issuance
and sale in a private placement (the &#8220;Private Placement&#8221;) of (i) an aggregate of 1,700,000 shares (the &#8220;Common Shares&#8221;)
of common stock of the Company, par value $0.0001 per share (the &#8220;Common Stock&#8221;), (ii) pre-funded warrants to purchase up
to 800,000 shares of Common Stock (the &#8220;Pre-Funded Warrants&#8221;), with an exercise price of $0.0001 per share, and (iii) common
warrants to purchase up to 2,500,000 shares of Common Stock (the &#8220;Common Warrants&#8221;, together with the Pre-Funded Warrants,
the &#8220;Warrants&#8221;), with an exercise price of $2.30 per share. The purchase price for one Common Share and accompanying Common
Warrant was $2.00 and the purchase price for one Pre-Funded Warrant and accompanying Common Warrant was $1.9999.&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The closing of
the Private Placement occurred on February 3, 2026. The Purchase Agreement contains customary representations, warranties and agreements
by the Company, customary conditions to closing, indemnification obligations of the Company and the Purchasers, including for liabilities
under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), other obligations of the parties and termination provisions.&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Common Warrants are exercisable for shares of Common Stock immediately at an exercise price of $2.30 per share and expire five years
from the date of issuance. The Pre-Funded Warrants are exercisable for shares of Common Stock immediately and expire when exercised in
full. The exercise price of the Common Warrants is subject to customary adjustments for stock dividends, stock splits, reclassifications
and the like, and subject to price-based adjustments in the event of any issuances of Common Stock, or securities convertible, exercisable
or exchangeable for Common Stock, at a price below the then-applicable exercise price (subject to certain exceptions). There is no established
public trading market for the Warrants and the Company does not intend to list the Warrants on any national securities exchange or nationally
recognized trading system.&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A holder of the Warrants may not exercise any portion of such holder&#8217;s Warrants to the extent that
the holder, together with its affiliates, would beneficially own more than 4.99% (or, at the election of the holder, 9.99%) of the Company&#8217;s
outstanding shares of Common Stock immediately after exercise, except that upon at least 61 days&#8217; prior notice from the holder
to the Company, the holder may increase the beneficial ownership limitation to up to 9.99% of the number of shares of Common Stock outstanding
immediately after giving effect to the exercise.&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In connection with the Private Placement, the Company entered into a registration
rights agreement (the &#8220;Registration Rights Agreement&#8221;), dated as of February 2, 2026, with the Purchasers, pursuant to which
the Company agreed to prepare and file a registration statement with the Securities and Exchange Commission (the &#8220;SEC&#8221;) registering
the resale of the Common Shares and shares of Common Stock underlying the Warrants no later than 60 days following the date of the Registration
Rights Agreement, and to use best efforts to have the registration statement declared effective as promptly as practical thereafter,
and in any event no later than 90 days following the date of the Registration Rights Agreement (or 120 days following the date of the
Registration Rights Agreement in the event of a &#8220;full review&#8221; by the SEC).&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The gross proceeds to the Company from the
Private Placement were approximately $5 million, before estimated offering expenses payable by the Company. The Company intends to use
the net proceeds received from the Private Placement for general corporate purposes and working capital.&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The foregoing descriptions
of terms and conditions of the Purchase Agreement, the Registration Rights Agreement the Common Warrants and the Pre-Funded Warrants
do not purport to be complete and are qualified in their entirety by the full text of the Purchase Agreement, the Registration Rights
Agreement, and Warrants, forms of which are attached hereto as Exhibits 10.1, 10.2 , 4.1, and 4.2 respectively.&#160;&#160;&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
3.02 Unregistered Sales of Equity Securities.</b>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information contained in Item 1.01 of this Current Report on Form 8-K in relation to the Common Shares and Warrants is incorporated herein
by reference. The issuance of the Common Shares and Warrants was not registered under the Securities Act or any state securities laws.
The issuance of the Common Shares and Warrants was issued in reliance on the exemptions from registration provided by Section 4(a)(2)
under the Securities Act and Regulation D promulgated thereunder.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item 8.01 Other Events.</b>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 2, 2026, the Company issued a press release announcing the Private Placement. A copy of the press release is attached as Exhibit
99.1 hereto.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item 9.01 Financial Statements and Exhibits.</b>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) Exhibits.&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: center; vertical-align: top; width: 0.65in"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit</b></span>&#160;<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>No.</b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; vertical-align: bottom; text-indent: 0pt; width: 0.15in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0pt; vertical-align: top; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex4-1.htm">Form of Warrant.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex4-2.htm">Form of Pre-Funded Warrant</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex10-1.htm">Securities Purchase Agreement, dated February 2, 2026, by and among the Company and the investors signatory thereto.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex10-2.htm">Registration Rights Agreement, dated February 2, 2026, by and among the Company and the investors signatory thereto.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex99-1.htm">Press Release, dated February 2, 2026.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; vertical-align: top; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; vertical-align: bottom; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover
    Page Interactive Data File (formatted as Inline XBRL)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">* Certain of the schedules (and similar attachments) to this exhibit have been omitted in accordance
with Item 601(a)(5) of Regulation S-K under the Securities Act because they do not contain information material to an investment or voting
decision and that information is not otherwise disclosed in the exhibit or the disclosure document. The registrant hereby agrees to furnish
a copy of all omitted schedules (or similar attachments) to the SEC upon its request.&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p>

<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SIGNATURES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.&#160;&#160; &#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>WRAP
    TECHNOLOGIES, INC.</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 47%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    February 4, 2026</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Scot Cohen</i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Scot
    Cohen</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer and Chairman of the Board</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p>

<!-- Field: Page; Sequence: 4; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjd0KgkAQhZ/Adxj2OkwtgrwrKYksQiS6XXKMJd2R2a3skXrLViUaBubvfHOEmIiUtqpGhss6z6DApq2lRcixQkZ9RadIdvsYXM3xpoxlqe0w/sCEHIOOWfhz6faD8qkMljEE0TSYTaOFa+JwCauD8Pp7QrpSJWqrZA1Sl3BialmhlfwePxSyI03Ne3A6IxtFOobQD8bzB6IgjOBIT/kivhvIskR4kyE8kTI9WqfadBZ1T8KmxsbZmZH+p/cFwtlKTQ== -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>2
<FILENAME>ex4-1.htm
<DESCRIPTION>EX-4.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Exhibit
4.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NEITHER
THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION
OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED
(THE &ldquo;SECURITIES ACT&rdquo;), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT
UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS
OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE
OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>COMMON
STOCK PURCHASE WARRANT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>WRAP
TECHNOLOGIES, Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 75%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant
    Shares: [&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 25%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issue
    Date: [&nbsp;&nbsp;], 2026</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Initial
    Exercise Date: [__], 2026</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIS
COMMON STOCK PURCHASE WARRANT (the &ldquo;<U>Warrant</U>&rdquo;) certifies that, for value received, [&nbsp;&nbsp;] or its assigns (the
&ldquo;<U>Holder</U>&rdquo;) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set
forth, at any time on or after the Initial Exercise Date and on or prior to 5:00 p.m. (New York City time) on _____________1 (the &ldquo;<U>Termination
Date</U>&rdquo;) but not thereafter, to subscribe for and purchase from Wrap Technologies, Inc., a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;),
up to [&nbsp;&nbsp;] shares (as subject to adjustment hereunder, the &ldquo;<U>Warrant Shares</U>&rdquo;) of the Company&rsquo;s Common
Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section
2(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
1</U>. <U>Definitions</U>. Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain
Securities Purchase Agreement (the &ldquo;<U>Purchase Agreement</U>&rdquo;), dated February 2, 2026, among the Company and the purchasers
signatory thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><SUP>1</SUP>
Insert the date that is the five year anniversary of the Issue Date, provided that, if such date is not a Trading Day, insert the immediately
following Trading Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
2</U>. <U>Exercise</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Exercise of Warrant</U>. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time
or times on or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed PDF
copy submitted by e-mail (or e-mail attachment) of the Notice of Exercise in the form annexed hereto (the &ldquo;<U>Notice of Exercise</U>&rdquo;).
Within the earlier of (i) one (1) Trading Day and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined
in Section 2(d)(i) herein) following the date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise Price for the
Warrant Shares specified in the applicable Notice of Exercise by wire transfer or cashier&rsquo;s check drawn on a United States bank
unless the cashless exercise procedure specified in Section 2(c) below is specified in the applicable Notice of Exercise. No ink-original
Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of
Exercise be required. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this
Warrant to the Company until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised
in full, in which case, the Holder shall surrender this Warrant to the Company for cancellation as soon as reasonably practicable following
the date on which the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases
of a portion of the total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant
Shares purchasable hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder and the Company shall
maintain records showing the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver any objection
to any Notice of Exercise within one (1) Trading Day of receipt of such notice. <B>The Holder and any assignee, by acceptance of this
Warrant, acknowledge and agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant
Shares hereunder, the number of Warrant Shares available for purchase hereunder at any given time may be less than the amount stated
on the face hereof.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Exercise Price</U>. The exercise price per share of Common Stock under this Warrant shall be <B>$[&nbsp;&nbsp;&nbsp;] </B>subject to adjustment hereunder
(the &ldquo;<U>Exercise Price</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Cashless Exercise</U>. If at the time of exercise hereof there is no effective registration statement registering, or the prospectus
contained therein is not available for the resale of the Warrant Shares by the Holder, then this Warrant may also be exercised, in whole
or in part, at such time by means of a &ldquo;cashless exercise&rdquo; in which the Holder shall be entitled to receive a number of Warrant
Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 93%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)</FONT></TD>
    <TD STYLE="text-align: center; width: 0.2in"><FONT STYLE="font-family: Times New Roman, Times, Serif">=</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">as applicable: (i) the VWAP
  on the Trading Day immediately preceding the date of the applicable Notice of Exercise if such Notice of Exercise is (1) both executed
  and delivered pursuant to Section 2(a) hereof on a day that is not a Trading Day or (2) both executed and delivered pursuant to Section
  2(a) hereof on a Trading Day prior to the opening of &ldquo;regular trading hours&rdquo; (as defined in Rule 600(b) of Regulation NMS
  promulgated under the federal securities laws) on such Trading Day, (ii) at the option of the Holder, either (y) the VWAP on the Trading
  Day immediately preceding the date of the applicable Notice of Exercise or (z) the Bid Price of the Common Stock on the principal Trading
  Market as reported by Bloomberg L.P. (&ldquo;<U>Bloomberg</U>&rdquo;) as of the time of the Holder&rsquo;s execution of the applicable
  Notice of Exercise if such Notice of Exercise is executed during &ldquo;regular trading hours&rdquo; on a Trading Day and is delivered
  within two (2) hours thereafter (including until two (2) hours after the close of &ldquo;regular trading hours&rdquo; on a Trading
  Day) pursuant to Section 2(a) hereof or (iii) the VWAP on the date of the applicable Notice of Exercise if the date of such Notice
  of Exercise is a Trading Day and such Notice of Exercise is both executed and delivered pursuant to Section 2(a) hereof after the close
  of &ldquo;regular trading hours&rdquo; on such Trading Day;</FONT></TD></TR>

<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">=</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the Exercise Price of this
  Warrant, as adjusted hereunder; and</FONT></TD></TR>

<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(X)</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">=</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the number of Warrant Shares
  that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such exercise were by means of
  a cash exercise rather than a cashless exercise.</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 103.5pt; text-align: justify; text-indent: -31.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 103.5pt; text-align: justify; text-indent: -31.5pt"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 103.5pt; text-align: justify; text-indent: -31.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><U>&ldquo;Bid
Price</U>&rdquo; means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock
is then listed or quoted on a Trading Market, the bid price of the Common Stock for the time in question (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m.
(New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average price
of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then
listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on The Pink Open Market (or a similar
organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported,
or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good
faith by the Holders of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company, the fees
and expenses of which shall be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">&ldquo;<U>VWAP</U>&rdquo;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">means, for any date, the price determined by the first
of the following clauses that applies: (a) if the Common Stock is then listed or quoted on a Trading Market, the daily volume weighted
average price of the Common Stock for such date (or the nearest preceding date) on the Trading Market on which the Common Stock is then
listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)),
(b) if the OTCQB Venture Market (&ldquo;<U>OTCQB</U>&rdquo;) or the OTCQX Best Market (&ldquo;<U>OTCQX</U>&rdquo;) is not a Trading Market,
the volume weighted average price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable,
(c) if the Common Stock is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported
on the Pink Open Market (&ldquo;<U>Pink Market</U>&rdquo;) operated by the OTC Markets, Inc. (or a similar organization or agency succeeding
to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported, or (d) in all other cases,
the fair market value of a share of Common Stock as determined by an independent appraiser selected in good faith by the Holders of a
majority in interest of the Securities then outstanding and reasonably acceptable to the Company, the fees and expenses of which shall
be paid by the Company<FONT STYLE="background-color: white">.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">If
Warrant Shares are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the
Securities Act, the holding period of the Warrant Shares being issued may be tacked on to the holding period of this Warrant. The Company
agrees not to take any position contrary to this Section 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Mechanics of Exercise</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.
<U>Delivery of Warrant Shares Upon Exercise</U>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by
the Transfer Agent to the Holder by crediting the account of the Holder&rsquo;s or its designee&rsquo;s balance account with The Depository
Trust Company through its Deposit or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;) if the Company is then a participant
in such system and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale
of the Warrant Shares by the Holder or (B) the Warrant Shares are eligible for resale by the Holder without volume or manner-of-sale
limitations pursuant to Rule 144 (assuming cashless exercise of the Warrants), and otherwise by physical delivery of a certificate, registered
in the Company&rsquo;s share register in the name of the Holder or its designee, for the number of Warrant Shares to which the Holder
is entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise by the date that is the earliest
of (i) one (1) Trading Day after the delivery to the Company of the Notice of Exercise, (ii) one (1) Trading Day after delivery of the
aggregate Exercise Price to the Company and (iii) the number of Trading Days comprising the Standard Settlement Period after the delivery
to the Company of the Notice of Exercise (such date, the &ldquo;<U>Warrant Share Delivery Date</U>&rdquo;). Upon delivery of the Notice
of Exercise, the Holder shall be deemed for all corporate purposes to have become the holder of record of the Warrant Shares with respect
to which this Warrant has been exercised, irrespective of the date of delivery of the Warrant Shares, provided that payment of the aggregate
Exercise Price (other than in the case of a cashless exercise) is received by the Warrant Share Delivery Date. If the Company fails for
any reason to deliver to the Holder the Warrant Shares subject to a Notice of Exercise by the Warrant Share Delivery Date, the Company
shall pay to the Holder, in cash, as liquidated damages and not as a penalty, for each $1,000 of Warrant Shares subject to such exercise
(based on the VWAP of the Common Stock on the date of the applicable Notice of Exercise), $10 per Trading Day (increasing to $20 per
Trading Day on the third (3<SUP>rd</SUP>) Trading Day after the Warrant Share Delivery Date) for each Trading Day after such Warrant
Share Delivery Date until such Warrant Shares are delivered or Holder rescinds such exercise. The Company agrees to maintain a transfer
agent that is a participant in the FAST program so long as this Warrant remains outstanding and exercisable. As used herein, &ldquo;<U>Standard
Settlement Period</U>&rdquo; means the standard settlement period, expressed in a number of Trading Days, on the Company&rsquo;s primary
Trading Market with respect to the Common Stock as in effect on the date of delivery of the Notice of Exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.
<U>Delivery of New Warrants Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request of
a Holder and upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant
evidencing the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in
all other respects be identical with this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii.
<U>Rescission Rights</U>. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section
2(d)(i) by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv.
<U>Compensation for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</U>. In addition to any other rights available to
the Holder, if the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions
of Section 2(d)(i) above pursuant to an exercise on or before the Warrant Share Delivery Date, and if after such date the Holder is required
by its broker to purchase (in an open market transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases, shares
of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon
such exercise (a &ldquo;<U>Buy-In</U>&rdquo;), then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x)
the Holder&rsquo;s total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased exceeds
(y) the amount obtained by multiplying (1) the number of Warrant Shares that the Company was required to deliver to the Holder in connection
with the exercise at issue times (2) the price at which the sell order giving rise to such purchase obligation was executed, and (B)
at the option of the Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise
was not honored (in which case such exercise shall be deemed rescinded) or deliver to the Holder the number of shares of Common Stock
that would have been issued had the Company timely complied with its exercise and delivery obligations hereunder. For example, if the
Holder purchases Common Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise of shares
of Common Stock with an aggregate sale price giving rise to such purchase obligation of $10,000, under clause (A) of the immediately
preceding sentence the Company shall be required to pay the Holder $1,000. The Holder shall provide the Company written notice indicating
the amounts payable to the Holder in respect of the Buy-In and, upon request of the Company, evidence of the amount of such loss. Nothing
herein shall limit a Holder&rsquo;s right to pursue any other remedies available to it hereunder, at law or in equity including, without
limitation, a decree of specific performance and/or injunctive relief with respect to the Company&rsquo;s failure to timely deliver shares
of Common Stock upon exercise of the Warrant as required pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">v.
<U>No Fractional Shares or Scrip</U>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise
of this Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company
shall, at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied
by the Exercise Price or round up to the next whole share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vi.
<U>Charges, Taxes and Expenses</U>. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax
or other incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company,
and such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; <U>provided</U>,
<U>however</U>, that in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when
surrendered for exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may
require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company
shall pay all Transfer Agent fees required for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company
(or another established clearing corporation performing similar functions) required for same-day electronic delivery of the Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vii.
<U>Closing of Books</U>. The Company will not close its stockholder books or records in any manner which prevents the timely exercise
of this Warrant, pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Holder&rsquo;s Exercise Limitations</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.
<U>Beneficial Ownership Limitation</U>. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the right
to exercise any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance
after exercise as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&rsquo;s Affiliates, and any other
Persons acting as a group together with the Holder or any of the Holder&rsquo;s Affiliates (such Persons, &ldquo;<U>Attribution Parties</U>&rdquo;)),
would beneficially own in excess of the Beneficial Ownership Limitation (as defined below). For purposes of the foregoing sentence, the
number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties shall include the number
of shares of Common Stock issuable upon exercise of this Warrant with respect to which such determination is being made, but shall exclude
the number of shares of Common Stock which would be issuable upon (i) exercise of the remaining, nonexercised portion of this Warrant
beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or
nonconverted portion of any other securities of the Company (including, without limitation, any other Common Stock Equivalents) subject
to a limitation on conversion or exercise analogous to the limitation contained herein beneficially owned by the Holder or any of its
Affiliates or Attribution Parties. Except as set forth in the preceding sentence, for purposes of this Section 2(e), beneficial ownership
shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder, it being
acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance with Section 13(d)
of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith. To the extent
that the limitation contained in this Section 2(e) applies, the determination of whether this Warrant is exercisable (in relation to
other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable
shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder&rsquo;s determination
of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution
Parties) and of which portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation, and the Company
shall have no obligation to verify or confirm the accuracy of such determination. In addition, a determination as to any group status
as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated
thereunder. For purposes of this Section 2(e), in determining the number of outstanding shares of Common Stock, a Holder may rely on
the number of outstanding shares of Common Stock as reflected in (A) the Company&rsquo;s most recent periodic or annual report filed
with the Commission, as the case may be, (B) a more recent public announcement by the Company or (C) a more recent written notice by
the Company or the Transfer Agent setting forth the number of shares of Common Stock outstanding. Upon the written or oral request of
a Holder, the Company shall within one (1) Trading Day confirm orally and in writing to the Holder the number of shares of Common Stock
then outstanding. In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion
or exercise of securities of the Company, including this Warrant, by the Holder or its Affiliates or Attribution Parties since the date
as of which such number of outstanding shares of Common Stock was reported. The &ldquo;<U>Beneficial Ownership Limitation</U>&rdquo;
shall be [4.99%][9.99%] of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares
of Common Stock issuable upon exercise of this Warrant. The Holder, upon notice to the Company, may increase or decrease the Beneficial
Ownership Limitation provisions of this Section 2(e), provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of
the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock upon exercise
of this Warrant held by the Holder and the provisions of this Section 2(e) shall continue to apply. Any increase in the Beneficial Ownership
Limitation will not be effective until the 61<SUP>st</SUP> day after such notice is delivered to the Company. The provisions of this
paragraph shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this Section 2(e) to correct
this paragraph (or any portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation herein
contained or to make changes or supplements necessary or desirable to properly give effect to such limitation. The limitations contained
in this paragraph shall apply to a successor holder of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 27pt"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
3</U>. <U>Certain Adjustments</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Stock Dividends and Splits</U>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise
makes a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares
of Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this
Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse
stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of the
Common Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which
the numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event
and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number of
shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant
shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record date for
the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the
effective date in the case of a subdivision, combination or re-classification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Subsequent Rights Offerings</U>. In addition to any adjustments pursuant to Section 3(a) above, if at any time the Company grants,
issues or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record
holders of any class of shares of Common Stock (the &ldquo;<U>Purchase Rights</U>&rdquo;), then the Holder will be entitled to acquire,
upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had
held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise
hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is taken for
the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of shares
of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights (<U>provided</U>, <U>however</U>, that to the
extent that the Holder&rsquo;s right to participate in any such Purchase Right would result in the Holder exceeding the Beneficial Ownership
Limitation, then the Holder shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership of such
shares of Common Stock as a result of such Purchase Right to such extent) and such Purchase Right to such extent shall be held in abeyance
for the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Pro Rata Distributions</U>. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or
other distribution of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital
or otherwise (including, without limitation, any distribution of cash, stock or other securities, property or options by way of a dividend,
spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a &ldquo;<U>Distribution</U>&rdquo;),
at any time after the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution
to the same extent that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable
upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial
Ownership Limitation) immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the
date as of which the record holders of shares of Common Stock are to be determined for the participation in such Distribution (<U>provided</U>,
<U>however</U>, that to the extent that the Holder&rsquo;s right to participate in any such Distribution would result in the Holder exceeding
the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent (or in
the beneficial ownership of any shares of Common Stock as a result of such Distribution to such extent) and the portion of such Distribution
shall be held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder
exceeding the Beneficial Ownership Limitation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Fundamental Transaction</U>. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or
more related transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company (or any Subsidiary),
directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially
all of the Company&rsquo;s assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer
or exchange offer (whether by the Company or another Person) is completed pursuant to which holders of Common Stock are permitted to
sell, tender or exchange their shares for other securities, cash or property and has been accepted by the holders of 50% or more of the
outstanding Common Stock or 50% or more of the voting power of the common equity of the Company, (iv) the Company, directly or indirectly,
in one or more related transactions effects any reclassification, reorganization or recapitalization of the Common Stock or any compulsory
share exchange pursuant to which the Common Stock is effectively converted into or exchanged for other securities, cash or property,
or (v) the Company, directly or indirectly, in one or more related transactions consummates a stock or share purchase agreement or other
business combination (including, without limitation, a reorganization, recapitalization, spin-off, merger or scheme of arrangement) with
another Person or group of Persons whereby such other Person or group acquires 50% or more of the outstanding shares of Common Stock
or 50% or more of the voting power of the common equity of the Company (each a &ldquo;<U>Fundamental Transaction</U>&rdquo;), then, upon
any subsequent exercise of this Warrant, the Holder shall have the right to receive, for each Warrant Share that would have been issuable
upon such exercise immediately prior to the occurrence of such Fundamental Transaction, at the option of the Holder (without regard to
any limitation in Section 2(e) on the exercise of this Warrant), the number of shares of Common Stock of the successor or acquiring corporation
or of the Company, if it is the surviving corporation, and any additional consideration (the &ldquo;<U>Alternate Consideration</U>&rdquo;)
receivable as a result of such Fundamental Transaction by a holder of the number of shares of Common Stock for which this Warrant is
exercisable immediately prior to such Fundamental Transaction (without regard to any limitation in Section 2(e) on the exercise of this
Warrant). For purposes of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such
Alternate Consideration based on the amount of Alternate Consideration issuable in respect of one share of Common Stock in such Fundamental
Transaction, and the Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the
relative value of any different components of the Alternate Consideration. If holders of Common Stock are given any choice as to the
securities, cash or property to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate
Consideration it receives upon any exercise of this Warrant following such Fundamental Transaction. Notwithstanding anything to the contrary,
in the event of a Fundamental Transaction, the Company or any Successor Entity (as defined below) shall, at the Holder&rsquo;s option,
exercisable at any time concurrently with, or within 30 days after, the consummation of the Fundamental Transaction (or, if later, the
date of the public announcement of the applicable Fundamental Transaction), purchase this Warrant from the Holder by paying to the Holder
an amount of cash equal to the Black Scholes Value (as defined below) of the remaining unexercised portion of this Warrant on the date
of the consummation of such Fundamental Transaction; provided, however, that, if the Fundamental Transaction is not within the Company&rsquo;s
control, including not approved by the Company&rsquo;s Board of Directors, the Holder shall only be entitled to receive from the Company
or any Successor Entity the same type or form of consideration (and in the same proportion), at the Black Scholes Value of the unexercised
portion of this Warrant, that is being offered and paid to the holders of Common Stock of the Company in connection with the Fundamental
Transaction, whether that consideration be in the form of cash, stock or any combination thereof, or whether the holders of Common Stock
are given the choice to receive from among alternative forms of consideration in connection with the Fundamental Transaction; provided,
further, that if holders of Common Stock of the Company are not offered or paid any consideration in such Fundamental Transaction, such
holders of Common Stock will be deemed to have received common stock of the Successor Entity (which Entity may be the Company following
such Fundamental Transaction) in such Fundamental Transaction. &ldquo;<U>Black Scholes Value</U>&rdquo; means the value of this Warrant
based on the Black-Scholes Option Pricing Model obtained from the &ldquo;OV&rdquo; function on Bloomberg determined as of the day of
consummation of the applicable Fundamental Transaction for pricing purposes and reflecting (A) a risk-free interest rate corresponding
to the U.S. Treasury rate for a period equal to the time between the date of the public announcement of the applicable contemplated Fundamental
Transaction and the Termination Date, (B) an expected volatility equal to the greater of (1) the 30 day volatility, (2) the 100 day volatility
or (3) the 365 day volatility, each of clauses (1)-(3) as obtained from the HVT function on Bloomberg (determined utilizing a 365 day
annualization factor) as of the Trading Day immediately following the public announcement of the applicable contemplated Fundamental
Transaction, (C) the underlying price per share used in such calculation shall be the sum of the price per share being offered in cash
in the applicable Fundamental Transaction (if any) plus the value of the non-cash consideration being offered in the applicable Fundamental
Transaction (if any), and (D) a remaining option time equal to the time between the date of the public announcement of the applicable
contemplated Fundamental Transaction and the Termination Date and (E) a zero cost of borrower. The payment of the Black Scholes Value
will be made by wire transfer of immediately available funds (or such other consideration) within the later of (i) five Business Days
of the Holder&rsquo;s election and (ii) the date of consummation of the Fundamental Transaction. The Company shall cause any successor
entity in a Fundamental Transaction in which the Company is not the survivor (the &ldquo;<U>Successor Entity</U>&rdquo;) to assume in
writing all of the obligations of the Company under this Warrant and the other Transaction Documents in accordance with the provisions
of this Section 3(d) pursuant to written agreements in form and substance reasonably satisfactory to the Holder and approved by the Holder
(without unreasonable delay) prior to such Fundamental Transaction and shall, at the option of the Holder, deliver to the Holder in exchange
for this Warrant a security of the Successor Entity evidenced by a written instrument substantially similar in form and substance to
this Warrant which is exercisable for a corresponding number of shares of capital stock of such Successor Entity (or its parent entity)
equivalent to the shares of Common Stock acquirable and receivable upon exercise of this Warrant (without regard to any limitations on
the exercise of this Warrant) prior to such Fundamental Transaction, and with an exercise price which applies the exercise price hereunder
to such shares of capital stock (but taking into account the relative value of the shares of Common Stock pursuant to such Fundamental
Transaction and the value of such shares of capital stock, such number of shares of capital stock and such exercise price being for the
purpose of protecting the economic value of this Warrant immediately prior to the consummation of such Fundamental Transaction), and
which is reasonably satisfactory in form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor
Entity shall be added to the term &ldquo;Company&rdquo; under this Warrant (so that from and after the occurrence or consummation of
such Fundamental Transaction, each and every provision of this Warrant and the other Transaction Documents referring to the &ldquo;Company&rdquo;
shall refer instead to each of the Company and the Successor Entity or Successor Entities, jointly and severally), and the Successor
Entity or Successor Entities, jointly and severally with the Company, may exercise every right and power of the Company prior thereto
and the Successor Entity or Successor Entities shall assume all of the obligations of the Company prior thereto under this Warrant and
the other Transaction Documents with the same effect as if the Company and such Successor Entity or Successor Entities, jointly and severally,
had been named as the Company herein. For the avoidance of doubt, the Holder shall be entitled to the benefits of the provisions of this
Section 3(d) regardless of (i) whether the Company has sufficient authorized shares of Common Stock for the issuance of Warrant Shares
and/or (ii) whether a Fundamental Transaction occurs prior to the Initial Exercise Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Subsequent Equity Sales</U>. If the Company or any Subsidiary thereof, as applicable, at any time while this Warrant is outstanding,
shall sell, enter into an agreement to sell or grant any option to purchase, or sell or grant any right to reprice, or otherwise dispose
of or issue (or announce any offer, sale, grant or any option to purchase or other disposition) any Common Stock or Common Stock Equivalents,
at an effective price per share less than the Exercise Price then in effect (such lower price, the &ldquo;Base Share Price&rdquo; and
such issuances collectively, a &ldquo;<U>Dilutive Issuance</U>&rdquo;) (it being understood and agreed that if the holder of the Common
Stock or Common Stock Equivalents so issued shall at any time, whether by operation of purchase price adjustments, reset provisions,
floating conversion, exercise or exchange prices or otherwise, or due to warrants, options or rights per share which are issued in connection
with such issuance, be entitled to receive shares of Common Stock at an effective price per share that is less than the Exercise Price,
such issuance shall be deemed to have occurred for less than the Exercise Price on such date of the Dilutive Issuance at such effective
price), then simultaneously with the consummation (or, if earlier, the announcement) of each Dilutive Issuance the Exercise Price shall
be reduced and only reduced to equal the Base Share Price. Notwithstanding the foregoing, no adjustments shall be made, paid or issued
under this Section 3(e) in respect of an Exempt Issuance. The Company shall notify the Holder, in writing, no later than the Trading
Day following the issuance or deemed issuance of any Common Stock or Common Stock Equivalents subject to this Section 3(e), indicating
therein the applicable issuance price, or applicable reset price, exchange price, conversion price and other pricing terms. Notwithstanding
anything to the contrary contained herein and for purposes of clarification, upon the occurrence of any Dilutive Issuance, the number
of Warrant Shares to be received by the Holder shall not proportionally increase based upon the adjustment of the Exercise Price to the
Base Share Price. For purposes hereof, &ldquo;<U>Exempt Issuance</U>&rdquo; means the issuance of (a) shares of Common Stock, restricted
stock units or options to employees, officers or directors of the Company pursuant to any equity incentive, stock or option plan duly
adopted for such purpose, by a majority of the non-employee members of the Board of Directors or a majority of the members of a committee
of non-employee directors established for such purpose for services rendered to the Company, (b) securities issuable upon the exercise
or exchange of or conversion of any Securities issued pursuant to the Securities Purchase Agreement and/or other securities exercisable
or exchangeable for or convertible into shares of Common Stock issued and outstanding on the Issue Date, provided that such securities
have not been amended since the Issue Date to increase the number of such securities or to decrease the exercise price, exchange price
or conversion price of such securities (other than in connection with stock splits or combinations) or to extend the term of such securities,
and (c) securities issued pursuant to acquisitions or strategic transactions approved by a majority of the disinterested directors of
the Company, provided that such securities are issued as &ldquo;restricted securities&rdquo; (as defined in Rule 144) and carry no registration
rights that require or permit the filing of any registration statement in connection therewith, and provided that any such issuance shall
only be to a Person (or to the equityholders of a Person) which is, itself or through its subsidiaries, an operating company or an owner
of an asset in a business synergistic with the business of the Company and shall provide to the Company additional benefits in addition
to the investment of funds, but shall not include a transaction in which the Company is issuing securities primarily for the purpose
of raising capital or to an entity whose primary business is investing in securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)
<U>Calculations</U>. All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the
case may be. For purposes of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date
shall be the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g)
<U>Notice to Holder</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.
<U>Adjustment to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company
shall promptly deliver to the Holder by email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment
to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.
<U>Notice to Allow Exercise by Holder</U>. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on
the Common Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the
Company shall authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of
capital stock of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with
any reclassification of the Common Stock, any consolidation or merger to which the Company (or any of its Subsidiaries) is a party, any
sale or transfer of all or substantially all of its assets, or any compulsory share exchange whereby the Common Stock is converted into
other securities, cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding
up of the affairs of the Company, then, in each case, the Company shall cause to be delivered by email to the Holder at its last email
address as it shall appear upon the Warrant Register of the Company, at least 20 calendar days prior to the applicable record or effective
date hereinafter specified, a notice stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution,
redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common Stock of record to
be entitled to such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on which such reclassification,
consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected
that holders of the Common Stock of record shall be entitled to exchange their shares of the Common Stock for securities, cash or other
property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange; provided that the failure to
deliver such notice or any defect therein or in the delivery thereof shall not affect the validity of the corporate action required to
be specified in such notice. To the extent that any notice provided in this Warrant constitutes, or contains, material, non-public information
regarding the Company or any of the Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a
Current Report on Form 8-K. The Holder shall remain entitled to exercise this Warrant during the period commencing on the date of such
notice to the effective date of the event triggering such notice except as may otherwise be expressly set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
4</U>. <U>Transfer of Warrant</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Transferability</U>. Subject to compliance with any applicable securities laws and the conditions set forth in Section 4(d) hereof
and to the provisions of Section 4.1 of the Securities Purchase Agreement, this Warrant and all rights hereunder (including, without
limitation, any registration rights) are transferable, in whole or in part, upon surrender of this Warrant at the principal office of
the Company or its designated agent, together with a written assignment of this Warrant substantially in the form attached hereto duly
executed by the Holder or its agent or attorney and funds sufficient to pay any transfer taxes payable upon the making of such transfer.
Upon such surrender and, if required, such payment, the Company shall execute and deliver a new Warrant or Warrants in the name of the
assignee or assignees, as applicable, and in the denomination or denominations specified in such instrument of assignment, and shall
issue to the assignor a new Warrant evidencing the portion of this Warrant not so assigned, and this Warrant shall promptly be cancelled.
Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company
unless the Holder has assigned this Warrant in full, in which case, the Holder shall surrender this Warrant to the Company within three
(3) Trading Days of the date on which the Holder delivers an assignment form to the Company assigning this Warrant in full. The Warrant,
if properly assigned in accordance herewith, may be exercised by a new holder for the purchase of Warrant Shares without having a new
Warrant issued.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>New Warrants</U>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of
the Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by
the Holder or its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division
or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided
or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the Issue Date of this Warrant
and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Warrant Register</U>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the
&ldquo;<U>Warrant Register</U>&rdquo;), in the name of the record Holder hereof from time to time. The Company may deem and treat the
registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder,
and for all other purposes, absent actual notice to the contrary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Transfer Restrictions</U>. If, at the time of the surrender of this Warrant in connection with any transfer of this Warrant, the transfer
of this Warrant shall not be either (i) registered pursuant to an effective registration statement under the Securities Act and under
applicable state securities or blue sky laws or (ii) eligible for resale without volume or manner-of-sale restrictions or current public
information requirements pursuant to Rule 144, the Company may require, as a condition of allowing such transfer, that the Holder or
transferee of this Warrant, as the case may be, comply with the provisions of Section 5.7 of the Securities Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Representation by the Holder</U>. The Holder, by the acceptance hereof, represents and warrants that it is acquiring this Warrant
and, upon any exercise hereof, will acquire the Warrant Shares issuable upon such exercise, for its own account and not with a view to
or for distributing or reselling such Warrant Shares or any part thereof in violation of the Securities Act or any applicable state securities
law, except pursuant to sales registered or exempted under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
5</U>. <U>Miscellaneous</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>No Rights as Stockholder Until Exercise; No Settlement in Cash</U>. This Warrant does not entitle the Holder to any voting rights,
dividends or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly
set forth in Section 3. Without limiting any rights of a Holder to receive Warrant Shares on a &ldquo;cashless exercise&rdquo; pursuant
to Section 2(c) or to receive cash payments pursuant to Section 2(d)(i) and Section 2(d)(iv) herein, in no event shall the Company be
required to net cash settle an exercise of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Loss, Theft, Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably
satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares,
and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant,
shall not include the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the
Company will make and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant
or stock certificate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Saturdays, Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required
or granted herein shall not be a Trading Day, then, such action may be taken or such right may be exercised on the next succeeding Trading
Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Authorized Shares</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company covenants that during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock a
sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant.
The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with
the duty of issuing the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all
such reasonable action as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any
applicable law or regulation, or of any requirements of the Trading Market upon which the Common Stock may be listed. The Company covenants
that all Warrant Shares which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise
of the purchase rights represented by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly
issued, fully paid and nonassessable and free from all taxes, liens and charges created by the Company in respect of the issue thereof
(other than taxes in respect of any transfer occurring contemporaneously with such issue).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending
its certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale
of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant,
but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary
or appropriate to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the
foregoing, the Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise
immediately prior to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company
may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially
reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof,
as may be, necessary to enable the Company to perform its obligations under this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Before
taking any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the
Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from
any public regulatory body or bodies having jurisdiction thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Jurisdiction</U>. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be determined
in accordance with the provisions of the Securities Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)
<U>Restrictions</U>. The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and
the Holder does not utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g)
<U>Nonwaiver and Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall
operate as a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies, notwithstanding the fact that
the right to exercise this Warrant terminates on the Termination Date. Without limiting any other provision of this Warrant, if the Company
willfully and knowingly fails to comply with any provision of this Warrant, which results in any material damages to the Holder, the
Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and expenses including, but not limited to, reasonable
attorneys&rsquo; fees, including those of appellate proceedings, incurred by the Holder in collecting any amounts due pursuant hereto
or in otherwise enforcing any of its rights, powers or remedies hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">h)
<U>Notices</U>. Any notice, request or other document required or permitted to be given or delivered to the Holder by the Company shall
be delivered in accordance with the notice provisions of the Securities Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i)
<U>Limitation of Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant
to purchase Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of
the Holder for the purchase price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company
or by creditors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">j)
<U>Remedies</U>. The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will
be entitled to specific performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate
compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to
assert the defense in any action for specific performance that a remedy at law would be adequate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">k)
<U>Successors and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall
inure to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns
of Holder. The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall
be enforceable by the Holder or holder of Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">l)
<U>Amendment</U>. This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company, on
the one hand, and the Holder of this Warrant, on the other hand.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">m)
<U>Severability</U>. Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid
under applicable law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall
be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining
provisions of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">n)
<U>Headings</U>. The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed
a part of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">********************</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(Signature
Page Follows)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><BR STYLE="clear: both"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above
indicated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>WRAP TECHNOLOGIES,
    Inc.</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTICE
OF EXERCISE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify; padding-left: 10pt; text-indent: -10pt; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">To:</FONT></TD>
  <TD STYLE="text-align: justify; padding-left: 10pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>WRAP
  TECHNOLOGIES, Inc.</B></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
The undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only
if exercised in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
Payment shall take the form of (check applicable box):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;
<FONT STYLE="font-size: 10pt">in lawful money of the United States; or</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;
if permitted the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection
2(c), to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure
set forth in subsection 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)
Please issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-indent: 1in; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Warrant Shares shall be delivered to the following DWAC Account Number:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)
<U>Accredited Investor</U>. The undersigned is an &ldquo;accredited investor&rdquo; as defined in Regulation D promulgated under the
Securities Act of 1933, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">[SIGNATURE
OF HOLDER]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Investing Entity: ___________________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Signature
of Authorized Signatory of Investing Entity</I>: _________________________________________________</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">____</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Authorized Signatory: ___________________________________________________________________</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">____</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
of Authorized Signatory: ____________________________________________________________________</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">____</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
________________________________________________________________________________________</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">___</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXHIBIT
B</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">ASSIGNMENT
FORM</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.15in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(To
assign the foregoing Warrant, execute this form and supply required information. Do not use this form to exercise the Warrant to purchase
shares.)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 10.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.15in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOR
VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.15in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 42%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 48%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 8%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please
    Print)</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please
    Print)</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Phone
    Number:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email
    Address:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:
    _______________ __, ______</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s
    Signature: ________________________</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s
    Address:</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif">_________________________</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 17; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.2
<SEQUENCE>3
<FILENAME>ex4-2.htm
<DESCRIPTION>EX-4.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
4.2</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NEITHER
THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION
OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED
(THE &ldquo;SECURITIES ACT&rdquo;), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT
UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS
OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE
OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PRE-FUNDED
COMMON STOCK PURCHASE WARRANT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>WRAP
TECHNOLOGIES, Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 75%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant
    Shares: _______</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 25%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issue
    Date: ______, 2026</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Initial
    Exercise Date: _______, 2026</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIS
PRE-FUNDED COMMON STOCK PURCHASE WARRANT (the &ldquo;<U>Warrant</U>&rdquo;) certifies that, for value received, _____________ or its
assigns (the &ldquo;<U>Holder</U>&rdquo;) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter
set forth, at any time on or after the date set forth above (the &ldquo;<U>Initial Exercise Date</U>&rdquo;) and until this Warrant is
exercised in full (the &ldquo;<U>Termination Date</U>&rdquo;) but not thereafter, to subscribe for and purchase from Wrap Technologies,
Inc., a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;), up to ______ shares (as subject to adjustment hereunder, the &ldquo;<U>Warrant
Shares</U>&rdquo;) of the Company&rsquo;s Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal
to the Exercise Price, as defined in Section 2(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
1</U>. <U>Definitions</U>. Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain
Securities Purchase Agreement (the &ldquo;<U>Purchase Agreement</U>&rdquo;), dated February 2, 2026, among the Company and the purchasers
signatory thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
2</U>. <U>Exercise</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a) <U>Exercise
of Warrant</U>. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time or times on
or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed PDF copy submitted
by e-mail (or e-mail attachment) of the Notice of Exercise in the form annexed hereto (the &ldquo;<U>Notice of Exercise</U>&rdquo;).
Within the earlier of (i) two (2) Trading Days and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined
in Section 2(d)(i) herein) following the date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise Price for the
Warrant Shares specified in the applicable Notice of Exercise by wire transfer or cashier&rsquo;s check drawn on a United States bank
unless the cashless exercise procedure specified in Section 2(c) below is specified in the applicable Notice of Exercise. No ink-original
Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of
Exercise be required. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this
Warrant to the Company until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised
in full, in which case, the Holder shall surrender this Warrant to the Company for cancellation as soon as reasonably practicable following
the date on which the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases
of a portion of the total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant
Shares purchasable hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder and the Company shall
maintain records showing the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver any objection
to any Notice of Exercise within one (1) Trading Day of receipt of such notice. <B>The Holder and any assignee, by acceptance of this
Warrant, acknowledge and agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant
Shares hereunder, the number of Warrant Shares available for purchase hereunder at any given time may be less than the amount stated
on the face hereof.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b) <U>Exercise
Price</U>. The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.0001 per Warrant Share, was pre-funded
to the Company on or prior to the Initial Exercise Date and, consequently, no additional consideration (other than the nominal exercise
price of $0.0001 per Warrant Share) shall be required to be paid by the Holder to any Person to effect any exercise of this Warrant.
The Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price under any
circumstance or for any reason whatsoever, including in the event this Warrant shall not have been exercised prior to the Termination
Date. The remaining unpaid exercise price per share of Common Stock under this Warrant shall be $0.0001, subject to adjustment hereunder
(the &ldquo;<U>Exercise Price</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c) <U>Cashless
Exercise</U>. This Warrant may also be exercised, in whole or in part, at such time by means of a &ldquo;cashless exercise&rdquo; in
which the Holder shall be entitled to receive a number of Warrant Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A),
where:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 1in">&nbsp;</TD>
  <TD STYLE="text-align: justify; padding-left: 10pt; text-indent: -10pt; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)</FONT></TD>
    <TD STYLE="width: 0.15in">=</TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> as applicable: (i) the VWAP on the Trading Day immediately
preceding the date of the applicable Notice of Exercise if such Notice of Exercise is (1) both executed and delivered pursuant to Section
2(a) hereof on a day that is not a Trading Day or (2) both executed and delivered pursuant to Section 2(a) hereof on a Trading Day prior
to the opening of &ldquo;regular trading hours&rdquo; (as defined in Rule 600(b) of Regulation NMS promulgated under the federal securities
laws) on such Trading Day, (ii) at the option of the Holder, either (y) the VWAP on the Trading Day immediately preceding the date of
the applicable Notice of Exercise or (z) the Bid Price of the Common Stock on the principal Trading Market as reported by Bloomberg L.P.
(&ldquo;<U>Bloomberg</U>&rdquo;) as of the time of the Holder&rsquo;s execution of the applicable Notice of Exercise if such Notice of
Exercise is executed during &ldquo;regular trading hours&rdquo; on a Trading Day and is delivered within two (2) hours thereafter (including
until two (2) hours after the close of &ldquo;regular trading hours&rdquo; on a Trading Day) pursuant to Section 2(a) hereof or (iii)
the VWAP on the date of the applicable Notice of Exercise if the date of such Notice of Exercise is a Trading Day and such Notice of
Exercise is both executed and delivered pursuant to Section 2(a) hereof after the close of &ldquo;regular trading hours&rdquo; on such
Trading Day;</FONT></TD></TR>

<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
  <TD STYLE="text-align: justify; padding-left: 10pt; text-indent: -10pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
  <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
  <TD STYLE="text-align: justify; padding-left: 10pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)</FONT></TD>
    <TD>=</TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> the Exercise Price of this Warrant, as adjusted hereunder;
and</FONT></TD></TR>

<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
  <TD STYLE="text-align: justify; padding-left: 10pt; text-indent: -10pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
  <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
  <TD STYLE="text-align: justify; padding-left: 10pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(X)</FONT></TD>
    <TD>=</TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> the number of Warrant Shares that would be issuable upon
exercise of this Warrant in accordance with the terms of this Warrant if such exercise were by means of a cash exercise rather than a
cashless exercise.</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 103.5pt; text-align: justify; text-indent: -31.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>&ldquo;Bid
Price</U>&rdquo; means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock
is then listed or quoted on a Trading Market, the bid price of the Common Stock for the time in question (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m.
(New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average price
of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then
listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on The Pink Open Market (or a similar
organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported,
or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good
faith by the Holders of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company, the fees
and expenses of which shall be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed
or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m.
(New York City time) to 4:02 p.m. (New York City time)), (b) if the OTCQB Venture Market (&ldquo;<U>OTCQB</U>&rdquo;) or the OTCQX Best
Market (&ldquo;<U>OTCQX</U>&rdquo;) is not a Trading Market, the volume weighted average price of the Common Stock for such date (or
the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then listed or quoted for trading on OTCQB
or OTCQX and if prices for the Common Stock are then reported on the Pink Open Market (&ldquo;<U>Pink Market</U>&rdquo;) operated by
the OTC Markets, Inc. (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price
per share of the Common Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined
by an independent appraiser selected in good faith by the Holders of a majority in interest of the Securities then outstanding and reasonably
acceptable to the Company, the fees and expenses of which shall be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
Warrant Shares are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the
Securities Act, the holding period of the Warrant Shares being issued may be tacked on to the holding period of this Warrant. The Company
agrees not to take any position contrary to this Section 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d) <U>Mechanics
of Exercise</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i. <U>Delivery
of Warrant Shares Upon Exercise</U>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by the Transfer
Agent to the Holder by crediting the account of the Holder&rsquo;s or its designee&rsquo;s balance account with The Depository Trust
Company through its Deposit or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;) if the Company is then a participant in such
system and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale of the
Warrant Shares by the Holder or (B) the Warrant Shares are eligible for resale by the Holder without volume or manner-of-sale limitations
pursuant to Rule 144 (assuming cashless exercise of the Warrants), and otherwise by physical delivery of a certificate, registered in
the Company&rsquo;s share register in the name of the Holder or its designee, for the number of Warrant Shares to which the Holder is
entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise by the date that is the earliest
of (i) one (1) Trading Day after the delivery to the Company of the Notice of Exercise, (ii) one (1) Trading Day after delivery of the
aggregate Exercise Price to the Company and (iii) the number of Trading Days comprising the Standard Settlement Period after the delivery
to the Company of the Notice of Exercise (such date, the &ldquo;<U>Warrant Share Delivery Date</U>&rdquo;). Upon delivery of the Notice
of Exercise, the Holder shall be deemed for all corporate purposes to have become the holder of record of the Warrant Shares with respect
to which this Warrant has been exercised, irrespective of the date of delivery of the Warrant Shares, provided that payment of the aggregate
Exercise Price (other than in the case of a cashless exercise) is received by the Warrant Share Delivery Date. If the Company fails for
any reason to deliver to the Holder the Warrant Shares subject to a Notice of Exercise by the Warrant Share Delivery Date, the Company
shall pay to the Holder, in cash, as liquidated damages and not as a penalty, for each $1,000 of Warrant Shares subject to such exercise
(based on the VWAP of the Common Stock on the date of the applicable Notice of Exercise), $10 per Trading Day (increasing to $20 per
Trading Day on the third (3<SUP>rd</SUP>) Trading Day after the Warrant Share Delivery Date) for each Trading Day after such Warrant
Share Delivery Date until such Warrant Shares are delivered or Holder rescinds such exercise. The Company agrees to maintain a transfer
agent that is a participant in the FAST program so long as this Warrant remains outstanding and exercisable. As used herein, &ldquo;<U>Standard
Settlement Period</U>&rdquo; means the standard settlement period, expressed in a number of Trading Days, on the Company&rsquo;s primary
Trading Market with respect to the Common Stock as in effect on the date of delivery of the Notice of Exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii. <U>Delivery
of New Warrants Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request of a Holder and
upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing
the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in all other
respects be identical with this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii. <U>Rescission
Rights</U>. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section 2(d)(i)
by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv. <U>Compensation
for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</U>. In addition to any other rights available to the Holder, if
the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions of Section
2(d)(i) above pursuant to an exercise on or before the Warrant Share Delivery Date, and if after such date the Holder is required by
its broker to purchase (in an open market transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases, shares
of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon
such exercise (a &ldquo;<U>Buy-In</U>&rdquo;), then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x)
the Holder&rsquo;s total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased exceeds
(y) the amount obtained by multiplying (1) the number of Warrant Shares that the Company was required to deliver to the Holder in connection
with the exercise at issue times (2) the price at which the sell order giving rise to such purchase obligation was executed, and (B)
at the option of the Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise
was not honored (in which case such exercise shall be deemed rescinded) or deliver to the Holder the number of shares of Common Stock
that would have been issued had the Company timely complied with its exercise and delivery obligations hereunder. For example, if the
Holder purchases Common Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise of shares
of Common Stock with an aggregate sale price giving rise to such purchase obligation of $10,000, under clause (A) of the immediately
preceding sentence the Company shall be required to pay the Holder $1,000. The Holder shall provide the Company written notice indicating
the amounts payable to the Holder in respect of the Buy-In and, upon request of the Company, evidence of the amount of such loss. Nothing
herein shall limit a Holder&rsquo;s right to pursue any other remedies available to it hereunder, at law or in equity including, without
limitation, a decree of specific performance and/or injunctive relief with respect to the Company&rsquo;s failure to timely deliver shares
of Common Stock upon exercise of the Warrant as required pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">v. <U>No
Fractional Shares or Scrip</U>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this
Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company shall,
at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the
Exercise Price or round up to the next whole share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vi. <U>Charges,
Taxes and Expenses</U>. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or other
incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company, and
such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; <U>provided</U>,
<U>however</U>, that in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when
surrendered for exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may
require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company
shall pay all Transfer Agent fees required for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company
(or another established clearing corporation performing similar functions) required for same-day electronic delivery of the Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vii. <U>Closing
of Books</U>. The Company will not close its stockholder books or records in any manner which prevents the timely exercise of this Warrant,
pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e) <U>Holder&rsquo;s
Exercise Limitations</U>. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the right to exercise
any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance after exercise
as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&rsquo;s Affiliates, and any other Persons acting
as a group together with the Holder or any of the Holder&rsquo;s Affiliates (such Persons, &ldquo;<U>Attribution Parties</U>&rdquo;)),
would beneficially own in excess of the Beneficial Ownership Limitation (as defined below). For purposes of the foregoing sentence, the
number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties shall include the number
of shares of Common Stock issuable upon exercise of this Warrant with respect to which such determination is being made, but shall exclude
the number of shares of Common Stock which would be issuable upon (i) exercise of the remaining, nonexercised portion of this Warrant
beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or
nonconverted portion of any other securities of the Company (including, without limitation, any other Common Stock Equivalents) subject
to a limitation on conversion or exercise analogous to the limitation contained herein beneficially owned by the Holder or any of its
Affiliates or Attribution Parties. Except as set forth in the preceding sentence, for purposes of this Section 2(e), beneficial ownership
shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder, it being
acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance with Section 13(d)
of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith. To the extent
that the limitation contained in this Section 2(e) applies, the determination of whether this Warrant is exercisable (in relation to
other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable
shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder&rsquo;s determination
of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution
Parties) and of which portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation, and the Company
shall have no obligation to verify or confirm the accuracy of such determination. In addition, a determination as to any group status
as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated
thereunder. For purposes of this Section 2(e), in determining the number of outstanding shares of Common Stock, a Holder may rely on
the number of outstanding shares of Common Stock as reflected in (A) the Company&rsquo;s most recent periodic or annual report filed
with the Commission, as the case may be, (B) a more recent public announcement by the Company or (C) a more recent written notice by
the Company or the Transfer Agent setting forth the number of shares of Common Stock outstanding. Upon the written or oral request of
a Holder, the Company shall within one (1) Trading Day confirm orally and in writing to the Holder the number of shares of Common Stock
then outstanding. In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion
or exercise of securities of the Company, including this Warrant, by the Holder or its Affiliates or Attribution Parties since the date
as of which such number of outstanding shares of Common Stock was reported. The &ldquo;<U>Beneficial Ownership Limitation</U>&rdquo;
shall be [4.99%/9.99%] of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares
of Common Stock issuable upon exercise of this Warrant. The Holder, upon notice to the Company, may increase or decrease the Beneficial
Ownership Limitation provisions of this Section 2(e), provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of
the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock upon exercise
of this Warrant held by the Holder and the provisions of this Section 2(e) shall continue to apply. Any increase in the Beneficial Ownership
Limitation will not be effective until the 61<SUP>st</SUP> day after such notice is delivered to the Company. The provisions of this
paragraph shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this Section 2(e) to correct
this paragraph (or any portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation herein
contained or to make changes or supplements necessary or desirable to properly give effect to such limitation. The limitations contained
in this paragraph shall apply to a successor holder of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
3</U>. <U>Certain Adjustments</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a) <U>Stock
Dividends and Splits</U>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise makes
a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares of
Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this
Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse
stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of the
Common Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which
the numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event
and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number of
shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant
shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record date for
the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the
effective date in the case of a subdivision, combination or re-classification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b) <U>Subsequent
Rights Offerings</U>. In addition to any adjustments pursuant to Section 3(a) above, if at any time the Company grants, issues or sells
any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record holders of any
class of shares of Common Stock (the &ldquo;<U>Purchase Rights</U>&rdquo;), then the Holder will be entitled to acquire, upon the terms
applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number
of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including
without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is taken for the grant, issuance
or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are
to be determined for the grant, issue or sale of such Purchase Rights (<U>provided</U>, <U>however</U>, that to the extent that the Holder&rsquo;s
right to participate in any such Purchase Right would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder
shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership of such shares of Common Stock as
a result of such Purchase Right to such extent) and such Purchase Right to such extent shall be held in abeyance for the Holder until
such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c) <U>Pro
Rata Distributions</U>. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or other distribution
of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital or otherwise (including,
without limitation, any distribution of cash, stock or other securities, property or options by way of a dividend, spin off, reclassification,
corporate rearrangement, scheme of arrangement or other similar transaction) (a &ldquo;<U>Distribution</U>&rdquo;), at any time after
the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution to the same extent
that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable upon complete
exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership
Limitation) immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the date as
of which the record holders of shares of Common Stock are to be determined for the participation in such Distribution (<U>provided</U>,
<U>however</U>, that to the extent that the Holder&rsquo;s right to participate in any such Distribution would result in the Holder exceeding
the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent (or in
the beneficial ownership of any shares of Common Stock as a result of such Distribution to such extent) and the portion of such Distribution
shall be held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder
exceeding the Beneficial Ownership Limitation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d) <U>Fundamental
Transaction</U>. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or more related transactions
effects any merger or consolidation of the Company with or into another Person, (ii) the Company (or any Subsidiary), directly or indirectly,
effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of the assets of
the Company in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange offer
(whether by the Company or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender or exchange
their shares for other securities, cash or property and has been accepted by the holders of 50% or more of the outstanding Common Stock
or 50% or more of the voting power of the common equity of the Company, (iv) the Company, directly or indirectly, in one or more related
transactions effects any reclassification, reorganization or recapitalization of the Common Stock or any compulsory share exchange pursuant
to which the Common Stock is effectively converted into or exchanged for other securities, cash or property, or (v) the Company, directly
or indirectly, in one or more related transactions consummates a stock or share purchase agreement or other business combination (including,
without limitation, a reorganization, recapitalization, spin-off, merger or scheme of arrangement) with another Person or group of Persons
whereby such other Person or group acquires 50% or more of the outstanding shares of Common Stock or 50% or more of the voting power
of the common equity of the Company (each a &ldquo;<U>Fundamental Transaction</U>&rdquo;), then, upon any subsequent exercise of this
Warrant, the Holder shall have the right to receive, for each Warrant Share that would have been issuable upon such exercise immediately
prior to the occurrence of such Fundamental Transaction, at the option of the Holder (without regard to any limitation in Section 2(e)
on the exercise of this Warrant), the number of shares of Common Stock of the successor or acquiring corporation or of the Company, if
it is the surviving corporation, and any additional consideration (the &ldquo;<U>Alternate Consideration</U>&rdquo;) receivable as a
result of such Fundamental Transaction by a holder of the number of shares of Common Stock for which this Warrant is exercisable immediately
prior to such Fundamental Transaction (without regard to any limitation in Section 2(e) on the exercise of this Warrant). For purposes
of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such Alternate Consideration
based on the amount of Alternate Consideration issuable in respect of one share of Common Stock in such Fundamental Transaction, and
the Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the relative value
of any different components of the Alternate Consideration. If holders of Common Stock are given any choice as to the securities, cash
or property to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration
it receives upon any exercise of this Warrant following such Fundamental Transaction. The Company shall cause any successor entity in
a Fundamental Transaction in which the Company is not the survivor (the &ldquo;Successor Entity&rdquo;) to assume in writing all of the
obligations of the Company under this Warrant and the other Transaction Documents in accordance with the provisions of this Section 3(d)
pursuant to written agreements in form and substance reasonably satisfactory to the Holder and approved by the Holder (without unreasonable
delay) prior to such Fundamental Transaction and shall, at the option of the Holder, deliver to the Holder in exchange for this Warrant
a security of the Successor Entity evidenced by a written instrument substantially similar in form and substance to this Warrant which
is exercisable for a corresponding number of shares of capital stock of such Successor Entity (or its parent entity) equivalent to the
shares of Common Stock acquirable and receivable upon exercise of this Warrant (without regard to any limitations on the exercise of
this Warrant) prior to such Fundamental Transaction, and with an exercise price which applies the exercise price hereunder to such shares
of capital stock (but taking into account the relative value of the shares of Common Stock pursuant to such Fundamental Transaction and
the value of such shares of capital stock, such number of shares of capital stock and such exercise price being for the purpose of protecting
the economic value of this Warrant immediately prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory
in form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall be added to
the term &ldquo;Company&rdquo; under this Warrant (so that from and after the occurrence or consummation of such Fundamental Transaction,
each and every provision of this Warrant and the other Transaction Documents referring to the &ldquo;Company&rdquo; shall refer instead
to each of the Company and the Successor Entity or Successor Entities, jointly and severally), and the Successor Entity or Successor
Entities, jointly and severally with the Company, may exercise every right and power of the Company prior thereto and the Successor Entity
or Successor Entities shall assume all of the obligations of the Company prior thereto under this Warrant and the other Transaction Documents
with the same effect as if the Company and such Successor Entity or Successor Entities, jointly and severally, had been named as the
Company herein. For the avoidance of doubt, the Holder shall be entitled to the benefits of the provisions of this Section 3(d) regardless
of (i) whether the Company has sufficient authorized shares of Common Stock for the issuance of Warrant Shares and/or (ii) whether a
Fundamental Transaction occurs prior to the Initial Exercise Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e) <U>Calculations</U>.
All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be. For purposes
of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be the sum of the
number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f) <U>Notice
to Holder</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i. <U>Adjustment
to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly
deliver to the Holder by email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the number
of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii. <U>Notice
to Allow Exercise by Holder</U>. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on the Common
Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the Company shall
authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of capital stock
of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with any reclassification
of the Common Stock, any consolidation or merger to which the Company (or any of its Subsidiaries) is a party, any sale or transfer of
all or substantially all of its assets, or any compulsory share exchange whereby the Common Stock is converted into other securities,
cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs
of the Company, then, in each case, the Company shall cause to be delivered by email to the Holder at its last email address as it shall
appear upon the Warrant Register of the Company, at least 20 calendar days prior to the applicable record or effective date hereinafter
specified, a notice stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution, redemption,
rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common Stock of record to be entitled
to such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on which such reclassification,
consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected
that holders of the Common Stock of record shall be entitled to exchange their shares of the Common Stock for securities, cash or other
property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange; provided that the failure to
deliver such notice or any defect therein or in the delivery thereof shall not affect the validity of the corporate action required to
be specified in such notice. To the extent that any notice provided in this Warrant constitutes, or contains, material, non-public information
regarding the Company or any of the Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a
Current Report on Form 8-K. The Holder shall remain entitled to exercise this Warrant during the period commencing on the date of such
notice to the effective date of the event triggering such notice except as may otherwise be expressly set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
4</U>. <U>Transfer of Warrant</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a) <U>Transferability</U>.
Subject to compliance with any applicable securities laws and the conditions set forth in Section 4(d) hereof and to the provisions of
Section 4.1 of the Purchase Agreement, this Warrant and all rights hereunder (including, without limitation, any registration rights)
are transferable, in whole or in part, upon surrender of this Warrant at the principal office of the Company or its designated agent,
together with a written assignment of this Warrant substantially in the form attached hereto duly executed by the Holder or its agent
or attorney and funds sufficient to pay any transfer taxes payable upon the making of such transfer. Upon such surrender and, if required,
such payment, the Company shall execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable,
and in the denomination or denominations specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing
the portion of this Warrant not so assigned, and this Warrant shall promptly be cancelled. Notwithstanding anything herein to the contrary,
the Holder shall not be required to physically surrender this Warrant to the Company unless the Holder has assigned this Warrant in full,
in which case, the Holder shall surrender this Warrant to the Company within three (3) Trading Days of the date on which the Holder delivers
an assignment form to the Company assigning this Warrant in full. The Warrant, if properly assigned in accordance herewith, may be exercised
by a new holder for the purchase of Warrant Shares without having a new Warrant issued.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b) <U>New
Warrants</U>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company,
together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or
its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division or combination,
the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in
accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the Issue Date of this Warrant and shall be
identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c) <U>Warrant
Register</U>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the &ldquo;<U>Warrant
Register</U>&rdquo;), in the name of the record Holder hereof from time to time. The Company may deem and treat the registered Holder
of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other
purposes, absent actual notice to the contrary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d) <U>Transfer
Restrictions</U>. If, at the time of the surrender of this Warrant in connection with any transfer of this Warrant, the transfer of this
Warrant shall not be either (i) registered pursuant to an effective registration statement under the Securities Act and under applicable
state securities or blue sky laws or (ii) eligible for resale without volume or manner-of-sale restrictions or current public information
requirements pursuant to Rule 144, the Company may require, as a condition of allowing such transfer, that the Holder or transferee of
this Warrant, as the case may be, comply with the provisions of Section 5.7 of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e) <U>Representation
by the Holder</U>. The Holder, by the acceptance hereof, represents and warrants that it is acquiring this Warrant and, upon any exercise
hereof, will acquire the Warrant Shares issuable upon such exercise, for its own account and not with a view to or for distributing or
reselling such Warrant Shares or any part thereof in violation of the Securities Act or any applicable state securities law, except pursuant
to sales registered or exempted under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
5</U>. <U>Miscellaneous</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a) <U>No
Rights as Stockholder Until Exercise; No Settlement in Cash</U>. This Warrant does not entitle the Holder to any voting rights, dividends
or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly set
forth in Section 3. Without limiting any rights of a Holder to receive Warrant Shares on a &ldquo;cashless exercise&rdquo; pursuant to
Section 2(c) or to receive cash payments pursuant to Section 2(d)(i) and Section 2(d)(iv) herein, in no event shall the Company be required
to net cash settle an exercise of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b) <U>Loss,
Theft, Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably satisfactory
to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares, and in case
of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant, shall not include
the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company will make
and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or stock certificate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c) <U>Saturdays,
Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required or granted
herein shall not be a Trading Day, then, such action may be taken or such right may be exercised on the next succeeding Trading Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d) <U>Authorized
Shares</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock a
sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant.
The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with
the duty of issuing the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all
such reasonable action as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any
applicable law or regulation, or of any requirements of the Trading Market upon which the Common Stock may be listed. The Company covenants
that all Warrant Shares which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise
of the purchase rights represented by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly
issued, fully paid and nonassessable and free from all taxes, liens and charges created by the Company in respect of the issue thereof
(other than taxes in respect of any transfer occurring contemporaneously with such issue).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending
its certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale
of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant,
but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary
or appropriate to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the
foregoing, the Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise
immediately prior to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company
may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially
reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof,
as may be, necessary to enable the Company to perform its obligations under this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Before
taking any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the
Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from
any public regulatory body or bodies having jurisdiction thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e) <U>Jurisdiction</U>.
All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be determined in accordance
with the provisions of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f) <U>Restrictions</U>.
The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and the Holder does not
utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g) <U>Nonwaiver
and Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate as
a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies, notwithstanding the fact that the right
to exercise this Warrant terminates on the Termination Date. Without limiting any other provision of this Warrant, if the Company willfully
and knowingly fails to comply with any provision of this Warrant, which results in any material damages to the Holder, the Company shall
pay to the Holder such amounts as shall be sufficient to cover any costs and expenses including, but not limited to, reasonable attorneys&rsquo;
fees, including those of appellate proceedings, incurred by the Holder in collecting any amounts due pursuant hereto or in otherwise
enforcing any of its rights, powers or remedies hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">h) <U>Notices</U>.
Any notice, request or other document required or permitted to be given or delivered to the Holder by the Company shall be delivered
in accordance with the notice provisions of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i) <U>Limitation
of Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase Warrant
Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase
price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company or by creditors of the
Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">j) <U>Remedies</U>.
The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific
performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation for any loss
incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any
action for specific performance that a remedy at law would be adequate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">k) <U>Successors
and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the
benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder.
The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable
by the Holder or holder of Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">l) <U>Amendment</U>.
This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company, on the one hand, and
the Holder of this Warrant, on the other hand.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">m) <U>Severability</U>.
Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law,
but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the
extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">n) <U>Headings</U>.
The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this
Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">********************</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(Signature
Page Follows)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>


<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above
indicated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>wrap technologies, Inc.</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 45%">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Name:</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Title:</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTICE
OF EXERCISE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">To: <B>WRAP
TECHNOLOGIES, Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1) The
undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only if exercised
in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2) Payment
shall take the form of (check applicable box):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in">&#9744;<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
 in lawful money of the United States; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in">&#9744;<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
 if permitted the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection
2(c), to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure
set forth in subsection 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3) Please
issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Warrant Shares shall be delivered to the following DWAC Account Number:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4) <U>Accredited
Investor</U>. The undersigned is an &ldquo;accredited investor&rdquo; as defined in Regulation D promulgated under the Securities Act
of 1933, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">[SIGNATURE
OF HOLDER]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Investing Entity: _______________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Signature
of Authorized Signatory of Investing Entity</I>: _________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Authorized Signatory: ___________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
of Authorized Signatory: ____________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
_______________________________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXHIBIT
B</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">ASSIGNMENT
FORM</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(To
assign the foregoing Warrant, execute this form and supply required information. Do not use this form to exercise the Warrant to purchase
shares.)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOR
VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 46%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 46%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U></U></FONT></TD>
    <TD STYLE="width: 8%">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please
    Print)</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U></U></FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please
    Print)</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Phone
    Number:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email
    Address:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:
    _______________ __, ______</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s
    Signature: ________________________</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s
    Address: _________________________</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 17; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>4
<FILENAME>ex10-1.htm
<DESCRIPTION>EX-10.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: right; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: right; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
10.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-transform: uppercase; text-align: center; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-transform: uppercase; text-align: center; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECURITIES
PURCHASE AGREEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Securities Purchase Agreement (this &ldquo;<U>Agreement</U>&rdquo;) is dated as of February 2, 2026, between Wrap Technologies, Inc.,
a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;), and each purchaser identified on the signature pages hereto (each, including
its successors and assigns, a &ldquo;<U>Purchaser</U>&rdquo; and collectively the &ldquo;<U>Purchasers</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREAS,
subject to the terms and conditions set forth in this Agreement and pursuant to Section 4(a)(2) of the Securities Act (as defined below),
and/or Rule 506 of Regulation D promulgated thereunder, the Company desires to issue and sell to each Purchaser, and each Purchaser,
severally and not jointly, desires to purchase from the Company, securities of the Company as more fully described in this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOW,
THEREFORE, IN CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration the receipt
and adequacy of which are hereby acknowledged, the Company and each Purchaser agree as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
I.</B><BR>
DEFINITIONS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1
<U>Definitions</U>. In addition to the terms defined elsewhere in this Agreement, for all purposes of this Agreement, the following terms
have the meanings set forth in this Section 1.1:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Acquiring
Person</U>&rdquo; shall have the meaning ascribed to such term in Section 4.5.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Action</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(j).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Affiliate</U>&rdquo;
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a Person as such terms are used in and construed under Rule 405 under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>BHCA</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(rr).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Board
of Directors</U>&rdquo; means the board of directors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Business
Day</U>&rdquo; means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized
or required by law to remain closed; <U>provided</U>, <U>however</U>, for clarification, commercial banks shall not be deemed to be authorized
or required by law to remain closed due to &ldquo;stay at home&rdquo;, &ldquo;shelter-in-place&rdquo;, &ldquo;non-essential employee&rdquo;&nbsp;or
any other similar orders or restrictions or the closure of any physical branch locations at the direction of any governmental authority
so long as the electronic funds transfer systems (including for wire transfers) of commercial banks in The City of New York are generally
open for use by customers on such day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Closing</U>&rdquo;
means the closing of the purchase and sale of the Shares and the Warrants pursuant to Section 2.1.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Closing
Date</U>&rdquo; means the Trading Day on which all of the Transaction Documents have been executed and delivered by the applicable parties
thereto, and all conditions precedent to (i) the Purchasers&rsquo; obligations to pay the Subscription Amount and (ii) the Company&rsquo;s
obligations to deliver the Shares and the Warrants, in each case, have been satisfied or waived.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Commission</U>&rdquo;
means the United States Securities and Exchange Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Common
Stock</U>&rdquo; means the common stock of the Company, par value $0.0001 per share, and any other class of securities into which such
securities may hereafter be reclassified or changed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Common
Stock Equivalents</U>&rdquo; means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire
at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument that is
at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Common
Warrants</U>&rdquo; means, collectively, the Common Stock purchase warrants delivered to the Purchasers at the Closing in accordance
with Section 2.2(a) hereof, which such Common Warrants shall be exercisable immediately upon issuance and have a term of exercise equal
to five years, in the form of <U>Exhibit A-2</U> attached hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Common
Warrant Shares</U>&rdquo; means the shares of Common Stock issuable upon exercise of the Common Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Company
Counsel</U>&rdquo; means Haynes and Boone, LLP, with offices located at 30 Rockefeller Plaza, 26th Floor, New York, New York 10102.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Disqualification
Event&rdquo; shall have the meaning ascribed to such term in Section 3.1(tt).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Effective
Date</U>&rdquo; means the earliest of the date that (a) the initial Registration Statement registering for resale all Shares and Warrant
Shares has been declared effective by the Commission, (b) all of the Shares and Warrant Shares have been sold pursuant to Rule 144 or
may be sold pursuant to Rule 144 without the requirement for the Company to be in compliance with the current public information required
under Rule 144 and without volume or manner-of-sale restrictions, (c) following the one year anniversary of the Closing Date provided
that a holder of Shares or Warrant Shares is not an Affiliate of the Company, or (d) all of the Shares and Warrant Shares may be sold
pursuant to an exemption from registration under Section 4(a)(1) of the Securities Act without volume or manner-of-sale restrictions
and Company Counsel has delivered to such holders a standing written unqualified opinion that resales may then be made by such holders
of the Shares and Warrant Shares pursuant to such exemption which opinion shall be in form and substance reasonably acceptable to such
holders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Evaluation
Date</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(s).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Exchange
Act</U>&rdquo; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>GAAP</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(h).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Indebtedness</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(bb).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Intellectual
Property Rights</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(p).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Legend
Removal Date</U>&rdquo; shall have the meaning ascribed to such term in Section 4.1(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Liens</U>&rdquo;
means a lien, charge, pledge, security interest, encumbrance, right of first refusal, preemptive right or other restriction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Material
Adverse Effect</U>&rdquo; shall have the meaning assigned to such term in Section 3.1(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Material
Permits</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(n).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Per
Share Purchase Price</U>&rdquo; equals $2.00, subject to adjustment for reverse and forward stock splits, stock dividends, stock combinations
and other similar transactions of the Common Stock that occur after the date of this Agreement and prior to the Closing Date, provided
that the purchase price per Pre-Funded Warrant shall be the Per Share Purchase Price minus $0.0001.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Person</U>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability
company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Pre-Funded
Warrants</U>&rdquo; means, collectively, the pre-funded Common Stock purchase warrants delivered to the Purchasers at the Closing in
accordance with Section 2.2(a) hereof, which Pre-Funded Warrants shall be exercisable immediately and shall expire when exercised in
full, in the form of <U>Exhibit A-1</U> attached hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Pre-Funded
Warrant Shares</U>&rdquo; means the shares of Common Stock issuable upon exercise of the Pre-Funded Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Proceeding</U>&rdquo;
means an action, claim, suit, investigation or proceeding (including, without limitation, an informal investigation or partial proceeding,
such as a deposition), whether commenced or threatened.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Public
Information Failure</U>&rdquo; shall have the meaning ascribed to such term in Section 4.2(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Public
Information Failure Payments</U>&rdquo; shall have the meaning ascribed to such term in Section 4.2(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Purchaser
Party</U>&rdquo; shall have the meaning ascribed to such term in Section 4.8.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Registration
Rights Agreement</U>&rdquo; means the Registration Rights Agreement, dated on or about the date hereof, among the Company and the Purchasers,
in the form of <U>Exhibit B</U> attached hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Registration
Statement</U>&rdquo; means a registration statement meeting the requirements set forth in the Registration Rights Agreement and covering
the resale by the Purchasers of the Shares and the Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Required
Approvals</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(e).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Rule
144</U>&rdquo; means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted
from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect
as such Rule.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Rule
424</U>&rdquo; means Rule 424 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted
from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect
as such Rule.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>SEC
Reports</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(h).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Securities</U>&rdquo;
means the Shares, the Warrants and the Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Securities
Act</U>&rdquo; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Shares</U>&rdquo;
means the shares of Common Stock issued or issuable to each Purchaser pursuant to this Agreement, but excluding the Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Short
Sales</U>&rdquo; means all &ldquo;short sales&rdquo; as defined in Rule 200 of Regulation SHO under the Exchange Act (but shall not be
deemed to include locating and/or borrowing shares of Common Stock).&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Subscription
Amount</U>&rdquo; means, as to each Purchaser, the aggregate amount to be paid for Shares, Pre-Funded Warrants (if applicable) and Common
Warrants purchased hereunder as specified below such Purchaser&rsquo;s name on the signature page of this Agreement and next to the heading
&ldquo;Subscription Amount,&rdquo; in United States dollars and in immediately available funds (excluding for the avoidance of doubt,
if applicable, a Purchaser&rsquo;s aggregate exercise price of the Pre-Funded Warrants, which amounts shall be paid as and when such
Pre-Funded Warrants are exercised for cash).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Subsidiary</U>&rdquo;
means any subsidiary of the Company as set forth on <U>Exhibit 21.1</U> of the Company&rsquo;s Annual Report on Form 10-K, and shall,
where applicable, also include any direct or indirect subsidiary of the Company formed or acquired after the date hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Stockholder
Approval</U>&rdquo; means such approval as may be required by the applicable rules and regulations of the Nasdaq Stock Market (or any
successor entity) from the stockholders of the Company with respect to the transactions contemplated by the Transaction Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Trading
Day</U>&rdquo; means a day on which the principal Trading Market is open for trading.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Trading
Market</U>&rdquo; means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date
in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market or the New York
Stock Exchange (or any successors to any of the foregoing).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Transaction
Documents</U>&rdquo; means this Agreement, the Warrants, the Registration Rights Agreement, all exhibits and schedules thereto and hereto
and any other documents or agreements executed in connection with the transactions contemplated hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Transfer
Agent</U>&rdquo; means Colonial Stock Transfer, the current transfer agent of the Company, and any successor transfer agent of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed
or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30
a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if the OTCQB Venture Market (&ldquo;<U>OTCQB</U>&rdquo;) or the OTCQX
Best Market (&ldquo;<U>OTCQX</U>&rdquo;) is not a Trading Market, the volume weighted average price of the Common Stock for such date
(or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then listed or quoted for trading on
OTCQB or OTCQX and if prices for the Common Stock are then reported on the Pink Open Market (&ldquo;<U>Pink Market</U>&rdquo;) operated
by OTC Markets, Inc. (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price
per share of the Common Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined
by an independent appraiser selected in good faith by the Purchasers of a majority in interest of the Securities then outstanding and
reasonably acceptable to the Company, the fees and expenses of which shall be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Warrants</U>&rdquo;
means, collectively, the Common Warrants and the Pre-Funded Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Warrant
Shares</U>&rdquo; means, collectively, the Common Warrant Shares and the Pre-Funded Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
II.</B><BR>
PURCHASE AND SALE</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1 <U>Closing</U>.
On the Closing Date, upon the terms and subject to the conditions set forth herein, the Company agrees to sell, and the Purchasers, severally
and not jointly, agree to purchase, an aggregate of $5,000,000 of Shares and Warrants; provided, however, that to the extent that a Purchaser
determines, in its sole discretion, that such Purchaser (together with such Purchaser&rsquo;s Affiliates, and any Person acting as a
group together with such Purchaser or any of such Purchaser&rsquo;s Affiliates) would beneficially own in excess of the Beneficial Ownership
Limitation, or as such Purchaser may otherwise choose, in lieu of purchasing Shares, such Purchaser may elect, by so indicating such
election prior to their issuance, to purchase Pre-Funded Warrants in lieu of Shares in such manner to result in the same aggregate purchase
price being paid by such Purchaser to the Company. The &ldquo;<U>Beneficial Ownership Limitation</U>&rdquo; shall be 4.99% (or, with
respect to each Purchaser, at the election of such Purchaser at Closing, 9.99%) of the number of shares of the Common Stock outstanding
immediately after giving effect to the issuance of the Shares on the Closing Date. In each case, the election to receive Pre-Funded Warrants
is solely at the option of the Purchaser. Each Purchaser shall deliver to the Company, via wire transfer, immediately available funds
equal to such Purchaser&rsquo;s Subscription Amount as set forth on the signature page hereto executed by such Purchaser. The Company
shall deliver to each Purchaser its respective Shares, Pre-Funded Warrants (if any) and Common Warrants, as determined pursuant to Section
2.2(a), and the Company and each Purchaser shall deliver the other items set forth in Section 2.2 deliverable at the Closing. Upon satisfaction
of the covenants and conditions set forth in Sections 2.2 and 2.3, the Closing shall occur at the offices of Company Counsel or such
other location (including remotely by electronic transmission).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2 <U>Deliveries</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) On
or prior to the Closing Date, the Company shall deliver or cause to be delivered to each Purchaser the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) this
Agreement duly executed by the Company;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii) a
legal opinion of Company Counsel, directed to the Purchasers, in form and substance reasonably acceptable to the Purchasers;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii) the
Company shall have provided each Purchaser with the Company&rsquo;s wire instructions;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv) a
copy of the irrevocable instructions to the Transfer Agent instructing the Transfer Agent to deliver on an expedited basis a certificate
evidencing a number of Shares equal to such Purchaser&rsquo;s Subscription Amount divided by the Per Share Purchase Price, registered
in the name of such Purchaser, or, at the election of such Purchaser, evidence of the issuance of such Purchaser&rsquo;s Shares hereunder
as held in DRS book-entry form by the Transfer Agent and registered in the name of such Purchaser, which evidence shall be reasonably
satisfactory to such Purchaser;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v) if
applicable, for each Purchaser of Pre-Funded Warrants pursuant to Section 2.1, a Pre-Funded Warrant registered in the name of such Purchaser
to purchase up to a number of shares of Common Stock equal to the portion of such Purchaser&rsquo;s Subscription Amount applicable to
Pre-Funded Warrants divided by the Per Share Purchase Price minus $0.0001, with an exercise price equal to $0.0001 per share of Common
Stock, subject to adjustment therein; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi) a
Common Warrant registered in the name of such Purchaser to purchase up to a number of shares of Common Stock equal to 100% of the sum
of such Purchaser&rsquo;s Shares and Pre-Funded Warrant Shares, with an exercise price equal to $2.30 per share of Common Stock, subject
to adjustment therein; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vii) the
Registration Rights Agreement duly executed by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) On
or prior to the Closing Date, each Purchaser shall deliver or cause to be delivered to the Company, the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) this
Agreement duly executed by such Purchaser; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii) such
Purchaser&rsquo;s Subscription Amount by wire transfer to the account specified in writing by the Company;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii) the
Registration Rights Agreement duly executed by such Purchaser.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.3 <U>Closing
Conditions</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) The
obligations of the Company hereunder in connection with the Closing are subject to the following conditions being met:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) the
accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse Effect,
in all respects) when made and on the Closing Date of the representations and warranties of the Purchasers contained herein (unless such
representation or warranty is as of a specific date therein in which case they shall be accurate in all material respects (or, to the
extent representations or warranties are qualified by materiality or Material Adverse Effect, in all respects) as of such date);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii) all
obligations, covenants and agreements of each Purchaser required to be performed at or prior to the Closing Date shall have been performed;
and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii) the
delivery by each Purchaser of the items set forth in Section 2.2(b) of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) The
respective obligations of the Purchasers hereunder in connection with the Closing are subject to the following conditions being met:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) the
accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse Effect,
in all respects) when made and on the Closing Date of the representations and warranties of the Company contained herein (unless such
representation or warranty is as of a specific date therein in which case they shall be accurate in all material respects (or, to the
extent representations or warranties are qualified by materiality or Material Adverse Effect, in all respects) as of such date);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii) all
obligations, covenants and agreements of the Company required to be performed at or prior to the Closing Date shall have been performed;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii) the
delivery by the Company of the items set forth in Section 2.2(a) of this Agreement;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv) there
shall have been no Material Adverse Effect with respect to the Company since the date hereof; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v) from
the date hereof to the Closing Date, trading in the Common Stock shall not have been suspended by the Commission or the Company&rsquo;s
principal Trading Market, and, at any time prior to the Closing Date, trading in securities generally as reported by Bloomberg L.P. shall
not have been suspended or limited, or minimum prices shall not have been established on securities whose trades are reported by such
service, or on any Trading Market, nor shall a banking moratorium have been declared either by the United States or New York State authorities
nor shall there have occurred any material outbreak or escalation of hostilities or other national or international calamity of such
magnitude in its effect on, or any material adverse change in, any financial market which, in each case, in the reasonable judgment of
such Purchaser, makes it impracticable or inadvisable to purchase the Securities at the Closing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
III.</B><BR>
REPRESENTATIONS AND WARRANTIES</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1 <U>Representations
and Warranties of the Company</U>. Except as set forth in the SEC Reports, which information contained in such SEC Reports shall be deemed
a part hereof and shall qualify any representation or otherwise made herein to the extent of the disclosure contained in the SEC Reports,
and any other section hereof to the extent that it is readily apparent from a reading of such disclosure that it also qualifies or applies
to such other sections, the Company hereby makes the following representations and warranties to each Purchaser:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <U>Subsidiaries</U>.
All of the direct and indirect subsidiaries of the Company are set forth in the SEC Reports. The Company owns, directly or indirectly,
all of the capital stock or other equity interests of each Subsidiary free and clear of any Liens, and all of the issued and outstanding
shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights
to subscribe for or purchase securities. If the Company has no subsidiaries, all other references to the Subsidiaries or any of them
in the Transaction Documents shall be disregarded.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <U>Organization
and Qualification</U>. The Company and each of the Subsidiaries is an entity duly incorporated or otherwise organized, validly existing
and in good standing under the laws of the jurisdiction of its incorporation or organization, with the requisite power and authority
to own and use its properties and assets and to carry on its business as currently conducted. Neither the Company nor any Subsidiary
is in violation nor default of any of the provisions of its respective certificate or articles of incorporation, bylaws or other organizational
or charter documents. Each of the Company and the Subsidiaries is duly qualified to conduct business and is in good standing as a foreign
corporation or other entity in each jurisdiction in which the nature of the business conducted or property owned by it makes such qualification
necessary, except where the failure to be so qualified or in good standing, as the case may be, could not have or reasonably be expected
to result in: (i) a material adverse effect on the legality, validity or enforceability of any Transaction Document, (ii) a material
adverse effect on the results of operations, assets, business, prospects or condition (financial or otherwise) of the Company and the
Subsidiaries, taken as a whole, or (iii) a material adverse effect on the Company&rsquo;s ability to perform in any material respect
on a timely basis its obligations under any Transaction Document (any of (i), (ii) or (iii), a &ldquo;<U>Material Adverse Effect</U>&rdquo;)
and no Proceeding has been instituted in any such jurisdiction revoking, limiting or curtailing or seeking to revoke, limit or curtail
such power and authority or qualification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) <U>Authorization;
Enforcement</U>. The Company has the requisite corporate power and authority to enter into and to consummate the transactions contemplated
by this Agreement and each of the other Transaction Documents and otherwise to carry out its obligations hereunder and thereunder. The
execution and delivery of this Agreement and each of the other Transaction Documents by the Company and the consummation by it of the
transactions contemplated hereby and thereby have been duly authorized by all necessary action on the part of the Company and no further
action is required by the Company, the Board of Directors or the Company&rsquo;s stockholders in connection herewith or therewith other
than in connection with the Required Approvals, including the Stockholder Approval. This Agreement and each other Transaction Document
to which it is a party has been (or upon delivery will have been) duly executed by the Company and, when delivered in accordance with
the terms hereof and thereof, will constitute the valid and binding obligation of the Company enforceable against the Company in accordance
with its terms, except (i) as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium
and other laws of general application affecting enforcement of creditors&rsquo; rights generally, (ii) as limited by laws relating to
the availability of specific performance, injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution
provisions may be limited by applicable law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) <U>No
Conflicts</U>. The execution, delivery and performance by the Company of this Agreement and the other Transaction Documents to which
it is a party, the issuance and sale of the Securities and the consummation by it of the transactions contemplated hereby and thereby
do not and will not (i) conflict with or violate any provision of the Company&rsquo;s or any Subsidiary&rsquo;s certificate or articles
of incorporation, bylaws or other organizational or charter documents, or (ii) conflict with, or constitute a default (or an event that
with notice or lapse of time or both would become a default) under, result in the creation of any Lien upon any of the properties or
assets of the Company or any Subsidiary, or give to others any rights of termination, amendment, anti-dilution or similar adjustments,
acceleration or cancellation (with or without notice, lapse of time or both) of, any agreement, credit facility, debt or other instrument
(evidencing a Company or Subsidiary debt or otherwise) or other understanding to which the Company or any Subsidiary is a party or by
which any property or asset of the Company or any Subsidiary is bound or affected, or (iii) subject to the Required Approvals, conflict
with or result in a violation of any law, rule, regulation, order, judgment, injunction, decree or other restriction of any court or
governmental authority to which the Company or a Subsidiary is subject (including federal and state securities laws and regulations),
or by which any property or asset of the Company or a Subsidiary is bound or affected; except in the case of each of clauses (ii) and
(iii), such as could not, individually or in the aggregate, have or reasonably be expected to result in a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) <U>Filings,
Consents and Approvals</U>. The Company is not required to obtain any consent, waiver, authorization or order of, give any notice to,
or make any filing or registration with, any court or other federal, state, local or other governmental authority or other Person in
connection with the execution, delivery and performance by the Company of the Transaction Documents, other than: (i) the filings required
pursuant to Section 4.4 of this Agreement, (ii) the filing with the Commission pursuant to the Registration Rights Agreement, (iii) the
notice and/or application(s) to each applicable Trading Market for the issuance and sale of the Securities and the listing of the Shares
and Warrant Shares for trading thereon in the time and manner required thereby, (iv) the filing of Form D with the Commission, (v) the
Stockholder Approval, and (vi) such filings as are required to be made under applicable state securities laws (collectively, the &ldquo;<U>Required
Approvals</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f) <U>Issuance
of the Securities</U>. The Shares are duly authorized and, when issued and paid for in accordance with the applicable Transaction Documents,
will be duly and validly issued, fully paid and nonassessable, free and clear of all Liens imposed by the Company other than restrictions
on transfer provided for in the Transaction Documents. The Warrants are duly authorized and when paid for and issued in accordance with
this Agreement, will be duly and validly issued, fully paid, free and clear of all Liens imposed by the Company, and will constitute
valid and binding obligations of the Company, enforceable against the Company in accordance with their respective terms, except as such
enforceability may be limited by bankruptcy, insolvency, reorganization or similar laws affecting the rights of creditors generally and
subject to general principles of equity. The Pre-Funded Warrant Shares are duly authorized, and when issued in accordance with the terms
of the Pre-Funded Warrants, will be validly issued, fully paid and nonassessable, free and clear of all Liens imposed by the Company.
The Common Warrant Shares are duly authorized, and when issued in accordance with the terms of the Common Warrants, will be validly issued,
fully paid and nonassessable, free and clear of all Liens imposed by the Company. The Company has reserved from its duly authorized capital
stock the maximum number of shares of Common Stock issuable pursuant to this Agreement and the Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g) <U>Capitalization</U>.
The capitalization of the Company as of the date hereof is as set forth in the SEC Reports. Except as set forth in the SEC Reports, the
Company has not issued any capital stock since its most recently filed periodic report under the Exchange Act, other than pursuant to
the exercise of employee stock options under the Company&rsquo;s stock option plans, the issuance of shares of Common Stock to employees
pursuant to the Company&rsquo;s employee stock purchase plans and pursuant to the conversion and/or exercise of Common Stock Equivalents
outstanding as of the date of the most recently filed periodic report under the Exchange Act. No Person has any right of first refusal,
preemptive right, right of participation, or any similar right to participate in the transactions contemplated by the Transaction Documents.
Except as set forth in the SEC Reports and as a result of the purchase and sale of the Securities, there are no outstanding options,
warrants, scrip rights to subscribe to, calls or commitments of any character whatsoever relating to, or securities, rights or obligations
convertible into or exercisable or exchangeable for, or giving any Person any right to subscribe for or acquire, any shares of Common
Stock or the capital stock of any Subsidiary, or contracts, commitments, understandings or arrangements by which the Company or any Subsidiary
is or may become bound to issue additional shares of Common Stock or Common Stock Equivalents or capital stock of any Subsidiary. The
issuance and sale of the Securities will not obligate the Company or any Subsidiary to issue shares of Common Stock or other securities
to any Person (other than the Purchasers). There are no outstanding securities or instruments of the Company or any Subsidiary with any
provision that adjusts the exercise, conversion, exchange or reset price of such security or instrument upon an issuance of securities
by the Company or any Subsidiary. There are no outstanding securities or instruments of the Company or any Subsidiary that contain any
redemption or similar provisions, and there are no contracts, commitments, understandings or arrangements by which the Company or any
Subsidiary is or may become bound to redeem a security of the Company or such Subsidiary. The Company does not have any stock appreciation
rights or &ldquo;phantom stock&rdquo; plans or agreements or any similar plan or agreement. All of the outstanding shares of capital
stock of the Company are duly authorized, validly issued, fully paid and nonassessable, have been issued in compliance with all federal
and state securities laws, and none of such outstanding shares was issued in violation of any preemptive rights or similar rights to
subscribe for or purchase securities. Other than the Stockholder Approval, no further approval or authorization of any stockholder, the
Board of Directors or others is required for the issuance and sale of the Securities. There are no stockholders agreements, voting agreements
or other similar agreements with respect to the Company&rsquo;s capital stock to which the Company is a party or, to the knowledge of
the Company, between or among any of the Company&rsquo;s stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h) <U>SEC
Reports; Financial Statements</U>. The Company has filed all reports, schedules, forms, statements and other documents required to be
filed by the Company under the Securities Act and the Exchange Act, including pursuant to Section 13(a) or 15(d) thereof, for the two
(2) years preceding the date hereof (or such shorter period as the Company was required by law or regulation to file such material) (the
foregoing materials, including the exhibits thereto and documents incorporated by reference therein, being collectively referred to herein
as the &ldquo;<U>SEC Reports</U>&rdquo;). As of their respective dates, the SEC Reports complied in all material respects with the requirements
of the Securities Act and the Exchange Act, as applicable, and none of the SEC Reports, when filed, contained any untrue statement of
a material fact or omitted to state a material fact required to be stated therein or necessary in order to make the statements therein,
in the light of the circumstances under which they were made, not misleading. The Company has never been an issuer subject to Rule 144(i)
under the Securities Act. The financial statements of the Company included in the SEC Reports comply in all material respects with applicable
accounting requirements and the rules and regulations of the Commission with respect thereto as in effect at the time of filing. Such
financial statements have been prepared in accordance with United States generally accepted accounting principles applied on a consistent
basis during the periods involved (&ldquo;<U>GAAP</U>&rdquo;), except as may be otherwise specified in such financial statements or the
notes thereto and except that unaudited financial statements may not contain all footnotes required by GAAP, and fairly present in all
material respects the financial position of the Company and its consolidated Subsidiaries as of and for the dates thereof and the results
of operations and cash flows for the periods then ended, subject, in the case of unaudited statements, to normal, immaterial, year-end
audit adjustments.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) <U>Material
Changes; Undisclosed Events, Liabilities or Developments</U>. Since the date of the latest audited financial statements included within
the SEC Reports, except as set forth in the SEC Reports, (i) there has been no event, occurrence or development that has had or that
could reasonably be expected to result in a Material Adverse Effect, (ii) the Company has not incurred any liabilities (contingent or
otherwise) other than (A) trade payables and accrued expenses incurred in the ordinary course of business consistent with past practice
and (B) liabilities not required to be reflected in the Company&rsquo;s financial statements pursuant to GAAP or disclosed in filings
made with the Commission, (iii) the Company has not altered its method of accounting, (iv) the Company has not declared or made any dividend
or distribution of cash or other property to its stockholders or purchased, redeemed or made any agreements to purchase or redeem any
shares of its capital stock and (v) the Company has not issued any equity securities to any officer, director or Affiliate, except pursuant
to existing Company equity compensation plans. The Company does not have pending before the Commission any request for confidential treatment
of information. Except for the issuance of the Securities contemplated by this Agreement or as set forth in the SEC Reports, no event,
liability, fact, circumstance, occurrence or development has occurred or exists or is reasonably expected to occur or exist with respect
to the Company or its Subsidiaries or their respective businesses, prospects, properties, operations, assets or financial condition that
would be required to be disclosed by the Company under applicable securities laws at the time this representation is made or deemed made
that has not been publicly disclosed at least one (1) Trading Day prior to the date that this representation is made.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j) <U>Litigation</U>.
Except as set forth in the SEC Reports, there is no action, suit, inquiry, notice of violation, proceeding or investigation pending or,
to the knowledge of the Company, threatened against or affecting the Company, any Subsidiary or any of their respective properties before
or by any court, arbitrator, governmental or administrative agency or regulatory authority (federal, state, county, local or foreign)
(collectively, an &ldquo;Action&rdquo;). None of the Actions set forth in the SEC Reports, (i) adversely affects or challenges the legality,
validity or enforceability of any of the Transaction Documents or the Securities or (ii) could, if there were an unfavorable decision,
have or reasonably be expected to result in a Material Adverse Effect. Neither the Company nor any Subsidiary, nor any director or officer
thereof, is or has been the subject of any Action involving a claim of violation of or liability under federal or state securities laws
or a claim of breach of fiduciary duty. There has not been, and to the knowledge of the Company, there is not pending or contemplated,
any investigation by the Commission involving the Company or any current or former director or officer of the Company. The Commission
has not issued any stop order or other order suspending the effectiveness of any registration statement filed by the Company or any Subsidiary
under the Exchange Act or the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k) <U>Labor
Relations</U>. No labor dispute exists or, to the knowledge of the Company, is imminent with respect to any of the employees of the Company,
which could reasonably be expected to result in a Material Adverse Effect. None of the Company&rsquo;s or its Subsidiaries&rsquo; employees
is a member of a union that relates to such employee&rsquo;s relationship with the Company or such Subsidiary, and neither the Company
nor any of its Subsidiaries is a party to a collective bargaining agreement, and the Company and its Subsidiaries believe that their
relationships with their employees are good. To the knowledge of the Company, no executive officer of the Company or any Subsidiary,
is, or is now expected to be, in violation of any material term of any employment contract, confidentiality, disclosure or proprietary
information agreement or non-competition agreement, or any other contract or agreement or any restrictive covenant in favor of any third
party, and the continued employment of each such executive officer does not subject the Company or any of its Subsidiaries to any liability
with respect to any of the foregoing matters. The Company and its Subsidiaries are in compliance with all U.S. federal, state, local
and foreign laws and regulations relating to employment and employment practices, terms and conditions of employment and wages and hours,
except where the failure to be in compliance could not, individually or in the aggregate, reasonably be expected to have a Material Adverse
Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l) <U>Compliance</U>.
Except as set forth in the SEC Reports<U>, </U>neither the Company nor any Subsidiary: (i) is in default under or in violation of (and
no event has occurred that has not been waived that, with notice or lapse of time or both, would result in a default by the Company or
any Subsidiary under), nor has the Company or any Subsidiary received notice of a claim that it is in default under or that it is in
violation of, any indenture, loan or credit agreement or any other agreement or instrument to which it is a party or by which it or any
of its properties is bound (whether or not such default or violation has been waived), (ii) is in violation of any judgment, decree or
order of any court, arbitrator or other governmental authority or (iii) is or has been in violation of any statute, rule, ordinance or
regulation of any governmental authority, including without limitation all foreign, federal, state and local laws relating to taxes,
environmental protection, occupational health and safety, product quality and safety and employment and labor matters, except in each
case as could not have or reasonably be expected to result in a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m) <U>Environmental
Laws</U>. The Company and its Subsidiaries (i) are in compliance with all federal, state, local and foreign laws relating to pollution
or protection of human health or the environment (including ambient air, surface water, groundwater, land surface or subsurface strata),
including laws relating to emissions, discharges, releases or threatened releases of chemicals, pollutants, contaminants, or toxic or
hazardous substances or wastes (collectively, &ldquo;<U>Hazardous Materials</U>&rdquo;) into the environment, or otherwise relating to
the manufacture, processing, distribution, use, treatment, storage, disposal, transport or handling of Hazardous Materials, as well as
all authorizations, codes, decrees, demands, or demand letters, injunctions, judgments, licenses, notices or notice letters, orders,
permits, plans or regulations, issued, entered, promulgated or approved thereunder (&ldquo;<U>Environmental Laws</U>&rdquo;); (ii) have
received all permits licenses or other approvals required of them under applicable Environmental Laws to conduct their respective businesses;
and (iii) are in compliance with all terms and conditions of any such permit, license or approval where in each clause (i), (ii) and
(iii), the failure to so comply could be reasonably expected to have, individually or in the aggregate, a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n) <U>Regulatory
Permits</U>. The Company and the Subsidiaries possess all certificates, authorizations and permits issued by the appropriate federal,
state, local or foreign regulatory authorities necessary to conduct their respective businesses as described in the SEC Reports, except
where the failure to possess such permits could not reasonably be expected to result in a Material Adverse Effect (&ldquo;<U>Material
Permits</U>&rdquo;), and neither the Company nor any Subsidiary has received any notice of proceedings relating to the revocation or
modification of any Material Permit.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(o) <U>Title
to Assets</U>. The Company and the Subsidiaries have good and marketable title in fee simple to all real property owned by them and good
and marketable title in all personal property owned by them that is material to the business of the Company and the Subsidiaries, in
each case free and clear of all Liens, except for (i) Liens as do not materially affect the value of such property and do not materially
interfere with the use made and proposed to be made of such property by the Company and the Subsidiaries and (ii) Liens for the payment
of federal, state or other taxes, for which appropriate reserves have been made therefor in accordance with GAAP and, the payment of
which is neither delinquent nor subject to penalties. Any real property and facilities held under lease by the Company and the Subsidiaries
are held by them under valid, subsisting and enforceable leases with which the Company and the Subsidiaries are in compliance, except
where such failure to comply would not reasonably be expected to have a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(p) <U>Intellectual
Property</U>. The Company and the Subsidiaries have, or have rights to use, all patents, patent applications, trademarks, trademark applications,
service marks, trade names, trade secrets, inventions, copyrights, licenses and other intellectual property rights and similar rights
necessary or required for use in connection with their respective businesses as described in the SEC Reports and which the failure to
so have could have a Material Adverse Effect (collectively, the &ldquo;<U>Intellectual Property Rights</U>&rdquo;). None of, and neither
the Company nor any Subsidiary has received a notice (written or otherwise) that any of, the Intellectual Property Rights has expired,
terminated or been abandoned, or is expected to expire or terminate or be abandoned, within two (2) years from the date of this Agreement,
except where such action would not reasonably be expected to have a Material Adverse Effect. Neither the Company nor any Subsidiary has
received, since the date of the latest audited financial statements included within the SEC Reports, a written notice of a claim or otherwise
has any knowledge that the Intellectual Property Rights violate or infringe upon the rights of any Person, except as could not have or
reasonably be expected to not have a Material Adverse Effect. To the knowledge of the Company, all such Intellectual Property Rights
are enforceable and there is no existing infringement by another Person of any of the Intellectual Property Rights. The Company and its
Subsidiaries have taken reasonable security measures to protect the secrecy, confidentiality and value of all of their intellectual properties,
except where failure to do so could not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.
The Company has no knowledge of any facts that would preclude it from having valid license rights or clear title to the Intellectual
Property Rights. The Company has no knowledge that it lacks or will be unable to obtain any rights or licenses to use all Intellectual
Property Rights that are necessary to conduct its business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(q) <U>Insurance</U>.
The Company and the Subsidiaries are insured by insurers of recognized financial responsibility against such losses and risks and in
such amounts as are prudent and customary in the businesses in which the Company and the Subsidiaries are engaged. Neither the Company
nor any Subsidiary has any reason to believe that it will not be able to renew its existing insurance coverage as and when such coverage
expires or to obtain similar coverage from similar insurers as may be necessary to continue its business without a significant increase
in cost.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(r) <U>Transactions
With Affiliates and Employees</U>. Except as set forth in the SEC Reports, none of the officers or directors of the Company or any Subsidiary
and, to the knowledge of the Company, none of the employees of the Company or any Subsidiary is presently a party to any transaction
with the Company or any Subsidiary (other than for services as employees, officers and directors), including any contract, agreement
or other arrangement providing for the furnishing of services to or by, providing for rental of real or personal property to or from,
providing for the borrowing of money from or lending of money to or otherwise requiring payments to or from any officer, director or
such employee or, to the knowledge of the Company, any entity in which any officer, director, or any such employee has a substantial
interest or is an officer, director, trustee, stockholder, member or partner, in each case in excess of $120,000 other than for (i) payment
of salary or consulting fees for services rendered, (ii) reimbursement for expenses incurred on behalf of the Company and (iii) other
employee benefits, including stock option agreements under any stock option plan of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(s) <U>Sarbanes-Oxley;
Internal Accounting Controls</U>. Except as set forth in the SEC Reports, the Company and the Subsidiaries are in compliance with any
and all applicable requirements of the Sarbanes-Oxley Act of 2002, as amended, that are effective as of the date hereof and as of the
Closing Date, and any and all applicable rules and regulations promulgated by the Commission thereunder that are effective as of the
date hereof and as of the Closing Date. The Company and the Subsidiaries maintain a system of internal accounting controls sufficient
to provide reasonable assurance that: (i) transactions are executed in accordance with management&rsquo;s general or specific authorizations,
(ii) transactions are recorded as necessary to permit preparation of financial statements in conformity with GAAP and to maintain asset
accountability, (iii) access to assets is permitted only in accordance with management&rsquo;s general or specific authorization, and
(iv) the recorded accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is taken
with respect to any differences. The Company and the Subsidiaries have established disclosure controls and procedures (as defined in
Exchange Act Rules 13a-15(e) and 15d-15(e)) for the Company and the Subsidiaries and designed such disclosure controls and procedures
to ensure that information required to be disclosed by the Company in the reports it files or submits under the Exchange Act is recorded,
processed, summarized and reported, within the time periods specified in the Commission&rsquo;s rules and forms. The Company&rsquo;s
certifying officers have evaluated the effectiveness of the disclosure controls and procedures of the Company and the Subsidiaries as
of the end of the period covered by the most recently filed periodic report under the Exchange Act (such date, the &ldquo;<U>Evaluation
Date</U>&rdquo;). The Company presented in its most recently filed periodic report under the Exchange Act the conclusions of the certifying
officers about the effectiveness of the disclosure controls and procedures based on their evaluations as of the Evaluation Date. Since
the Evaluation Date, there have been no changes in the internal control over financial reporting (as such term is defined in the Exchange
Act) of the Company and its Subsidiaries that have materially affected, or is reasonably likely to materially affect, the internal control
over financial reporting of the Company and its Subsidiaries.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(t) <U>Certain
Fees</U>. No brokerage or finder&rsquo;s fees or commissions are or will be payable by the Company or any Subsidiary to any broker, financial
advisor or consultant, finder, placement agent, investment banker, bank or other Person with respect to the transactions contemplated
by the Transaction Documents. The Purchasers shall have no obligation with respect to any fees or with respect to any claims made by
or on behalf of other Persons for fees of a type contemplated in this Section that may be due in connection with the transactions contemplated
by the Transaction Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(u) <U>Private
Placement</U>. Assuming the accuracy of the Purchasers&rsquo; representations and warranties set forth in Section 3.2, no registration
under the Securities Act is required for the offer and sale of the Securities by the Company to the Purchasers as contemplated hereby.
The issuance and sale of the Securities hereunder does not contravene the rules and regulations of the Trading Market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v) <U>Investment
Company</U>. The Company is not, and is not an Affiliate of, and immediately after receipt of payment for the Securities, will not be
or be an Affiliate of, an &ldquo;investment company&rdquo; within the meaning of the Investment Company Act of 1940, as amended. The
Company shall conduct its business in a manner so that it will not become an &ldquo;investment company&rdquo; subject to registration
under the Investment Company Act of 1940, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(w) <U>Registration
Rights</U>. Except as set forth in the SEC Reports and other than to each of the Purchasers pursuant to the Registration Rights Agreement,
no Person has any right to cause the Company or any Subsidiary to effect the registration under the Securities Act of any securities
of the Company or any Subsidiary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(x) <U>Listing
and Maintenance Requirements</U>. The Common Stock is registered pursuant to Section 12(b) or 12(g) of the Exchange Act, and the Company
has taken no action designed to, or which to its knowledge is likely to have the effect of, terminating the registration of the Common
Stock under the Exchange Act nor has the Company received any notification that the Commission is contemplating terminating such registration.
Except as set forth in the SEC Reports, the Company has not, in the 12 months preceding the date hereof, received notice from any Trading
Market on which the Common Stock is or has been listed or quoted to the effect that the Company is not in compliance with the listing
or maintenance requirements of such Trading Market. Except as set forth in the SEC Reports, the Company is, and has no reason to believe
that it will not in the foreseeable future continue to be, in compliance with all such listing and maintenance requirements. The Common
Stock is currently eligible for electronic transfer through the Depository Trust Company or another established clearing corporation
and the Company is current in payment of the fees to the Depository Trust Company (or such other established clearing corporation) in
connection with such electronic transfer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(y) <U>Application
of Takeover Protections</U>. The Company and the Board of Directors have taken all necessary action, if any, in order to render inapplicable
any control stock acquisition, business combination, poison pill (including any distribution under a rights agreement) or other similar
anti-takeover provision under the Company&rsquo;s certificate of incorporation (or similar charter documents) or the laws of its state
of incorporation that is or could become applicable to the Purchasers as a result of the Purchasers and the Company fulfilling their
obligations or exercising their rights under the Transaction Documents, including without limitation as a result of the Company&rsquo;s
issuance of the Securities and the Purchasers&rsquo; ownership of the Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(z) <U>Disclosure</U>.
Except with respect to the material terms and conditions of the transactions contemplated by the Transaction Documents, the Company confirms
that neither it nor any other Person acting on its behalf has provided any of the Purchasers or their agents or counsel with any information
that it believes constitutes or might constitute material, non-public information. The Company understands and confirms that the Purchasers
will rely on the foregoing representation in effecting transactions in securities of the Company. All of the disclosure furnished by
or on behalf of the Company to the Purchasers regarding the Company and its Subsidiaries, their respective businesses and the transactions
contemplated hereby is true and correct in all material respects and does not contain any untrue statement of a material fact or omit
to state any material fact necessary in order to make the statements made therein, in the light of the circumstances under which they
were made, not misleading. The press releases disseminated by the Company during the twelve months preceding the date of this Agreement
taken as a whole do not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein
or necessary in order to make the statements therein, in the light of the circumstances under which they were made and when made, not
misleading. The Company acknowledges and agrees that no Purchaser makes or has made any representations or warranties with respect to
the transactions contemplated hereby other than those specifically set forth in Section 3.2 hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(aa) <U>No
Integrated Offering</U>. Assuming the accuracy of the Purchasers&rsquo; representations and warranties set forth in Section 3.2, neither
the Company, nor any of its Affiliates, nor any Person acting on its or their behalf has, directly or indirectly, made any offers or
sales of any security or solicited any offers to buy any security, under circumstances that would cause this offering of the Securities
to be integrated with prior offerings by the Company for purposes of (i) the Securities Act which would require the registration of any
such Securities under the Securities Act, or (ii) any applicable stockholder approval provisions of any Trading Market on which any of
the securities of the Company are listed or designated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(bb) <U>Solvency</U>.
Based on the consolidated financial condition of the Company as of the Closing Date, after giving effect to the receipt by the Company
of the proceeds from the sale of the Securities hereunder, (i) the fair saleable value of the Company&rsquo;s assets exceeds the amount
that will be required to be paid on or in respect of the Company&rsquo;s existing debts and other liabilities (including known contingent
liabilities) as they mature, (ii) the Company&rsquo;s assets do not constitute unreasonably small capital to carry on its business as
now conducted and as proposed to be conducted including its capital needs taking into account the particular capital requirements of
the business conducted by the Company, consolidated and projected capital requirements and capital availability thereof, and (iii) the
current cash flow of the Company, together with the proceeds the Company would receive, were it to liquidate all of its assets, after
taking into account all anticipated uses of the cash, would be sufficient to pay all amounts on or in respect of its liabilities when
such amounts are required to be paid. The Company does not intend to incur debts beyond its ability to pay such debts as they mature
(taking into account the timing and amounts of cash to be payable on or in respect of its debt). The Company has no knowledge of any
facts or circumstances which lead it to believe that it will file for reorganization or liquidation under the bankruptcy or reorganization
laws of any jurisdiction within one year from the Closing Date. The SEC Reports set forth as of the date hereof all outstanding secured
and unsecured Indebtedness of the Company or any Subsidiary, or for which the Company or any Subsidiary has commitments. For the purposes
of this Agreement, &ldquo;<U>Indebtedness</U>&rdquo; means (x) any liabilities for borrowed money or amounts owed in excess of $100,000
(other than trade accounts payable incurred in the ordinary course of business), (y) all guaranties, endorsements and other contingent
obligations in respect of indebtedness of others, whether or not the same are or should be reflected in the Company&rsquo;s consolidated
balance sheet (or the notes thereto), except guaranties by endorsement of negotiable instruments for deposit or collection or similar
transactions in the ordinary course of business; and (z) the present value of any lease payments in excess of $100,000 due under leases
required to be capitalized in accordance with GAAP. Neither the Company nor any Subsidiary is in default with respect to any Indebtedness.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(cc) <U>Tax
Status</U>. Except for matters that would not, individually or in the aggregate, have or reasonably be expected to result in a Material
Adverse Effect, the Company and its Subsidiaries each (i) has made or filed all United States federal, state and local income and all
foreign income and franchise tax returns, reports and declarations required by any jurisdiction to which it is subject, (ii) has paid
all taxes and other governmental assessments and charges that are material in amount, shown or determined to be due on such returns,
reports and declarations and (iii) has set aside on its books provision reasonably adequate for the payment of all material taxes for
periods subsequent to the periods to which such returns, reports or declarations apply. There are no unpaid taxes in any material amount
claimed to be due by the taxing authority of any jurisdiction, and the officers of the Company or of any Subsidiary know of no basis
for any such claim.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(dd) <U>No
General Solicitation</U>. Neither the Company nor any Person acting on behalf of the Company has offered or sold any of the Securities
by any form of general solicitation or general advertising. The Company has offered the Securities for sale only to the Purchasers and
certain other &ldquo;accredited investors&rdquo; within the meaning of Rule 501 under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ee) <U>Foreign
Corrupt Practices</U>. Neither the Company nor any Subsidiary, nor to the knowledge of the Company or any Subsidiary, any agent or other
person acting on behalf of the Company or any Subsidiary, has (i) directly or indirectly, used any funds for unlawful contributions,
gifts, entertainment or other unlawful expenses related to foreign or domestic political activity, (ii) made any unlawful payment to
foreign or domestic government officials or employees or to any foreign or domestic political parties or campaigns from corporate funds,
(iii) failed to disclose fully any contribution made by the Company or any Subsidiary (or made by any person acting on its behalf of
which the Company is aware) which is in violation of law, or (iv) violated in any material respect any provision of FCPA.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ff) <U>Accountants</U>.
The Company&rsquo;s independent registered public accounting firm is HTL International, LLC. To the knowledge and belief of the Company,
such accounting firm (i) is a registered public accounting firm as required by the Exchange Act and (ii) shall express its opinion with
respect to the financial statements to be included in the Company&rsquo;s Annual Report for the fiscal year ended December 31, 2025. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(gg)
<U>No Disagreements with Accountants and Lawyers.</U> There are no disagreements of any kind presently existing, or reasonably anticipated
by the Company to arise, between the Company and the accountants and lawyers formerly or presently employed by the Company and the Company
is current with respect to any fees owed to its accountants and lawyers which could affect the Company&rsquo;s ability to perform any
of its obligations under any of the Transaction Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(hh) <U>Acknowledgment
Regarding Purchasers&rsquo; Purchase of Securities</U>. The Company acknowledges and agrees that each of the Purchasers is acting solely
in the capacity of an arm&rsquo;s length purchaser with respect to the Transaction Documents and the transactions contemplated thereby.
The Company further acknowledges that no Purchaser is acting as a financial advisor or fiduciary of the Company (or in any similar capacity)
with respect to the Transaction Documents and the transactions contemplated thereby and any advice given by any Purchaser or any of their
respective representatives or agents in connection with the Transaction Documents and the transactions contemplated thereby is merely
incidental to the Purchasers&rsquo; purchase of the Securities. The Company further represents to each Purchaser that the Company&rsquo;s
decision to enter into this Agreement and the other Transaction Documents has been based solely on the independent evaluation of the
transactions contemplated hereby by the Company and its representatives.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
<U>Acknowledgment Regarding Purchaser&rsquo;s Trading Activity</U>. Anything in this Agreement or elsewhere herein to the contrary notwithstanding
(except for Sections 3.2(f) and 4.14 hereof), it is understood and acknowledged by the Company that: (i) none of the Purchasers has been
asked by the Company to agree, nor has any Purchaser agreed, to desist from purchasing or selling, long and/or short, securities of the
Company, or &ldquo;derivative&rdquo; securities based on securities issued by the Company or to hold the Securities for any specified
term; (ii) past or future open market or other transactions by any Purchaser, specifically including, without limitation, Short Sales
or &ldquo;derivative&rdquo; transactions, before or after the closing of this or future private placement transactions, may negatively
impact the market price of the Company&rsquo;s publicly-traded securities; (iii) any Purchaser, and counter-parties in &ldquo;derivative&rdquo;
transactions to which any such Purchaser is a party, directly or indirectly, presently may have a &ldquo;short&rdquo; position in the
Common Stock, and (iv) each Purchaser shall not be deemed to have any affiliation with or control over any arm&rsquo;s length counter-party
in any &ldquo;derivative&rdquo; transaction. The Company further understands and acknowledges that (y) one or more Purchasers may engage
in hedging activities at various times during the period that the Securities are outstanding, including, without limitation, during the
periods that the value of the Warrant Shares deliverable with respect to Securities are being determined, and (z) such hedging activities
(if any) could reduce the value of the existing stockholders&rsquo; equity interests in the Company at and after the time that the hedging
activities are being conducted.&nbsp; The Company acknowledges that such aforementioned hedging activities do not constitute a breach
of any of the Transaction Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(jj) <U>Regulation
M Compliance</U>.&nbsp; The Company has not, and to its knowledge no one acting on its behalf has, (i) taken, directly or indirectly,
any action designed to cause or to result in the stabilization or manipulation of the price of any security of the Company to facilitate
the sale or resale of any of the Securities, (ii) sold, bid for, purchased, or, paid any compensation for soliciting purchases of, any
of the Securities, or (iii) paid or agreed to pay to any Person any compensation for soliciting another to purchase any other securities
of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(kk) [RESERVED].</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ll) <U>[RESERVED].</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(mm) <U>Stock
Option Plans</U>. Each stock option granted by the Company under the Company&rsquo;s stock option plan was granted (i) in accordance
with the terms of the Company&rsquo;s stock option plan and (ii) with an exercise price at least equal to the fair market value of the
Common Stock on the date such stock option would be considered granted under GAAP and applicable law. No stock option granted under the
Company&rsquo;s stock option plan has been backdated. The Company has not knowingly granted, and there is no and has been no Company
policy or practice to knowingly grant, stock options prior to, or otherwise knowingly coordinate the grant of stock options with, the
release or other public announcement of material information regarding the Company or its Subsidiaries or their financial results or
prospects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(nn) <U>Cybersecurity</U>.&nbsp;
(i)(x) To the best of the Company&rsquo;s knowledge, there has been no security breach or other compromise of or relating to any of the
Company&rsquo;s or any Subsidiary&rsquo;s information technology and computer systems, networks, hardware, software, data (including
the data of its respective customers, employees, suppliers, vendors and any third party data maintained by or on behalf of it), equipment
or technology (collectively, &ldquo;<U>IT Systems and Data</U>&rdquo;) and (y) the Company and the Subsidiaries have not been notified
of, and have no knowledge of any event or condition that would reasonably be expected to result in, any security breach or other compromise
to its IT Systems and Data; (ii) the Company and the Subsidiaries are presently in compliance with all applicable laws or statutes and
all judgments, orders, rules and regulations of any court or arbitrator or governmental or regulatory authority, internal policies and
contractual obligations relating to the privacy and security of IT Systems and Data and to the protection of such IT Systems and Data
from unauthorized use, access, misappropriation or modification, except as would not, individually or in the aggregate, have a Material
Adverse Effect; (iii)&nbsp;the Company and the Subsidiaries have implemented and maintained commercially reasonable safeguards to maintain
and protect its material confidential information and the integrity, continuous operation, redundancy and security of all IT Systems
and Data; and (iv) the Company and the Subsidiaries have implemented backup and disaster recovery technology consistent with industry
standards and practices.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(oo) <U>Compliance
with Data Privacy Laws</U>. (i)&nbsp;The Company and the Subsidiaries are, and at all times during the last three (3) years were, in
compliance with all applicable state, federal and foreign data privacy and security laws and regulations, including, without limitation,
the European Union General Data Protection Regulation (&ldquo;<U>GDPR</U>&rdquo;) (EU 2016/679) (collectively, &ldquo;<U>Privacy Laws</U>&rdquo;);
(ii)&nbsp;the Company and the Subsidiaries have in place, comply with, and take appropriate steps reasonably designed to ensure compliance
with their policies and procedures relating to data privacy and security and the collection, storage, use, disclosure, handling and analysis
of Personal Data (as defined below) (the &ldquo;<U>Policies</U>&rdquo;); (iii)&nbsp;the Company provides accurate notice of its applicable
Policies to its customers, employees, third party vendors and representatives as required by the Privacy Laws; and (iv)&nbsp;applicable
Policies provide accurate and sufficient notice of the Company&rsquo;s then-current privacy practices relating to its subject matter,
and do not contain any material omissions of the Company&rsquo;s then-current privacy practices, as required by Privacy Laws.&nbsp;&ldquo;<U>Personal
Data</U>&rdquo; means (i)&nbsp;a natural person&rsquo;s name, street address, telephone number, email address, photograph, social security
number, bank information, or customer or account number; (ii)&nbsp;any information which would qualify as &ldquo;personally identifying
information&rdquo; under the Federal Trade Commission Act, as amended; (iii) &ldquo;personal data&rdquo; as defined by GDPR; and (iv)&nbsp;any
other piece of information that allows the identification of such natural person, or his or her family, or permits the collection or
analysis of any identifiable data related to an identified person&rsquo;s health or sexual orientation. (i)&nbsp;None of such disclosures
made or contained in any of the Policies have been inaccurate, misleading, or deceptive in violation of any Privacy Laws and (ii)&nbsp;the
execution, delivery and performance of the Transaction Documents will not result in a breach of any Privacy Laws or Policies.&nbsp; Neither
the Company nor the Subsidiaries (i)&nbsp;to the knowledge of the Company, has received written notice of any actual or potential liability
of the Company or the Subsidiaries under, or actual or potential violation by the Company or the Subsidiaries of, any of the Privacy
Laws; (ii)&nbsp;is currently conducting or paying for, in whole or in part, any investigation, remediation or other corrective action
pursuant to any regulatory request or demand pursuant to any Privacy Law; or (iii)&nbsp;is a party to any order, decree, or agreement
by or with any court or arbitrator or governmental or regulatory authority that imposed any obligation or liability under any Privacy
Law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 20; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(pp) <U>Office
of Foreign Assets Control</U>. Neither the Company nor any Subsidiary nor, to the Company&rsquo;s knowledge, any director, officer, agent,
employee or affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign
Assets Control of the U.S. Treasury Department (&ldquo;<U>OFAC</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(qq) <U>U.S.
Real Property Holding Corporation</U>. The Company is not and has never been a U.S. real property holding corporation within the meaning
of Section 897 of the Internal Revenue Code of 1986, as amended, and the Company shall so certify upon Purchaser&rsquo;s request.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(rr) <U>Bank
Holding Company Act</U>. Neither the Company nor any of its Subsidiaries or Affiliates is subject to the Bank Holding Company Act of
1956, as amended (the &ldquo;<U>BHCA</U>&rdquo;) and to regulation by the Board of Governors of the Federal Reserve System (the &ldquo;<U>Federal
Reserve</U>&rdquo;). Neither the Company nor any of its Subsidiaries or Affiliates owns or controls, directly or indirectly, five percent
(5%) or more of the outstanding shares of any class of voting securities or twenty-five percent (25%) or more of the total equity of
a bank or any entity that is subject to the BHCA and to regulation by the Federal Reserve. Neither the Company nor any of its Subsidiaries
or Affiliates exercises a controlling influence over the management or policies of a bank or any entity that is subject to the BHCA and
to regulation by the Federal Reserve.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ss) <U>Money
Laundering</U>. The operations of the Company and its Subsidiaries are and have been conducted at all times in compliance with applicable
financial record-keeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended, applicable
money laundering statutes and applicable rules and regulations thereunder (collectively, the &ldquo;<U>Money Laundering Laws</U>&rdquo;),
and no Action or Proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Company
or any Subsidiary with respect to the Money Laundering Laws is pending or, to the knowledge of the Company or any Subsidiary, threatened.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 21; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(tt) <U>No
Disqualification Events</U>. With respect to the Securities to be offered and sold hereunder in reliance on Rule 506 under the Securities
Act, none of the Company, any of its predecessors, any affiliated issuer, any director, executive officer, other officer of the Company
participating in the offering hereunder, any beneficial owner of 20% or more of the Company&rsquo;s outstanding voting equity securities,
calculated on the basis of voting power, nor any promoter (as that term is defined in Rule 405 under the Securities Act) connected with
the Company in any capacity at the time of sale (each, an &ldquo;<U>Issuer Covered Person</U>&rdquo;) is subject to any of the &ldquo;Bad
Actor&rdquo; disqualifications described in Rule 506(d)(1)(i) to (viii) under the Securities Act (a &ldquo;<U>Disqualification Event</U>&rdquo;),
except for a Disqualification Event covered by Rule 506(d)(2) or (d)(3). The Company has exercised reasonable care to determine whether
any Issuer Covered Person is subject to a Disqualification Event. The Company has complied, to the extent applicable, with its disclosure
obligations under Rule 506(e), and has furnished to the Purchasers a copy of any disclosures provided thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(uu) <U>Other
Covered Persons</U>. The Company is not aware of any person (other than any Issuer Covered Person) that has been or will be paid (directly
or indirectly) remuneration for solicitation of purchasers in connection with the sale of any Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vv) <U>Notice
of Disqualification Events</U>. The Company will notify the Purchasers in writing, prior to the Closing Date of (i) any Disqualification
Event relating to any Issuer Covered Person and (ii) any event that would, with the passage of time, reasonably be expected to become
a Disqualification Event relating to any Issuer Covered Person.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2 <U>Representations
and Warranties of the Purchasers</U>. Each Purchaser, for itself and for no other Purchaser, hereby represents and warrants as of the
date hereof and as of the Closing Date to the Company as follows (unless as of a specific date therein, in which case they shall be accurate
as of such date):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 21pt; text-align: justify; text-indent: 51pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 21pt; text-align: justify; text-indent: 51pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <U>Organization;
Authority</U>. Such Purchaser is either an individual or an entity duly incorporated or formed, validly existing and in good standing
under the laws of the jurisdiction of its incorporation or formation with full right, corporate, partnership, limited liability company
or similar power and authority to enter into and to consummate the transactions contemplated by the Transaction Documents and otherwise
to carry out its obligations hereunder and thereunder. The execution and delivery of the Transaction Documents and performance by such
Purchaser of the transactions contemplated by the Transaction Documents have been duly authorized by all necessary corporate, partnership,
limited liability company or similar action, as applicable, on the part of such Purchaser. Each Transaction Document to which it is a
party has been duly executed by such Purchaser, and when delivered by such Purchaser in accordance with the terms hereof, will constitute
the valid and legally binding obligation of such Purchaser, enforceable against it in accordance with its terms, except: (i) as limited
by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application
affecting enforcement of creditors&rsquo; rights generally, (ii) as limited by laws relating to the availability of specific performance,
injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited by applicable
law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 21pt; text-align: justify; text-indent: 51pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 21pt; text-align: justify; text-indent: 51pt"></P>

<!-- Field: Page; Sequence: 22; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 21pt; text-align: justify; text-indent: 51pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 21pt; text-align: justify; text-indent: 51pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <U>Understandings
or Arrangements</U>. Such Purchaser is acquiring the Securities as principal for its own account and has no direct or indirect arrangement
or understandings with any other persons to distribute or regarding the distribution of such Securities (this representation and warranty
not limiting such Purchaser&rsquo;s right to sell the Securities pursuant to the Registration Statement or otherwise in compliance with
applicable federal and state securities laws). Such Purchaser understands that the Securities are &ldquo;restricted securities&rdquo;
and have not been registered under the Securities Act or any applicable state securities law and is acquiring such Securities as principal
for his, her or its own account and not with a view to or for distributing or reselling such Securities or any part thereof in violation
of the Securities Act or any applicable state securities law, has no present intention of distributing any of such Securities in violation
of the Securities Act or any applicable state securities law and has no direct or indirect arrangement or understandings with any other
persons to distribute or regarding the distribution of such Securities in violation of the Securities Act or any applicable state securities
law (this representation and warranty not limiting such Purchaser&rsquo;s right to sell such Securities pursuant to the Registration
Statement or otherwise in compliance with applicable federal and state securities laws). Such Purchaser is acquiring the Securities hereunder
in the ordinary course of its business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 21pt; text-align: justify; text-indent: 51pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 21pt; text-align: justify; text-indent: 51pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) <U>Purchaser
Status</U>. At the time such Purchaser was offered the Securities, it was, and as of the date hereof it is, and on each date on which
it exercises any Warrants, it will be either: (i) an &ldquo;accredited investor&rdquo; as defined in Rule 501(a)(1), (a)(2), (a)(3),
(a)(7), (a)(8), (a)(9), (a)(12), or (a)(13) under the Securities Act or (ii) a &ldquo;qualified institutional buyer&rdquo; as defined
in Rule 144A(a) under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 21pt; text-align: justify; text-indent: 51pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 21pt; text-align: justify; text-indent: 51pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) <U>Experience
of Such Purchaser</U>. Such Purchaser, either alone or together with its representatives, has such knowledge, sophistication and experience
in business and financial matters so as to be capable of evaluating the merits and risks of the prospective investment in the Securities,
and has so evaluated the merits and risks of such investment. Such Purchaser is able to bear the economic risk of an investment in the
Securities and, at the present time, is able to afford a complete loss of such investment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 21pt; text-align: justify; text-indent: 51pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 21pt; text-align: justify; text-indent: 51pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) <U>Access
to Information</U>. Such Purchaser acknowledges that it has had the opportunity to review the Transaction Documents (including all exhibits
and schedules thereto) and the SEC Reports and has been afforded, (i) the opportunity to ask such questions as it has deemed necessary
of, and to receive answers from, representatives of the Company concerning the terms and conditions of the offering of the Securities
and the merits and risks of investing in the Securities; (ii) access to information about the Company and its financial condition, results
of operations, business, properties, management and prospects sufficient to enable it to evaluate its investment; and (iii) the opportunity
to obtain such additional information that the Company possesses or can acquire without unreasonable effort or expense that is necessary
to make an informed investment decision with respect to the investment.&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 21pt; text-align: justify; text-indent: 51pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 21pt; text-align: justify; text-indent: 51pt"></P>

<!-- Field: Page; Sequence: 23; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 21pt; text-align: justify; text-indent: 51pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 21pt; text-align: justify; text-indent: 51pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f) <U>Certain
Transactions and Confidentiality</U>. Other than consummating the transactions contemplated hereunder, such Purchaser has not, nor has
any Person acting on behalf of or pursuant to any understanding with such Purchaser, directly or indirectly executed any purchases or
sales, including Short Sales,&nbsp;of the securities of the Company during the period commencing as of the time that such Purchaser first
received a term sheet (written or oral) from the Company or any other Person representing the Company setting forth the material terms
of the transactions contemplated hereunder and ending immediately prior to the execution hereof. Notwithstanding the foregoing, in the
case of a Purchaser that is a multi-managed investment vehicle whereby separate portfolio managers manage separate portions of such Purchaser&rsquo;s
assets and the portfolio managers have no direct knowledge of the investment decisions made by the portfolio managers managing other
portions of such Purchaser&rsquo;s assets, the representation set forth above shall only apply with respect to the portion of assets
managed by the portfolio manager that made the investment decision to purchase the Securities covered by this Agreement. Other than to
other Persons party to this Agreement or to such Purchaser&rsquo;s representatives, including, without limitation, its officers, directors,
partners, legal and other advisors, employees, agents and Affiliates, such Purchaser has maintained the confidentiality of all disclosures
made to it in connection with this transaction (including the existence and terms of this transaction). Notwithstanding the foregoing,
for the avoidance of doubt, nothing contained herein shall constitute a representation or warranty, or preclude any actions, with respect
to locating or borrowing shares in order to effect Short Sales or similar transactions in the future.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 21pt; text-align: justify; text-indent: 51pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 21pt; text-align: justify; text-indent: 51pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g) <U>General
Solicitation</U>. Such Purchaser is not purchasing the Securities as a result of any advertisement, article, notice or other communication
regarding the Securities published in any newspaper, magazine or similar media or broadcast over television or radio or presented at
any seminar or, to the knowledge of such Purchaser, any other general solicitation or general advertisement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company acknowledges and agrees that the representations contained in this Section 3.2 shall not modify, amend or affect such Purchaser&rsquo;s
right to rely on the Company&rsquo;s representations and warranties contained in this Agreement or any representations and warranties
contained in any other Transaction Document or any other document or instrument executed and/or delivered in connection with this Agreement
or the consummation of the transactions contemplated hereby. Notwithstanding the foregoing, for the avoidance of doubt, nothing contained
herein shall constitute a representation or warranty, or preclude any actions, with respect to locating or borrowing shares in order
to effect Short Sales or similar transactions in the future.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 24; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
IV.</B><BR>
OTHER AGREEMENTS OF THE PARTIES</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1 <U>Transfer
Restrictions</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 45pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) The
Securities may only be disposed of in compliance with state and federal securities laws. In connection with any transfer of the Securities
other than pursuant to an effective registration statement or Rule 144, to the Company or to an Affiliate of a Purchaser or in connection
with a pledge as contemplated in Section 4.1(b), the Company may require the transferor thereof to provide to the Company an opinion
of counsel selected by the transferor and reasonably acceptable to the Company, the form and substance of which opinion shall be reasonably
satisfactory to the Company, to the effect that such transfer does not require registration of such transferred Securities under the
Securities Act. As a condition of transfer, any such transferee shall agree in writing to be bound by the terms of this Agreement and
the Registration Rights Agreement and shall have the rights and obligations of a Purchaser under this Agreement and the Registration
Rights Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 45pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 45pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
The Purchasers agree to the imprinting, so long as is required by this Section 4.1, of a legend on any of the Securities in the following
form:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NEITHER
THIS SECURITY NOR THE SECURITIES INTO WHICH THIS SECURITY IS EXERCISABLE HAS BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION
OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED
(THE &ldquo;SECURITIES ACT&rdquo;), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT
UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS
OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE
OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT WITH A REGISTERED BROKER-DEALER OR OTHER LOAN WITH A FINANCIAL
INSTITUTION THAT IS AN &ldquo;ACCREDITED INVESTOR&rdquo; AS DEFINED IN RULE 501(a) UNDER THE SECURITIES ACT OR OTHER LOAN SECURED BY
SUCH SECURITIES.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company acknowledges and agrees that a Purchaser may from time to time pledge pursuant to a bona fide margin agreement with a registered
broker-dealer or grant a security interest in some or all of the Securities to a financial institution that is an &ldquo;accredited investor&rdquo;
as defined in Rule 501(a) under the Securities Act and, if required under the terms of such arrangement, such Purchaser may transfer
pledged or secured Securities to the pledgees or secured parties. Such a pledge or transfer would not be subject to approval of the Company
and no legal opinion of legal counsel of the pledgee, secured party or pledgor shall be required in connection therewith. Further, no
notice shall be required of such pledge. At the appropriate Purchaser&rsquo;s expense, the Company will execute and deliver such reasonable
documentation as a pledgee or secured party of Securities may reasonably request in connection with a pledge or transfer of the Securities,
including, if the Securities are subject to registration pursuant to the Registration Rights Agreement, the preparation and filing of
any required prospectus supplement under Rule 424(b)(3) under the Securities Act or other applicable provision of the Securities Act
to appropriately amend the list of Selling Stockholders (as defined in the Registration Rights Agreement) thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 25; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) Certificates
evidencing the Shares and Warrant Shares shall not contain any legend (including the legend set forth in Section 4.1(b) hereof), (i)
while a registration statement (including the Registration Statement) covering the resale of such security is effective under the Securities
Act, (ii) following any sale of such Shares or Warrant Shares pursuant to Rule 144 (assuming cashless exercise of the Warrants), (iii)
if such Shares or Warrant Shares are eligible for sale under Rule 144 (assuming cashless exercise of the Warrants), without the requirement
for the Company to be in compliance with the current public information required under Rule 144 as to such Shares and Warrant Shares
and without volume or manner-of-sale restrictions, or (iv) if such legend is not required under applicable requirements of the Securities
Act (including judicial interpretations and pronouncements issued by the staff of the Commission). The Company shall cause its counsel
to issue a legal opinion to the Transfer Agent or the Purchaser promptly after the Effective Date if required by the Transfer Agent to
effect the removal of the legend hereunder, or if requested by a Purchaser, respectively. If all or any portion of a Warrant is exercised
at a time when there is an effective registration statement to cover the resale of the Warrant Shares, or if such Shares or Warrant Shares
may be sold under Rule 144 and the Company is then in compliance with the current public information required under Rule 144 (assuming
cashless exercise of the Warrants), or if the Shares or Warrant Shares may be sold under Rule 144 without the requirement for the Company
to be in compliance with the current public information required under Rule 144 as to such Shares or Warrant Shares or if such legend
is not otherwise required under applicable requirements of the Securities Act (including judicial interpretations and pronouncements
issued by the staff of the Commission) then such Warrant Shares shall be issued free of all legends. The Company agrees that following
the Effective Date or at such time as such legend is no longer required under this Section 4.1(c), it will, no later than the earlier
of (i) one (1) Trading Day and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined below) following
the delivery by a Purchaser to the Company or the Transfer Agent of a certificate representing Shares or Warrant Shares, as the case
may be, issued with a restrictive legend (such date, the &ldquo;<U>Legend Removal Date</U>&rdquo;), deliver or cause to be delivered
to such Purchaser a certificate representing such shares that is free from all restrictive and other legends. The Company may not make
any notation on its records or give instructions to the Transfer Agent that enlarge the restrictions on transfer set forth in this Section
4. Certificates for Securities subject to legend removal hereunder shall be transmitted by the Transfer Agent to the Purchaser by crediting
the account of the Purchaser&rsquo;s prime broker with the Depository Trust Company System as directed by such Purchaser. As used herein,
&ldquo;<U>Standard Settlement Period</U>&rdquo; means the standard settlement period, expressed in a number of Trading Days, on the Company&rsquo;s
primary Trading Market with respect to the Common Stock as in effect on the date of delivery of a certificate representing Shares or
Warrant Shares, as the case may be, issued with a restrictive legend.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 26; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) In
addition to such Purchaser&rsquo;s other available remedies, the Company shall pay to a Purchaser, in cash, (i) as partial liquidated
damages and not as a penalty, for each $1,000 of Shares or Warrant Shares (based on the VWAP of the Common Stock on the date such Securities
are submitted to the Transfer Agent) delivered for removal of the restrictive legend and subject to Section 4.1(c), $10 per Trading Day
(increasing to $20 per Trading Day five (5) Trading Days after the Legend Removal Date) for each Trading Day after the Legend Removal
Date until such certificate is delivered without a legend and (ii) if the Company fails to (a) issue and deliver (or cause to be delivered)
to a Purchaser by the Legend Removal Date a certificate representing the Securities so delivered to the Company by such Purchaser that
is free from all restrictive and other legends and (b) if after the Legend Removal Date such Purchaser purchases (in an open market transaction
or otherwise) shares of Common Stock to deliver in satisfaction of a sale by such Purchaser of all or any portion of the number of shares
of Common Stock, or a sale of a number of shares of Common Stock equal to all or any portion of the number of shares of Common Stock,
that such Purchaser anticipated receiving from the Company without any restrictive legend, then an amount equal to the excess of such
Purchaser&rsquo;s total purchase price (including brokerage commissions and other out-of-pocket expenses, if any) for the shares of Common
Stock so purchased (including brokerage commissions and other out-of-pocket expenses, if any) over the product of (A) such number of
Shares or Warrant Shares that the Company was required to deliver to such Purchaser by the Legend Removal Date multiplied by (B) the
lowest closing sale price of the Common Stock on any Trading Day during the period commencing on the date of the delivery by such Purchaser
to the Company of the applicable Shares or Warrant Shares (as the case may be) and ending on the date of such delivery and payment under
this Section 4.1(d).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) Each
Purchaser, severally and not jointly with the other Purchasers, agrees with the Company that such Purchaser will sell any Securities
pursuant to either the registration requirements of the Securities Act, including any applicable prospectus delivery requirements, or
an exemption therefrom, and that if Securities are sold pursuant to a Registration Statement, they will be sold in compliance with the
plan of distribution set forth therein, and acknowledges that the removal of the restrictive legend from certificates representing Securities
as set forth in this Section 4.1 is predicated upon the Company&rsquo;s reliance upon this understanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2 <U>Furnishing
of Information; Public Information</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) Until
the earlier of the time that (i) no Purchaser owns Securities or (ii) the Warrants have expired, the Company covenants to maintain the
registration of the Common Stock under Section 12(b) or 12(g) of the Exchange Act and to timely file (or obtain extensions in respect
thereof and file within the applicable grace period) all reports required to be filed by the Company after the date hereof pursuant to
the Exchange Act even if the Company is not then subject to the reporting requirements of the Exchange Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 27; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) At
any time during the period commencing from the six (6) month anniversary of the date hereof and ending at such time that all of the Securities
may be sold without the requirement for the Company to be in compliance with Rule 144(c)(1) and otherwise without restriction or limitation
pursuant to Rule 144, if the Company (i) shall fail for any reason to satisfy the current public information requirement under Rule 144(c)
or (ii) has ever been an issuer described in Rule 144(i)(1)(i) or becomes an issuer in the future, and the Company shall fail to satisfy
any condition set forth in Rule 144(i)(2) (a &ldquo;<U>Public Information Failure</U>&rdquo;) then, in addition to such Purchaser&rsquo;s
other available remedies, the Company shall pay to a Purchaser, in cash, as partial liquidated damages and not as a penalty, by reason
of any such delay in or reduction of its ability to sell the Securities, an amount in cash equal to one percent (1.0%) of the Subscription
Amount of such Purchaser&rsquo;s Securities on the day of a Public Information Failure and on every thirtieth (30<SUP>th</SUP>) day (pro
rated for periods totaling less than thirty days) thereafter until the earlier of (a) the date such Public Information Failure is cured
and (b) such time that such public information is no longer required&nbsp; for the Purchasers to transfer the Shares and Warrant Shares
pursuant to Rule 144.&nbsp; The payments to which a Purchaser shall be entitled pursuant to this Section 4.2(b) are referred to herein
as &ldquo;<U>Public Information Failure Payments</U>.&rdquo;&nbsp; Public Information Failure Payments shall be paid on the earlier of
(i) the last day of the calendar month during which such Public Information Failure Payments are incurred and (ii) the third (3<SUP>rd</SUP>)
Business Day after the event or failure giving rise to the Public Information Failure Payments is cured.&nbsp; In the event the Company
fails to make Public Information Failure Payments in a timely manner, such Public Information Failure Payments shall bear interest at
the rate of 0.5% per month (prorated for partial months) until paid in full. Nothing herein shall limit such Purchaser&rsquo;s right
to pursue actual damages for the Public Information Failure, and such Purchaser shall have the right to pursue all remedies available
to it at law or in equity including, without limitation, a decree of specific performance and/or injunctive relief.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3 <U>Integration</U>.
The Company shall not sell, offer for sale or solicit offers to buy or otherwise negotiate in respect of any security (as defined in
Section 2 of the Securities Act) that would be integrated with the offer or sale of the Securities in a manner that would require the
registration under the Securities Act of the sale of the Securities or that would be integrated with the offer or sale of the Securities
for purposes of the rules and regulations of any Trading Market such that it would require stockholder approval prior to the closing
of such other transaction unless stockholder approval is obtained before the closing of such subsequent transaction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4 <U>Securities
Laws Disclosure; Publicity</U>. The Company shall file a Current Report on Form 8-K, including the Transaction Documents as exhibits
thereto, with the Commission within the time required by the Exchange Act. From and after the filing of the Form 8-K, the Company represents
to the Purchasers that it shall have publicly disclosed all material, non-public information delivered to any of the Purchasers by the
Company or any of its Subsidiaries, or any of their respective officers, directors, employees or agents in connection with the transactions
contemplated by the Transaction Documents. In addition, effective upon the filing of the Form 8-K, the Company acknowledges and agrees
that any and all confidentiality or similar obligations under any agreement, whether written or oral, between the Company, any of its
Subsidiaries or any of their respective officers, directors, agents, employees or Affiliates on the one hand, and any of the Purchasers
or any of their Affiliates on the other hand, shall terminate and be of no further force or effect. The Company understands and confirms
that each Purchaser shall be relying on the foregoing covenant in effecting transactions in securities of the Company. The Company and
each Purchaser shall consult with each other in issuing any press releases with respect to the transactions contemplated hereby, and
neither the Company nor any Purchaser shall issue any such press release nor otherwise make any such public statement without the prior
consent of the Company, with respect to any press release of any Purchaser, or without the prior consent of each Purchaser, with respect
to any press release of the Company, which consent shall not unreasonably be withheld or delayed, except if such disclosure is required
by law, in which case the disclosing party shall promptly provide the other party with prior notice of such public statement or communication.
Notwithstanding the foregoing, the Company shall not publicly disclose the name of any Purchaser, or include the name of any Purchaser
in any filing with the Commission or any regulatory agency or Trading Market, without the prior written consent of such Purchaser, except
(a) as required by federal securities law in connection with (i) any registration statement contemplated by the Registration Rights Agreement
and (ii) the filing of final Transaction Documents with the Commission and (b) to the extent such disclosure is required by law or Trading
Market regulations, in which case the Company shall provide the Purchasers with prior notice of such disclosure permitted under this
clause (b) and reasonably cooperate with such Purchaser regarding such disclosure.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 28; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.5 <U>Stockholder
Rights Plan</U>. No claim will be made or enforced by the Company or, with the consent of the Company, any other Person, that any Purchaser
is an &ldquo;<U>Acquiring Person</U>&rdquo; under any control stock acquisition, business combination, poison pill (including any distribution
under a rights agreement) or similar anti-takeover plan or arrangement in effect or hereafter adopted by the Company, or that any Purchaser
could be deemed to trigger the provisions of any such plan or arrangement, by virtue of receiving Securities under the Transaction Documents
or under any other agreement between the Company and the Purchasers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.6 <U>Non-Public
Information</U>. Except with respect to the material terms and conditions of the transactions contemplated by the Transaction Documents,
which shall be disclosed pursuant to Section 4.4, the Company covenants and agrees that neither it, nor any other Person acting on its
behalf will provide any Purchaser or its agents or counsel with any information that constitutes, or the Company reasonably believes
constitutes, material non-public information, unless prior thereto such Purchaser shall have consented in writing to the receipt of such
information and agreed in writing with the Company to keep such information confidential. The Company understands and confirms that each
Purchaser shall be relying on the foregoing covenant in effecting transactions in securities of the Company. To the extent that the Company,
any of its Subsidiaries, or any of their respective officers, directors, agents, employees or Affiliates delivers any material, non-public
information to a Purchaser without such Purchaser&rsquo;s consent, the Company hereby covenants and agrees that such Purchaser shall
not have any duty of confidentiality to the Company, any of its Subsidiaries, or any of their respective officers, directors, agents,
employees or Affiliates, or a duty to the Company, any of its Subsidiaries or any of their respective officers, directors, agents, employees
or Affiliates not to trade on the basis of, such material, non-public information, provided that the Purchaser shall remain subject to
applicable law. To the extent that any notice provided pursuant to any Transaction Document constitutes, or contains, material, non-public
information regarding the Company or any Subsidiaries, the Company shall simultaneously with the delivery of such notice file such notice
with the Commission pursuant to a Current Report on Form 8-K. The Company understands and confirms that each Purchaser shall be relying
on the foregoing covenant in effecting transactions in securities of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.7 <U>Use
of Proceeds</U>. The Company shall use the net proceeds from the sale of the Securities hereunder for working capital purposes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 29; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.8 <U>Indemnification
of Purchasers.</U> Subject to the provisions of this Section 4.8, the Company will indemnify and hold each Purchaser and its directors,
officers, stockholders, members, partners, employees and agents (and any other Persons with a functionally equivalent role of a Person
holding such titles notwithstanding a lack of such title or any other title), each Person who controls such Purchaser (within the meaning
of Section 15 of the Securities Act and Section 20 of the Exchange Act), and the directors, officers, stockholders, agents, members,
partners or employees (and any other Persons with a functionally equivalent role of a Person holding such titles notwithstanding a lack
of such title or any other title) of such controlling persons (each, a &ldquo;Purchaser Party&rdquo;) harmless from any and all losses,
liabilities, obligations, claims, contingencies, damages, costs and expenses, including all judgments, amounts paid in settlements, court
costs and reasonable attorneys&rsquo; fees and costs of investigation that any such Purchaser Party may suffer or incur as a result of
or relating to (a) any breach of any of the representations, warranties, covenants or agreements made by the Company in this Agreement
or in the other Transaction Documents (b) any action instituted against the Purchaser Parties in any capacity, or any of them or their
respective Affiliates, by any stockholder of the Company who is not an Affiliate of such Purchaser Party, with respect to any of the
transactions contemplated by the Transaction Documents (unless such action is solely based upon a material breach of such Purchaser Party&rsquo;s
representations, warranties or covenants under the Transaction Documents or any agreements or understandings such Purchaser Party may
have with any such stockholder or any violations by such Purchaser Party of state or federal securities laws or any conduct by such Purchaser
Party which is finally judicially determined to constitute fraud, gross negligence or willful misconduct), or (c) in connection with
any registration statement of the Company providing for the resale by the Purchasers of the Warrant Shares issued and issuable upon exercise
of the Warrants, the Company will indemnify each Purchaser Party, to the fullest extent permitted by applicable law, from and against
any and all losses, claims, damages, liabilities, costs (including, without limitation, reasonable attorneys&rsquo; fees) and expenses,
as incurred, arising out of or relating to (i) any untrue or alleged untrue statement of a material fact contained in such registration
statement, any prospectus or any form of prospectus or in any amendment or supplement thereto or in any preliminary prospectus, or arising
out of or relating to any omission or alleged omission of a material fact required to be stated therein or necessary to make the statements
therein (in the case of any prospectus or supplement thereto, in the light of the circumstances under which they were made) not misleading,
except to the extent, but only to the extent, that such untrue statements or omissions are based solely upon information regarding such
Purchaser Party furnished in writing to the Company by such Purchaser Party expressly for use therein, or (ii) any violation or alleged
violation by the Company of the Securities Act, the Exchange Act or any state securities law, or any rule or regulation thereunder in
connection therewith. If any action shall be brought against any Purchaser Party in respect of which indemnity may be sought pursuant
to this Agreement, such Purchaser Party shall promptly notify the Company in writing, and the Company shall have the right to assume
the defense thereof with counsel of its own choosing reasonably acceptable to the Purchaser Party. Any Purchaser Party shall have the
right to employ separate counsel in any such action and participate in the defense thereof, but the fees and expenses of such counsel
shall be at the expense of such Purchaser Party except to the extent that (x) the employment thereof has been specifically authorized
by the Company in writing, (y) the Company has failed after a reasonable period of time to assume such defense and to employ counsel
or (z) in such action there is, in the reasonable opinion of counsel, a material conflict on any material issue between the position
of the Company and the position of such Purchaser Party, in which case the Company shall be responsible for the reasonable fees and expenses
of no more than one such separate counsel. The Company will not be liable to any Purchaser Party under this Agreement (1) for any settlement
by a Purchaser Party effected without the Company&rsquo;s prior written consent, which shall not be unreasonably withheld or delayed;
or (2) to the extent, but only to the extent that a loss, claim, damage or liability is attributable to any Purchaser Party&rsquo;s breach
of any of the representations, warranties, covenants or agreements made by such Purchaser Party in this Agreement or in the other Transaction
Documents. The indemnification required by this Section 4.8 shall be made by periodic payments of the amount thereof during the course
of the investigation or defense, as and when bills are received or are incurred. The indemnity agreements contained herein shall be in
addition to any cause of action or similar right of any Purchaser Party against the Company or others and any liabilities the Company
may be subject to pursuant to law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 30; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.9 <U>Reservation
of Common Stock</U>. As of the date hereof, the Company has reserved and the Company shall continue to reserve and keep available at
all times, free of preemptive rights, a sufficient number of shares of Common Stock for the purpose of enabling the Company to issue
Shares pursuant to this Agreement and Warrant Shares pursuant to any exercise of the Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.10 <U>Listing
of Common Stock</U>. The Company hereby agrees to use best efforts to maintain the listing or quotation of the Common Stock on the Trading
Market on which it is currently listed, and concurrently with the Closing, the Company shall apply to list or quote all of the Shares
and Warrant Shares on such Trading Market and promptly secure the listing of all of the Shares and Warrant Shares on such Trading Market.
The Company further agrees, if the Company applies to have the Common Stock traded on any other Trading Market, it will then include
in such application all of the Shares and Warrant Shares, and will take such other action as is necessary to cause all of the Shares
and Warrant Shares to be listed or quoted on such other Trading Market as promptly as possible. The Company will then take all action
reasonably necessary to continue the listing and trading of its Common Stock on a Trading Market and will comply in all respects with
the Company&rsquo;s reporting, filing and other obligations under the bylaws or rules of the Trading Market. The Company agrees to maintain
the eligibility of the Common Stock for electronic transfer through the Depository Trust Company or another established clearing corporation,
including, without limitation, by timely payment of fees to the Depository Trust Company or such other established clearing corporation
in connection with such electronic transfer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.11 <U>[RESERVED]</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.12 <U>[RESERVED]</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.13 <U>Equal
Treatment of Purchasers</U>. No consideration (including any modification of this Agreement) shall be offered or paid to any Person to
amend or consent to a waiver or modification of any provision of this Agreement unless the same consideration is also offered to all
of the parties to this Agreement. For clarification purposes, this provision constitutes a separate right granted to each Purchaser by
the Company and negotiated separately by each Purchaser, and is intended for the Company to treat the Purchasers as a class and shall
not in any way be construed as the Purchasers acting in concert or as a group with respect to the purchase, disposition or voting of
Securities or otherwise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.14 <U>Certain
Transactions and Confidentiality</U>. Each Purchaser, severally and not jointly with the other Purchasers, covenants that neither it,
nor any Affiliate acting on its behalf or pursuant to any understanding with it will execute any purchases or sales, including Short
Sales, of any of the Company&rsquo;s securities during the period commencing with the execution of this Agreement and ending at such
time that the transactions contemplated by this Agreement are first publicly announced pursuant to the initial press release as described
in Section 4.4.&nbsp; Each Purchaser, severally and not jointly with the other Purchasers, covenants that until such time as the transactions
contemplated by this Agreement are publicly disclosed by the Company pursuant to the initial press release as described in Section 4.4,
such Purchaser will maintain the confidentiality of the existence and terms of this transaction (other than as disclosed to its legal
and other representatives).&nbsp; Notwithstanding the foregoing and notwithstanding anything contained in this Agreement to the contrary,
the Company expressly acknowledges and agrees that (i) no Purchaser makes any representation, warranty or covenant hereby that it will
not engage in effecting transactions in any securities of the Company after the time that the transactions contemplated by this Agreement
are first publicly announced pursuant to the initial press release as described in Section 4.4, (ii) no Purchaser shall be restricted
or prohibited from effecting any transactions in any securities of the Company in accordance with applicable securities laws from and
after the time that the transactions contemplated by this Agreement are first publicly announced pursuant to the initial press release
as described in Section 4.4 and (iii) no Purchaser shall have any duty of confidentiality or duty not to trade in the securities of the
Company to the Company, any of its Subsidiaries, or any of their respective officers, directors, employees, Affiliates or agent, after
the issuance of the initial press release as described in Section 4.4.&nbsp; Notwithstanding the foregoing, in the case of a Purchaser
that is a multi-managed investment vehicle whereby separate portfolio managers manage separate portions of such Purchaser&rsquo;s assets
and the portfolio managers have no direct knowledge of the investment decisions made by the portfolio managers managing other portions
of such Purchaser&rsquo;s assets, the covenant set forth above shall only apply with respect to the portion of assets managed by the
portfolio manager that made the investment decision to purchase the Securities covered by this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 31; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.15 <U>Acknowledgment
of Dilution</U>. The Company acknowledges that the issuance of the Securities may result in dilution of the outstanding shares of Common
Stock, which dilution may be substantial under certain market conditions. The Company further acknowledges that its obligations under
the Transaction Documents, including, without limitation, its obligation to issue the Shares and Warrant Shares pursuant to the Transaction
Documents, are unconditional and absolute and not subject to any right of set off, counterclaim, delay or reduction, regardless of the
effect of any such dilution or any claim the Company may have against any Purchaser and regardless of the dilutive effect that such issuance
may have on the ownership of the other stockholders of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.16 <U>Exercise
Procedures</U>. The form of Notice of Exercise included in the Warrants set forth the totality of the procedures required of the Purchasers
in order to exercise the Warrants. No additional legal opinion, other information or instructions shall be required of the Purchasers
to exercise their Warrants. Without limiting the preceding sentences, no ink-original Notice of Exercise shall be required, nor shall
any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise form be required in order to exercise
the Warrants. The Company shall honor exercises of the Warrants and shall deliver Warrant Shares in accordance with the terms, conditions
and time periods set forth in the Transaction Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.17 [Reserved].
</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.18 <U>Form
D; Blue Sky Filings</U>. If required, the Company agrees to timely file a Form D with respect to the Securities as required under Regulation
D and to provide a copy thereof, promptly upon request of any Purchaser. The Company shall take such action as the Company shall reasonably
determine is necessary in order to obtain an exemption for, or to qualify the Securities for, sale to the Purchasers at the Closing under
applicable securities or &ldquo;Blue Sky&rdquo; laws of the states of the United States, and shall provide evidence of such actions promptly
upon request of any Purchaser.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
V.</B><BR>
MISCELLANEOUS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1 <U>Termination</U>.&nbsp;
This Agreement may be terminated by any Purchaser, as to such Purchaser&rsquo;s obligations hereunder only and without any effect whatsoever
on the obligations between the Company and the other Purchasers, by written notice to the other parties, if the Closing has not been
consummated on or before the fifth (5<SUP>th</SUP>) Trading Day following the date hereof; <U>provided</U>, <U>however</U>, that no such
termination will affect the right of any party to sue for any breach by any other party (or parties).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.2 <U>Fees
and Expenses</U>. Except as expressly set forth in the Transaction Documents to the contrary, each party shall pay the fees and expenses
of its advisers, counsel, accountants and other experts, if any, and all other expenses incurred by such party incident to the negotiation,
preparation, execution, delivery and performance of this Agreement. The Company shall pay all Transfer Agent fees (including, without
limitation, any fees required for same-day processing of any instruction letter delivered by the Company and any exercise notice delivered
by a Purchaser), stamp taxes and other taxes and duties levied in connection with the delivery of any Securities to the Purchasers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.3 <U>Entire
Agreement</U>. The Transaction Documents, together with the exhibits and schedules thereto, contain the entire understanding of the parties
with respect to the subject matter hereof and thereof and supersede all prior agreements and understandings, oral or written, with respect
to such matters, which the parties acknowledge have been merged into such documents, exhibits and schedules.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 32; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.4 <U>Notices</U>.
Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be in writing and shall
be deemed given and effective on the earliest of: (a) the time of transmission, if such notice or communication is delivered via email
attachment at the email address as set forth on the signature pages attached hereto at or prior to 5:30 p.m. (New York City time) on
a Trading Day, (b) the next Trading Day after the time of transmission, if such notice or communication is delivered via email attachment
at the email address as set forth on the signature pages attached hereto on a day that is not a Trading Day or later than 5:30 p.m. (New
York City time) on any Trading Day, (c) the second (2<SUP>nd</SUP>) Trading Day following the date of mailing, if sent by U.S. nationally
recognized overnight courier service or (d) upon actual receipt by the party to whom such notice is required to be given. The address
for such notices and communications shall be as set forth on the signature pages attached hereto. To the extent that any notice provided
pursuant to any Transaction Document constitutes, or contains, material, non-public information regarding the Company or any Subsidiaries,
the Company shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.5 <U>Amendments;
Waivers</U>. No provision of this Agreement may be waived, modified, supplemented or amended except in a written instrument signed, in
the case of an amendment, by the Company and Purchasers which purchased at least 50.1% in interest of the Shares and the Pre-Funded Warrants
based on the initial Subscription Amounts hereunder (or, prior to the Closing, the Company and each Purchaser) or, in the case of a waiver,
by the party against whom enforcement of any such waived provision is sought, provided that if any amendment, modification or waiver
disproportionately and adversely impacts a Purchaser (or group of Purchasers), the consent of at least 50.1% in interest of such disproportionately
impacted Purchaser (or group of Purchasers) shall also be required. No waiver of any default with respect to any provision, condition
or requirement of this Agreement shall be deemed to be a continuing waiver in the future or a waiver of any subsequent default or a waiver
of any other provision, condition or requirement hereof, nor shall any delay or omission of any party to exercise any right hereunder
in any manner impair the exercise of any such right. Any proposed amendment or waiver that disproportionately, materially and adversely
affects the rights and obligations of any Purchaser relative to the comparable rights and obligations of the other Purchasers shall require
the prior written consent of such adversely affected Purchaser. Any amendment effected in accordance with this Section 5.5 shall be binding
upon each Purchaser and holder of Securities and the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.6 <U>Headings</U>.
The headings herein are for convenience only, do not constitute a part of this Agreement and shall not be deemed to limit or affect any
of the provisions hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.7 <U>Successors
and Assigns</U>. This Agreement shall be binding upon and inure to the benefit of the parties and their successors and permitted assigns.
The Company may not assign this Agreement or any rights or obligations hereunder without the prior written consent of each Purchaser
(other than by merger). Any Purchaser may assign any or all of its rights under this Agreement to any Person to whom such Purchaser assigns
or transfers any Securities, provided that such transferee agrees in writing to be bound, with respect to the transferred Securities,
by the provisions of the Transaction Documents that apply to the &ldquo;Purchasers.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.8 <U>No
Third-Party Beneficiaries</U>. This Agreement is intended for the benefit of the parties hereto and their respective successors and permitted
assigns and is not for the benefit of, nor may any provision hereof be enforced by, any other Person, except as otherwise set forth in
Section 4.8 and this Section 5.8.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 33; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.9 <U>Governing
Law</U>. All questions concerning the construction, validity, enforcement and interpretation of the Transaction Documents shall be governed
by and construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles of conflicts
of law thereof. Each party agrees that all legal Proceedings concerning the interpretations, enforcement and defense of the transactions
contemplated by this Agreement and any other Transaction Documents (whether brought against a party hereto or its respective affiliates,
directors, officers, stockholders, partners, members, employees or agents) shall be commenced exclusively in the state and federal courts
sitting in the City of New York. Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts
sitting in the City of New York, Borough of Manhattan for the adjudication of any dispute hereunder or in connection herewith or with
any transaction contemplated hereby or discussed herein (including with respect to the enforcement of any of the Transaction Documents),
and hereby irrevocably waives, and agrees not to assert in any Action or Proceeding, any claim that it is not personally subject to the
jurisdiction of any such court, that such Action or Proceeding is improper or is an inconvenient venue for such Proceeding. Each party
hereby irrevocably waives personal service of process and consents to process being served in any such Action or Proceeding by mailing
a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect
for notices to it under this Agreement and agrees that such service shall constitute good and sufficient service of process and notice
thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted by law.
If any party shall commence an Action or Proceeding to enforce any provisions of the Transaction Documents, then, in addition to the
obligations of the Company under Section 4.8, the prevailing party in such Action or Proceeding shall be reimbursed by the non-prevailing
party for its reasonable attorneys&rsquo; fees and other costs and expenses incurred with the investigation, preparation and prosecution
of such Action or Proceeding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.10 <U>Survival</U>.
The representations and warranties contained herein shall survive the Closing and the delivery of the Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.11 <U>Execution</U>.
This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one and the same agreement
and shall become effective when counterparts have been signed by each party and delivered to each other party, it being understood that
the parties need not sign the same counterpart. In the event that any signature is delivered by e-mail delivery (including any electronic
signature covered by the U.S. federal ESIGN Act of 2000, Uniform Electronic Transactions Act, the Electronic Signatures and Records Act
or other applicable law, e.g., www.docusign.com) or other transmission method, such signature shall be deemed to have been duly and validly
delivered and shall create a valid and binding obligation of the party executing (or on whose behalf such signature is executed) with
the same force and effect as if such &ldquo;.pdf&rdquo; signature page were an original thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.12 <U>Severability</U>.
If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to be invalid, illegal,
void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall remain in full force
and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their commercially reasonable efforts
to find and employ an alternative means to achieve the same or substantially the same result as that contemplated by such term, provision,
covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that they would have executed the remaining
terms, provisions, covenants and restrictions without including any of such that may be hereafter declared invalid, illegal, void or
unenforceable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 34; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.13 <U>Rescission
and Withdrawal Right</U>. Notwithstanding anything to the contrary contained in (and without limiting any similar provisions of) any
of the other Transaction Documents, whenever any Purchaser exercises a right, election, demand or option under a Transaction Document
and the Company does not timely perform its related obligations within the periods therein provided, then such Purchaser may rescind
or withdraw, in its sole discretion from time to time upon written notice to the Company, any relevant notice, demand or election in
whole or in part without prejudice to its future actions and rights; <U>provided</U>, <U>however</U>, that, in the case of a rescission
of an exercise of a Warrant, the applicable Purchaser shall be required to return any shares of Common Stock subject to any such rescinded
exercise notice concurrently with the return to such Purchaser of the aggregate exercise price paid to the Company for such shares and
the restoration of such Purchaser&rsquo;s right to acquire such shares pursuant to such Purchaser&rsquo;s Warrant (including, issuance
of a replacement warrant certificate evidencing such restored right).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.14 <U>Replacement
of Securities</U>. If any certificate or instrument evidencing any Securities is mutilated, lost, stolen or destroyed, the Company shall
issue or cause to be issued in exchange and substitution for and upon cancellation thereof (in the case of mutilation), or in lieu of
and substitution therefor, a new certificate or instrument, but only upon receipt of evidence reasonably satisfactory to the Company
of such loss, theft or destruction. The applicant for a new certificate or instrument under such circumstances shall also pay any reasonable
third-party costs (including customary indemnity) associated with the issuance of such replacement Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.15 <U>Remedies</U>.
In addition to being entitled to exercise all rights provided herein or granted by law, including recovery of damages, each of the Purchasers
and the Company will be entitled to specific performance under the Transaction Documents. The parties agree that monetary damages may
not be adequate compensation for any loss incurred by reason of any breach of obligations contained in the Transaction Documents and
hereby agree to waive and not to assert in any Action for specific performance of any such obligation the defense that a remedy at law
would be adequate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.16 <U>Payment
Set Aside</U>. To the extent that the Company makes a payment or payments to any Purchaser pursuant to any Transaction Document or a
Purchaser enforces or exercises its rights thereunder, and such payment or payments or the proceeds of such enforcement or exercise or
any part thereof are subsequently invalidated, declared to be fraudulent or preferential, set aside, recovered from, disgorged by or
are required to be refunded, repaid or otherwise restored to the Company, a trustee, receiver or any other Person under any law (including,
without limitation, any bankruptcy law, state or federal law, common law or equitable cause of action), then to the extent of any such
restoration the obligation or part thereof originally intended to be satisfied shall be revived and continued in full force and effect
as if such payment had not been made or such enforcement or setoff had not occurred.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.17 <U>Independent
Nature of Purchasers&rsquo; Obligations and Rights</U>. The obligations of each Purchaser under any Transaction Document are several
and not joint with the obligations of any other Purchaser, and no Purchaser shall be responsible in any way for the performance or non-performance
of the obligations of any other Purchaser under any Transaction Document. Nothing contained herein or in any other Transaction Document,
and no action taken by any Purchaser pursuant hereto or thereto, shall be deemed to constitute the Purchasers as a partnership, an association,
a joint venture or any other kind of entity, or create a presumption that the Purchasers are in any way acting in concert or as a group
with respect to such obligations or the transactions contemplated by the Transaction Documents. Each Purchaser shall be entitled to independently
protect and enforce its rights including, without limitation, the rights arising out of this Agreement or out of the other Transaction
Documents, and it shall not be necessary for any other Purchaser to be joined as an additional party in any Proceeding for such purpose.
Each Purchaser has been represented by its own separate legal counsel in its review and negotiation of the Transaction Documents. The
Company has elected to provide all Purchasers with the same terms and Transaction Documents for the convenience of the Company and not
because it was required or requested to do so by any of the Purchasers. It is expressly understood and agreed that each provision contained
in this Agreement and in each other Transaction Document is between the Company and a Purchaser, solely, and not between the Company
and the Purchasers collectively and not between and among the Purchasers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 35; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.18 <U>Liquidated
Damages</U>. The Company&rsquo;s obligations to pay any partial liquidated damages or other amounts owing under the Transaction Documents
is a continuing obligation of the Company and shall not terminate until all unpaid partial liquidated damages and other amounts have
been paid notwithstanding the fact that the instrument or security pursuant to which such partial liquidated damages or other amounts
are due and payable shall have been canceled.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.19 <U>Saturdays,
Sundays, Holidays, etc.</U> If the last or appointed day for the taking of any action or the expiration of any right required or granted
herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.20 <U>Construction</U>.
The parties agree that each of them and/or their respective counsel have reviewed and had an opportunity to revise the Transaction Documents
and, therefore, the normal rule of construction to the effect that any ambiguities are to be resolved against the drafting party shall
not be employed in the interpretation of the Transaction Documents or any amendments thereto. In addition, each and every reference to
share prices and shares of Common Stock in any Transaction Document shall be subject to adjustment for reverse and forward stock splits,
stock dividends, stock combinations and other similar transactions of the Common Stock that occur after the date of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.21 <B><U>WAIVER
OF JURY TRIAL</U>. <U>IN ANY ACTION, SUIT, OR PROCEEDING IN ANY JURISDICTION BROUGHT BY ANY PARTY AGAINST ANY OTHER PARTY, THE PARTIES
EACH KNOWINGLY AND INTENTIONALLY, TO THE GREATEST EXTENT PERMITTED BY APPLICABLE LAW, HEREBY ABSOLUTELY, UNCONDITIONALLY, IRREVOCABLY
AND EXPRESSLY WAIVES FOREVER TRIAL BY JURY. </U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(Signature
Pages Follow)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 36; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN WITNESS WHEREOF, the parties hereto have caused this Securities Purchase Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WRAP
    TECHNOLOGIES, INC. <FONT STYLE="text-transform: uppercase">&nbsp;</FONT></B>&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Address
    for Notice:</U></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; width: 44%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; padding-right: 0pt; padding-left: 0pt; width: 49%"><P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Scot
    Cohen</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">E-Mail:
scohen@wrap.com</FONT></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer and Chairman of the Board</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[REMAINDER
OF PAGE INTENTIONALLY LEFT BLANK</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SIGNATURE
PAGE FOR PURCHASER FOLLOWS]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 37; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[PURCHASER
SIGNATURE PAGES TO WRAP SECURITIES PURCHASE AGREEMENT]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories
as of the date first indicated above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Purchaser: ________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Signature
of Authorized Signatory of Purchaser</I>: _________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Authorized Signatory: _______________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
of Authorized Signatory: ________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email
Address of Authorized Signatory: _________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address
for Notice to Purchaser:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address
for Delivery of Securities to Purchaser (if not same as address for notice):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subscription
Amount: $_________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares:
_________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-Funded
Warrants: _______________ Beneficial Ownership Blocker &#9744; 4.99% or &#9744; 9.99%</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
Warrants: _____________ Beneficial Ownership Blocker &#9744; 4.99% or &#9744; 9.99%</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EIN
Number: _______________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[SIGNATURE
PAGES CONTINUE]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P>

<!-- Field: Page; Sequence: 38; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>5
<FILENAME>ex10-2.htm
<DESCRIPTION>EX-10.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibit
10.2</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">REGISTRATION
RIGHTS AGREEMENT</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Registration Rights Agreement (this &ldquo;<U>Agreement</U>&rdquo;) is made and entered into as of February 2, 2026, by and between Wrap
Technologies, Inc., a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;), and each of the several purchasers signatory hereto (each
such purchaser, a &ldquo;<U>Purchaser</U>&rdquo; and, collectively, the &ldquo;<U>Purchasers</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Agreement is made pursuant to the Securities Purchase Agreement, dated as of the date hereof, between the Company and each Purchaser
(the &ldquo;<U>Purchase Agreement</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company and each Purchaser hereby agree as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
<U>Definitions</U>.</FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Capitalized
terms used and not otherwise defined herein that are defined in the Purchase Agreement shall have the meanings given such terms in the
Purchase Agreement.</B> As used in this Agreement, the following terms shall have the following meanings:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Advice</U>&rdquo;
shall have the meaning set forth in Section 6(d).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Effectiveness
Date</U>&rdquo; means, with respect to the Initial Registration Statement required to be filed hereunder, the 90<SUP>th</SUP> calendar
day following the date hereof (or, in the event of a &ldquo;full review&rdquo; by the Commission, the 120<SUP>th</SUP> calendar day following
the date hereof) and with respect to any additional Registration Statements which may be required pursuant to Section 2(c) or Section
3(c), the 90<SUP>th</SUP> calendar day following the date on which an additional Registration Statement is required to be filed hereunder
(or, in the event of a &ldquo;full review&rdquo; by the Commission, the 120<SUP>th</SUP> calendar day following the date such additional
Registration Statement is required to be filed hereunder); <U>provided</U>, <U>however</U>, that in the event the Company is notified
by the Commission that one or more of the above Registration Statements will not be reviewed or is no longer subject to further review
and comments, the Effectiveness Date as to such Registration Statement shall be the fifth (5<SUP>th</SUP>) Trading Day following the
date on which the Company is so notified if such date precedes the dates otherwise required above, provided, further, if Stockholder
Approval (if required) is not received by such date, the Effectiveness Date as to such Registration Statement shall be the second (2<SUP>nd</SUP>)
Trading Day following the Stockholder Approval Date; provided further, if such Effectiveness Date falls on a day that is not a Trading
Day, then the Effectiveness Date shall be the next succeeding Trading Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Effectiveness
Period</U>&rdquo; shall have the meaning set forth in Section 2(a).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Event</U>&rdquo;
shall have the meaning set forth in Section 2(d).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Event
Date</U>&rdquo; shall have the meaning set forth in Section 2(d).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Filing
Date</U>&rdquo; means, with respect to the Initial Registration Statement required hereunder, the 60<SUP>th</SUP> calendar day following
the date hereof and, with respect to any additional Registration Statements which may be required pursuant to Section 2(c) or Section
3(c), the earliest practicable date on which the Company is permitted by SEC Guidance to file such additional Registration Statement
related to the Registrable Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Holder</U>&rdquo;
or &ldquo;<U>Holders</U>&rdquo; means the holder or holders, as the case may be, from time to time of Registrable Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Indemnified
Party</U>&rdquo; shall have the meaning set forth in Section 5(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Indemnifying
Party</U>&rdquo; shall have the meaning set forth in Section 5(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Initial
Registration Statement</U>&rdquo; means the initial Registration Statement filed pursuant to this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Losses</U>&rdquo;
shall have the meaning set forth in Section 5(a).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Plan
of Distribution</U>&rdquo; shall have the meaning set forth in Section 2(a).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Prospectus</U>&rdquo;
means the prospectus included in a Registration Statement (including, without limitation, a prospectus that includes any information
previously omitted from a prospectus filed as part of an effective registration statement in reliance upon Rule 430A promulgated by the
Commission pursuant to the Securities Act), as amended or supplemented by any prospectus supplement, with respect to the terms of the
offering of any portion of the Registrable Securities covered by a Registration Statement, and all other amendments and supplements to
the Prospectus, including post-effective amendments, and all material incorporated by reference or deemed to be incorporated by reference
in such Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Registrable
Securities</U>&rdquo; means, as of any date of determination, (a) all Shares, (b) all Warrant Shares then issued and issuable upon exercise
of the Warrants (assuming on such date the Warrants are exercised in full without regard to any exercise limitations therein), and (c)
any securities issued or then issuable upon any stock split, dividend or other distribution, recapitalization or similar event with respect
to the foregoing; <U>provided, however</U>, that any such Registrable Securities shall cease to be Registrable Securities (and the Company
shall not be required to maintain the effectiveness of any, or file another, Registration Statement hereunder with respect thereto) for
so long as (a) a Registration Statement with respect to the sale of such Registrable Securities is declared effective by the Commission
under the Securities Act and such Registrable Securities have been disposed of by the Holder in accordance with such effective Registration
Statement, (b) such Registrable Securities have been previously sold in accordance with Rule 144, or (c) such securities become eligible
for resale without volume or manner-of-sale restrictions and without current public information pursuant to Rule 144 as set forth in
a written opinion letter to such effect, addressed, delivered and acceptable to the Transfer Agent and the affected Holders (assuming
that such securities and any securities issuable upon exercise, conversion or exchange of which, or as a dividend upon which, such securities
were issued or are issuable, were at no time held by any Affiliate of the Company, as reasonably determined by the Company, upon the
advice of counsel to the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Registration
Statement</U>&rdquo; means any registration statement required to be filed hereunder pursuant to Section 2(a) and any additional registration
statements contemplated by Section 2(c) or Section 3(c), including (in each case) the Prospectus, amendments and supplements to any such
registration statement or Prospectus, including pre- and post-effective amendments, all exhibits thereto, and all material incorporated
by reference or deemed to be incorporated by reference in any such registration statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Rule
415</U>&rdquo; means Rule 415 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted
from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect
as such Rule.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Rule
424</U>&rdquo; means Rule 424 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted
from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect
as such Rule.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Selling
Stockholder Questionnaire</U>&rdquo; shall have the meaning set forth in Section 3(a).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>SEC
Guidance</U>&rdquo; means (i) any publicly-available written or oral guidance of the Commission staff, or any comments, requirements
or requests of the Commission staff and (ii) the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
<U>Shelf Registration</U>.</FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
On or prior to each Filing Date, the Company shall prepare and file with the Commission a Registration Statement covering the resale
of all of the Registrable Securities that are not then registered on an effective Registration Statement for an offering to be made on
a continuous basis pursuant to Rule 415. Each Registration Statement filed hereunder shall be on Form S-3 (except if the Company is not
then eligible to register for resale the Registrable Securities on Form S-3, in which case such registration shall be on another appropriate
form in accordance herewith, subject to the provisions of Section 2(e)) and shall contain (unless otherwise directed by at least 85%
in interest of the Holders) substantially the &ldquo;<U>Plan of Distribution</U>&rdquo; attached hereto as <U>Annex A</U> and substantially
the &ldquo;<U>Selling Stockholder</U>&rdquo; section attached hereto as <U>Annex B</U>; <U>provided</U>, <U>however</U>, that no Holder
shall be required to be named as an &ldquo;underwriter&rdquo; without such Holder&rsquo;s express prior written consent. Subject to the
terms of this Agreement, the Company shall use its best efforts to cause a Registration Statement filed under this Agreement (including,
without limitation, under Section 3(c)) to be declared effective under the Securities Act as promptly as possible after the filing thereof,
but in any event no later than the applicable Effectiveness Date, and shall use its best efforts to keep such Registration Statement
continuously effective under the Securities Act until the date that all Registrable Securities covered by such Registration Statement
(i) have been sold, thereunder or pursuant to Rule 144, or (ii) may be sold without volume or manner-of-sale restrictions pursuant to
Rule 144 and without the requirement for the Company to be in compliance with the current public information requirement under Rule 144,
as determined by the counsel to the Company pursuant to a written opinion letter to such effect, addressed and acceptable to the Transfer
Agent and the affected Holders (the &ldquo;<U>Effectiveness Period</U>&rdquo;). The Company shall telephonically request effectiveness
of a Registration Statement as of 5:00 p.m. (New York City time) on a Trading Day. The Company shall immediately notify the Holders via
e-mail of the effectiveness of a Registration Statement on the same Trading Day that the Company telephonically confirms effectiveness
with the Commission, which shall be the date requested for effectiveness of such Registration Statement. The Company shall, by 9:30 a.m.
(New York City time) on the Trading Day after the effective date of such Registration Statement, file a final Prospectus with the Commission
as required by Rule 424. Failure to so notify the Holder within one (1) Trading Day of such notification of effectiveness or failure
to file a final Prospectus as foresaid shall be deemed an Event under Section 2(d).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Notwithstanding the registration obligations set forth in Section 2(a), if the Commission informs the Company that all of the Registrable
Securities cannot, as a result of the application of Rule 415, be registered for resale as a secondary offering on a single registration
statement, the Company agrees to promptly inform each of the Holders thereof and use its commercially reasonable efforts to file amendments
to the Initial Registration Statement as required by the Commission, covering the maximum number of Registrable Securities permitted
to be registered by the Commission, on Form S-3 or such other form available to register for resale the Registrable Securities as a secondary
offering, subject to the provisions of Section 2(e); with respect to filing on Form S-3 or other appropriate form, and subject to the
provisions of Section 2(d) with respect to the payment of liquidated damages; <U>provided</U>, <U>however</U>, that prior to filing such
amendment, the Company shall be obligated to use diligent efforts to advocate with the Commission for the registration of all of the
Registrable Securities in accordance with the SEC Guidance, including without limitation, Compliance and Disclosure Interpretation 612.09.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
Notwithstanding any other provision of this Agreement and subject to the payment of liquidated damages pursuant to Section 2(d), if the
Commission or any SEC Guidance sets forth a limitation on the number of Registrable Securities permitted to be registered on a particular
Registration Statement as a secondary offering (and notwithstanding that the Company used diligent efforts to advocate with the Commission
for the registration of all or a greater portion of Registrable Securities), unless otherwise directed in writing by a Holder as to its
Registrable Securities, the number of Registrable Securities to be registered on such Registration Statement will be reduced as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">First,
                                            the Company shall reduce or eliminate any securities to be included other than Registrable
                                            Securities;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Second,
                                            the Company shall reduce Registrable Securities represented by Common Warrant Shares (applied,
                                            in the case that some Common Warrant Shares may be registered, to the Holders on a pro rata
                                            basis based on the total number of unregistered Common Warrant Shares held by such Holders);
                                            and</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Third,
                                            the Company shall reduce Registrable Securities represented by Shares and Pre-Funded Warrants
                                            (applied, in the case that some Shares and Pre-Funded Warrants may be registered, to the
                                            Holders on a pro rata basis based on the total number of unregistered Shares and Pre-Funded
                                            Warrants held by such Holders).</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event of a cutback hereunder, the Company shall give the Holder at least five (5) Trading Days prior written notice along with the
calculations as to such Holder&rsquo;s allotment. In the event the Company amends the Initial Registration Statement in accordance with
the foregoing, the Company will use its best efforts to file with the Commission, as promptly as allowed by the Commission or SEC Guidance
provided to the Company or to registrants of securities in general, one or more registration statements on Form S-3 or such other form
available to register for resale those Registrable Securities that were not registered for resale on the Initial Registration Statement,
as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
If: (i) the Initial Registration Statement is not filed on or prior to its Filing Date (if the Company files the Initial Registration
Statement without affording the Holders the opportunity to review and comment on the same as required by Section 3(a) herein or the Company
subsequently withdraws the filing of the Registration Statement, the Company shall be deemed to have not satisfied this clause (i) as
of the Filing Date), or (ii) the Company fails to file with the Commission a request for acceleration of a Registration Statement in
accordance with Rule 461 promulgated by the Commission pursuant to the Securities Act, within five (5) Trading Days of the date that
the Company is notified (orally or in writing, whichever is earlier) by the Commission that such Registration Statement will not be &ldquo;reviewed&rdquo;
or will not be subject to further review, or (iii) prior to the effective date of a Registration Statement, the Company fails to file
a pre-effective amendment and otherwise respond in writing to comments made by the Commission in respect of such Registration Statement
within ten (10) calendar days after the receipt of comments by or notice from the Commission that such amendment is required in order
for such Registration Statement to be declared effective, or (iv) a Registration Statement registering for resale all of the Registrable
Securities is not declared effective by the Commission by the Effectiveness Date of the Initial Registration Statement, or (v) after
the effective date of a Registration Statement, such Registration Statement ceases for any reason to remain continuously effective as
to all Registrable Securities included in such Registration Statement, or the Holders are otherwise not permitted to utilize the Prospectus
therein to resell such Registrable Securities, for more than ten (10) consecutive calendar days or more than an aggregate of fifteen
(15) calendar days (which need not be consecutive calendar days) during any 12-month period (any such failure or breach being referred
to as an &ldquo;<U>Event</U>&rdquo;, and for purposes of clauses (i) and (iv), the date on which such Event occurs, and for purpose of
clause (ii) the date on which such five (5) Trading Day period is exceeded, and for purpose of clause (iii) the date which such ten (10)
calendar day period is exceeded, and for purpose of clause (v) the date on which such ten (10) or fifteen (15) calendar day period, as
applicable, is exceeded being referred to as &ldquo;<U>Event Date</U>&rdquo;), then, in addition to any other rights the Holders may
have hereunder or under applicable law, on each such Event Date and on each monthly anniversary of each such Event Date (if the applicable
Event shall not have been cured by such date) until the applicable Event is cured, the Company shall pay to each Holder an amount in
cash, as partial liquidated damages and not as a penalty, equal to the product of 1.0% multiplied by the aggregate Subscription Amount
paid by such Holder pursuant to the Purchase Agreement. The parties agree that the maximum aggregate liquidated damages payable to a
Holder under this Agreement shall be 6% of the aggregate Subscription Amount paid by such Holder pursuant to the Purchase Agreement.
If the Company fails to pay any partial liquidated damages pursuant to this Section in full within seven days after the date payable,
the Company will pay interest thereon at a rate of 18% per annum (or such lesser maximum amount that is permitted to be paid by applicable
law) to the Holder, accruing daily from the date such partial liquidated damages are due until such amounts, plus all such interest thereon,
are paid in full. The partial liquidated damages pursuant to the terms hereof shall apply on a daily pro rata basis for any portion of
a month prior to the cure of an Event.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
If Form S-3 is not available for the registration of the resale of Registrable Securities hereunder, the Company shall (i) register the
resale of the Registrable Securities on another appropriate form and (ii) undertake to register the Registrable Securities on Form S-3
as soon as such form is available, provided that the Company shall maintain the effectiveness of the Registration Statement then in effect
until such time as a Registration Statement on Form S-3 covering the Registrable Securities has been declared effective by the Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
Notwithstanding anything to the contrary contained herein, in no event shall the Company be permitted to name any Holder or affiliate
of a Holder as any underwriter without the prior written consent of such Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
<U>Registration Procedures</U>.</FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Company&rsquo;s registration obligations hereunder, the Company shall:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Not less than five (5) Trading Days prior to the filing of each Registration Statement and not less than one (1) Trading Day prior to
the filing of any related Prospectus or any amendment or supplement thereto (including any document that would be incorporated or deemed
to be incorporated therein by reference), the Company shall (i) furnish to each Holder copies of all such documents proposed to be filed,
which documents (other than those incorporated or deemed to be incorporated by reference) will be subject to the review of such Holders,
and (ii) cause its officers and directors, counsel and independent registered public accountants to respond to such inquiries as shall
be necessary, in the reasonable opinion of respective counsel to each Holder, to conduct a reasonable investigation within the meaning
of the Securities Act. The Company shall not file a Registration Statement or any such Prospectus or any amendments or supplements thereto
to which the Holders of a majority of the Registrable Securities shall reasonably object in good faith, provided that, the Company is
notified of such objection in writing no later than five (5) Trading Days after the Holders have been so furnished copies of a Registration
Statement or one (1) Trading Day after the Holders have been so furnished copies of any related Prospectus or amendments or supplements
thereto. Each Holder agrees to furnish to the Company a completed questionnaire in the form attached to this Agreement as <U>Annex C</U>
(a &ldquo;<U>Selling Stockholder Questionnaire</U>&rdquo;) on a date that is not less than two (2) Trading Days prior to the Filing Date
or by the end of the fourth (4<SUP>th</SUP>) Trading Day following the date on which such Holder receives draft materials in accordance
with this Section.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
(i) Prepare and file with the Commission such amendments, including post-effective amendments, to a Registration Statement and the Prospectus
used in connection therewith as may be necessary to keep a Registration Statement continuously effective as to the applicable Registrable
Securities for the Effectiveness Period and prepare and file with the Commission such additional Registration Statements in order to
register for resale under the Securities Act all of the Registrable Securities, (ii) cause the related Prospectus to be amended or supplemented
by any required Prospectus supplement (subject to the terms of this Agreement), and, as so supplemented or amended, to be filed pursuant
to Rule 424, (iii) respond as promptly as reasonably possible to any comments received from the Commission with respect to a Registration
Statement or any amendment thereto and provide as promptly as reasonably possible to the Holders true and complete copies of all correspondence
from and to the Commission relating to a Registration Statement (provided that, the Company shall excise any information contained therein
which would constitute material non-public information regarding the Company or any of its Subsidiaries), and (iv) comply in all material
respects with the applicable provisions of the Securities Act and the Exchange Act with respect to the disposition of all Registrable
Securities covered by a Registration Statement during the applicable period in accordance (subject to the terms of this Agreement) with
the intended methods of disposition by the Holders thereof set forth in such Registration Statement as so amended or in such Prospectus
as so supplemented.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
If during the Effectiveness Period, the number of Registrable Securities at any time exceeds 100% of the number of shares of Common Stock
then registered in a Registration Statement, then the Company shall file as soon as reasonably practicable, but in any case prior to
the applicable Filing Date, an additional Registration Statement covering the resale by the Holders of not less than the number of such
Registrable Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
Notify the Holders of Registrable Securities to be sold (which notice shall, pursuant to clauses (iii) through (vi) hereof, be accompanied
by an instruction to suspend the use of the Prospectus until the requisite changes have been made) as promptly as reasonably possible
(and, in the case of (i)(A) below, not less than one (1) Trading Day prior to such filing) and (if requested by any such Person) confirm
such notice in writing no later than one (1) Trading Day following the day (i)(A) when a Prospectus or any Prospectus supplement or post-effective
amendment to a Registration Statement is proposed to be filed, (B) when the Commission notifies the Company whether there will be a &ldquo;review&rdquo;
of such Registration Statement and whenever the Commission comments in writing on such Registration Statement, and (C) with respect to
a Registration Statement or any post-effective amendment, when the same has become effective, (ii) of any request by the Commission or
any other federal or state governmental authority for amendments or supplements to a Registration Statement or Prospectus or for additional
information, (iii) of the issuance by the Commission or any other federal or state governmental authority of any stop order suspending
the effectiveness of a Registration Statement covering any or all of the Registrable Securities or the initiation of any Proceedings
for that purpose, (iv) of the receipt by the Company of any notification with respect to the suspension of the qualification or exemption
from qualification of any of the Registrable Securities for sale in any jurisdiction, or the initiation or threatening of any Proceeding
for such purpose, (v) of the occurrence of any event or passage of time that makes the financial statements included in a Registration
Statement ineligible for inclusion therein or any statement made in a Registration Statement or Prospectus or any document incorporated
or deemed to be incorporated therein by reference untrue in any material respect or that requires any revisions to a Registration Statement,
Prospectus or other documents so that, in the case of a Registration Statement or the Prospectus, as the case may be, it will not contain
any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements
therein, in light of the circumstances under which they were made, not misleading, and (vi) of the occurrence or existence of any pending
corporate development with respect to the Company that the Company believes may be material and that, in the determination of the Company,
makes it not in the best interest of the Company to allow continued availability of a Registration Statement or Prospectus; <U>provided</U>,
<U>however</U>, that in no event shall any such notice contain any information which would constitute material, non-public information
regarding the Company or any of its Subsidiaries, and the Company agrees that the Holders shall not have any duty of confidentiality
to the Company or any of its Subsidiaries and shall not have any duty to the Company or any of its Subsidiaries not to trade on the basis
of such information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
Use its best efforts to avoid the issuance of, or, if issued, obtain the withdrawal of (i) any order stopping or suspending the effectiveness
of a Registration Statement, or (ii) any suspension of the qualification (or exemption from qualification) of any of the Registrable
Securities for sale in any jurisdiction, at the earliest practicable moment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
Furnish to each Holder, without charge, at least one conformed copy of each such Registration Statement and each amendment thereto, including
financial statements and schedules, all documents incorporated or deemed to be incorporated therein by reference to the extent requested
by such Person, and all exhibits to the extent requested by such Person (including those previously furnished or incorporated by reference)
promptly after the filing of such documents with the Commission; provided, that any such item which is available on the EDGAR system
(or successor thereto) need not be furnished in physical form.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
Subject to the terms of this Agreement, the Company hereby consents to the use of such Prospectus and each amendment or supplement thereto
by each of the selling Holders in connection with the offering and sale of the Registrable Securities covered by such Prospectus and
any amendment or supplement thereto, except after the giving of any notice pursuant to Section 3(d).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
Prior to any resale of Registrable Securities by a Holder, use its commercially reasonable efforts to register or qualify or cooperate
with the selling Holders in connection with the registration or qualification (or exemption from the registration or qualification) of
such Registrable Securities for the resale by the Holder under the securities or Blue Sky laws of such jurisdictions within the United
States as any Holder reasonably requests in writing, to keep each registration or qualification (or exemption therefrom) effective during
the Effectiveness Period and to do any and all other acts or things reasonably necessary to enable the disposition in such jurisdictions
of the Registrable Securities covered by each Registration Statement; provided, that the Company shall not be required to qualify generally
to do business in any jurisdiction where it is not then so qualified, subject the Company to any material tax in any such jurisdiction
where it is not then so subject or file a general consent to service of process in any such jurisdiction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
If requested by a Holder, cooperate with such Holder to facilitate the timely preparation and delivery of certificates representing Registrable
Securities to be delivered to a transferee pursuant to a Registration Statement, which certificates shall be free, to the extent permitted
by the Purchase Agreement, of all restrictive legends, and to enable such Registrable Securities to be in such denominations and registered
in such names as any such Holder may request.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)
Upon the occurrence of any event contemplated by Section 3(d), as promptly as reasonably possible under the circumstances taking into
account the Company&rsquo;s good faith assessment of any adverse consequences to the Company and its stockholders of the premature disclosure
of such event, prepare a supplement or amendment, including a post-effective amendment, to a Registration Statement or a supplement to
the related Prospectus or any document incorporated or deemed to be incorporated therein by reference, and file any other required document
so that, as thereafter delivered, neither a Registration Statement nor such Prospectus will contain an untrue statement of a material
fact or omit to state a material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances
under which they were made, not misleading. <FONT STYLE="text-decoration-style: double">If the Company notifies the Holders in accordance
with clauses (iii) through (vi) of Section 3(d) above to suspend the use of any Prospectus until the requisite changes to such Prospectus
have been made, then the Holders shall suspend use of such Prospectus. The Company will use its best efforts to ensure that the use of
the Prospectus may be resumed as promptly as is practicable. The Company shall be entitled to exercise its right under this Section 3(j)
to suspend the availability of a Registration Statement and Prospectus, subject to the payment of partial liquidated damages otherwise
required pursuant to Section 2(d), for a period not to exceed 60 calendar days (which need not be consecutive days) in any 12-month period</FONT>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)
Otherwise use commercially reasonable efforts to comply with all applicable rules and regulations of the Commission under the Securities
Act and the Exchange Act, including, without limitation, Rule 172 under the Securities Act, file any final Prospectus, including any
supplement or amendment thereof, with the Commission pursuant to Rule 424 under the Securities Act, promptly inform the Holders in writing
if, at any time during the Effectiveness Period, the Company does not satisfy the conditions specified in Rule 172 and, as a result thereof,
the Holders are required to deliver a Prospectus in connection with any disposition of Registrable Securities and take such other actions
as may be reasonably necessary to facilitate the registration of the Registrable Securities hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)
The Company shall use its best efforts to maintain eligibility for use of Form S-3 (or any successor form thereto) for the registration
of the resale of Registrable Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)
The Company may require each selling Holder to furnish to the Company a certified statement as to the number of shares of Common Stock
beneficially owned by such Holder and, if required by the Commission, the natural persons thereof that have voting and dispositive control
over the shares. During any periods that the Company is unable to meet its obligations hereunder with respect to the registration of
the Registrable Securities solely because any Holder fails to furnish such information within three Trading Days of the Company&rsquo;s
request, any liquidated damages that are accruing at such time as to such Holder only shall be tolled and any Event that may otherwise
occur solely because of such delay shall be suspended as to such Holder only, until such information is delivered to the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.
<U>Registration Expenses</U>. All fees and expenses incident to the performance of or compliance with, this Agreement by the Company
shall be borne by the Company whether or not any Registrable Securities are sold pursuant to a Registration Statement. The fees and expenses
referred to in the foregoing sentence shall include, without limitation, (i) all registration and filing fees (including, without limitation,
fees and expenses of the Company&rsquo;s counsel and independent registered public accountants) (A) with respect to filings made with
the Commission, (B) with respect to filings required to be made with any Trading Market on which the Common Stock is then listed for
trading, and (C) in compliance with applicable state securities or Blue Sky laws reasonably agreed to by the Company in writing (including,
without limitation, fees and disbursements of counsel for the Company in connection with Blue Sky qualifications or exemptions of the
Registrable Securities), (ii) printing expenses (including, without limitation, expenses of printing certificates for Registrable Securities),
(iii) messenger, telephone and delivery expenses, (iv) fees and disbursements of counsel for the Company, (v) Securities Act liability
insurance, if the Company so desires such insurance, and (vi) fees and expenses of all other Persons retained by the Company in connection
with the consummation of the transactions contemplated by this Agreement. In addition, the Company shall be responsible for all of its
internal expenses incurred in connection with the consummation of the transactions contemplated by this Agreement (including, without
limitation, all salaries and expenses of its officers and employees performing legal or accounting duties), the expense of any annual
audit and the fees and expenses incurred in connection with the listing of the Registrable Securities on any securities exchange as required
hereunder. In no event shall the Company be responsible for any broker or similar commissions of any Holder or, except to the extent
provided for in the Transaction Documents, any legal fees or other costs of the Holders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.
<U>Indemnification</U>.</FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Indemnification by the Company</U>. The Company shall, notwithstanding any termination of this Agreement, indemnify and hold harmless
each Holder, the officers, directors, members, partners, agents, brokers (including brokers who offer and sell Registrable Securities
as principal as a result of a pledge or any failure to perform under a margin call of Common Stock), investment advisors and employees
(and any other Persons with a functionally equivalent role of a Person holding such titles, notwithstanding a lack of such title or any
other title) of each of them, each Person who controls any such Holder (within the meaning of Section 15 of the Securities Act or Section
20 of the Exchange Act) and the officers, directors, members, stockholders, partners, agents and employees (and any other Persons with
a functionally equivalent role of a Person holding such titles, notwithstanding a lack of such title or any other title) of each such
controlling Person, to the fullest extent permitted by applicable law, from and against any and all losses, claims, damages, liabilities,
costs (including, without limitation, reasonable attorneys&rsquo; fees) and expenses (collectively, &ldquo;<U>Losses</U>&rdquo;), as
incurred, arising out of or relating to (1) any untrue or alleged untrue statement of a material fact contained in a Registration Statement,
any Prospectus or any form of prospectus or in any amendment or supplement thereto or in any preliminary prospectus, or arising out of
or relating to any omission or alleged omission of a material fact required to be stated therein or necessary to make the statements
therein (in the case of any Prospectus or supplement thereto, in light of the circumstances under which they were made) not misleading
or (2) any violation or alleged violation by the Company of the Securities Act, the Exchange Act or any state securities law, or any
rule or regulation thereunder, in connection with the performance of its obligations under this Agreement, except to the extent, but
only to the extent, that (i) such untrue statements or omissions are based solely upon information regarding such Holder furnished in
writing to the Company by such Holder expressly for use therein, or to the extent that such information relates to such Holder or such
Holder&rsquo;s proposed method of distribution of Registrable Securities and was reviewed and expressly approved in writing by such Holder
expressly for use in a Registration Statement, such Prospectus or in any amendment or supplement thereto (it being understood that the
Holder has approved <U>Annex A</U> hereto for this purpose) or (ii) in the case of an occurrence of an event of the type specified in
Section 3(d)(iii)-(vi), the use by such Holder of an outdated, defective or otherwise unavailable Prospectus after the Company has notified
such Holder in writing that the Prospectus is outdated, defective or otherwise unavailable for use by such Holder and prior to the receipt
by such Holder of the Advice contemplated in Section 6(d). The Company shall notify the Holders promptly of the institution, threat or
assertion of any Proceeding arising from or in connection with the transactions contemplated by this Agreement of which the Company is
aware. Such indemnity shall remain in full force and effect regardless of any investigation made by or on behalf of such indemnified
person and shall survive the transfer of any Registrable Securities by any of the Holders in accordance with Section 6(g).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Indemnification by Holders</U>. Each Holder shall, severally and not jointly, indemnify and hold harmless the Company, its directors,
officers, agents and employees, each Person who controls the Company (within the meaning of Section 15 of the Securities Act and Section
20 of the Exchange Act), and the directors, officers, agents or employees of such controlling Persons, to the fullest extent permitted
by applicable law, from and against all Losses, as incurred, to the extent arising out of or based solely upon: any untrue or alleged
untrue statement of a material fact contained in any Registration Statement, any Prospectus, or in any amendment or supplement thereto
or in any preliminary prospectus, or arising out of or relating to any omission or alleged omission of a material fact required to be
stated therein or necessary to make the statements therein (in the case of any Prospectus or supplement thereto, in light of the circumstances
under which they were made) not misleading (i) to the extent, but only to the extent, that such untrue statement or omission is contained
in any information so furnished in writing by such Holder to the Company expressly for inclusion in such Registration Statement or such
Prospectus or (ii) to the extent, but only to the extent, that such information relates to such Holder&rsquo;s information provided in
the Selling Stockholder Questionnaire or the proposed method of distribution of Registrable Securities and was reviewed and expressly
approved in writing by such Holder expressly for use in a Registration Statement (it being understood that the Holder has approved <U>Annex
A</U> hereto for this purpose), such Prospectus or in any amendment or supplement thereto. In no event shall the liability of a selling
Holder be greater in amount than the dollar amount of the proceeds (net of all expenses paid by such Holder in connection with any claim
relating to this Section 5 and the amount of any damages such Holder has otherwise been required to pay by reason of such untrue statement
or omission) received by such Holder upon the sale of the Registrable Securities included in the Registration Statement giving rise to
such indemnification obligation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Conduct of Indemnification Proceedings</U>. If any Proceeding shall be brought or asserted against any Person entitled to indemnity
hereunder (an &ldquo;<U>Indemnified Party</U>&rdquo;), such Indemnified Party shall promptly notify the Person from whom indemnity is
sought (the &ldquo;<U>Indemnifying Party</U>&rdquo;) in writing, and the Indemnifying Party shall have the right to assume the defense
thereof, including the employment of counsel reasonably satisfactory to the Indemnified Party and the payment of all fees and expenses
incurred in connection with defense thereof, provided that the failure of any Indemnified Party to give such notice shall not relieve
the Indemnifying Party of its obligations or liabilities pursuant to this Agreement, except (and only) to the extent that it shall be
finally determined by a court of competent jurisdiction (which determination is not subject to appeal or further review) that such failure
shall have materially and adversely prejudiced the Indemnifying Party.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
Indemnified Party shall have the right to employ separate counsel in any such Proceeding and to participate in the defense thereof, but
the fees and expenses of such counsel shall be at the expense of such Indemnified Party or Parties unless: (1) the Indemnifying Party
has agreed in writing to pay such fees and expenses, (2) the Indemnifying Party shall have failed promptly to assume the defense of such
Proceeding and to employ counsel reasonably satisfactory to such Indemnified Party in any such Proceeding, or (3) the named parties to
any such Proceeding (including any impleaded parties) include both such Indemnified Party and the Indemnifying Party, and counsel to
the Indemnified Party shall reasonably believe that a material conflict of interest is likely to exist if the same counsel were to represent
such Indemnified Party and the Indemnifying Party (in which case, if such Indemnified Party notifies the Indemnifying Party in writing
that it elects to employ separate counsel at the expense of the Indemnifying Party, the Indemnifying Party shall not have the right to
assume the defense thereof and the reasonable fees and expenses of no more than one separate counsel shall be at the expense of the Indemnifying
Party). The Indemnifying Party shall not be liable for any settlement of any such Proceeding effected without its written consent, which
consent shall not be unreasonably withheld or delayed. No Indemnifying Party shall, without the prior written consent of the Indemnified
Party, effect any settlement of any pending Proceeding in respect of which any Indemnified Party is a party, unless such settlement includes
an unconditional release of such Indemnified Party from all liability on claims that are the subject matter of such Proceeding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the terms of this Agreement, all reasonable fees and expenses of the Indemnified Party (including reasonable fees and expenses to
the extent incurred in connection with investigating or preparing to defend such Proceeding in a manner not inconsistent with this Section)
shall be paid to the Indemnified Party, as incurred, within ten Trading Days of written notice thereof to the Indemnifying Party, provided
that the Indemnified Party shall promptly reimburse the Indemnifying Party for that portion of such fees and expenses applicable to such
actions for which such Indemnified Party is finally determined by a court of competent jurisdiction (which determination is not subject
to appeal or further review) not to be entitled to indemnification hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Contribution</U>. If the indemnification under Section 5(a) or 5(b) is unavailable to an Indemnified Party or insufficient to hold
an Indemnified Party harmless for any Losses, then each Indemnifying Party shall contribute to the amount paid or payable by such Indemnified
Party, in such proportion as is appropriate to reflect the relative fault of the Indemnifying Party and Indemnified Party in connection
with the actions, statements or omissions that resulted in such Losses as well as any other relevant equitable considerations. The relative
fault of such Indemnifying Party and Indemnified Party shall be determined by reference to, among other things, whether any action in
question, including any untrue or alleged untrue statement of a material fact or omission or alleged omission of a material fact, has
been taken or made by, or relates to information supplied by, such Indemnifying Party or Indemnified Party, and the parties&rsquo; relative
intent, knowledge, access to information and opportunity to correct or prevent such action, statement or omission. The amount paid or
payable by a party as a result of any Losses shall be deemed to include, subject to the limitations set forth in this Agreement, any
reasonable attorneys&rsquo; or other fees or expenses incurred by such party in connection with any Proceeding to the extent such party
would have been indemnified for such fees or expenses if the indemnification provided for in this Section was available to such party
in accordance with its terms.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
parties hereto agree that it would not be just and equitable if contribution pursuant to this Section 5(d) were determined by pro rata
allocation or by any other method of allocation that does not take into account the equitable considerations referred to in the immediately
preceding paragraph. In no event shall the contribution obligation of a Holder of Registrable Securities be greater in amount than the
dollar amount of the proceeds (net of all expenses paid by such Holder in connection with any claim relating to this Section 5 and the
amount of any damages such Holder has otherwise been required to pay by reason of such untrue or alleged untrue statement or omission
or alleged omission) received by it upon the sale of the Registrable Securities giving rise to such contribution obligation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
indemnity and contribution agreements contained in this Section are in addition to any liability that the Indemnifying Parties may have
to the Indemnified Parties.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.
<U>Miscellaneous</U>.</FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Remedies</U>. In the event of a breach by the Company or by a Holder of any of their respective obligations under this Agreement,
each Holder or the Company, as the case may be, in addition to being entitled to exercise all rights granted by law and under this Agreement,
including recovery of damages, shall be entitled to specific performance of its rights under this Agreement. Each of the Company and
each Holder agrees that monetary damages would not provide adequate compensation for any losses incurred by reason of a breach by it
of any of the provisions of this Agreement and hereby further agrees that, in the event of any action for specific performance in respect
of such breach, it shall not assert or shall waive the defense that a remedy at law would be adequate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>No Piggyback on Registrations; Prohibition on Filing Other Registration Statements</U>. Neither the Company nor any of its security
holders (other than the Holders in such capacity pursuant hereto) may include securities of the Company in any Registration Statements
other than the Registrable Securities. The Company shall not file any other registration statements until all Registrable Securities
are registered pursuant to a Registration Statement that is declared effective by the Commission, provided that this Section 6(b) shall
not prohibit the Company from filing amendments to registration statements filed prior to the date of this Agreement so long as no new
securities are registered on any such existing registration statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
[RESERVED]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Discontinued Disposition</U>. By its acquisition of Registrable Securities, each Holder agrees that, upon receipt of a notice from
the Company of the occurrence of any event of the kind described in Section 3(d)(iii) through (vi), such Holder will forthwith discontinue
disposition of such Registrable Securities under a Registration Statement until it is advised in writing (the &ldquo;<U>Advice</U>&rdquo;)
by the Company that the use of the applicable Prospectus (as it may have been supplemented or amended) may be resumed. The Company will
use its best efforts to ensure that the use of the Prospectus may be resumed as promptly as is practicable. The Company agrees and acknowledges
that any periods during which the Holder is required to discontinue the disposition of the Registrable Securities hereunder shall be
subject to the provisions of Section 2(d).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Amendments and Waivers</U>. The provisions of this Agreement, including the provisions of this sentence, may not be amended, modified
or supplemented, and waivers or consents to departures from the provisions hereof may not be given, unless the same shall be in writing
and signed by the Company and the Holders of 50.1% or more of the then outstanding Registrable Securities (for purposes of clarification,
this includes any Registrable Securities issuable upon exercise or conversion of any Security), provided that, if any amendment, modification
or waiver disproportionately and adversely impacts a Holder (or group of Holders), the consent of such disproportionately impacted Holder
(or group of Holders) shall be required. If a Registration Statement does not register all of the Registrable Securities pursuant to
a waiver or amendment done in compliance with the previous sentence, then the number of Registrable Securities to be registered for each
Holder shall be reduced pro rata among all Holders and each Holder shall have the right to designate which of its Registrable Securities
shall be omitted from such Registration Statement. Notwithstanding the foregoing, a waiver or consent to depart from the provisions hereof
with respect to a matter that relates exclusively to the rights of a Holder or some Holders and that does not directly or indirectly
affect the rights of other Holders may be given only by such Holder or Holders of all of the Registrable Securities to which such waiver
or consent relates; <U>provided</U>, <U>however</U>, that the provisions of this sentence may not be amended, modified, or supplemented
except in accordance with the provisions of the first sentence of this Section 6(e). No consideration shall be offered or paid to any
Person to amend or consent to a waiver or modification of any provision of this Agreement unless the same consideration also is offered
to all of the parties to this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<U>Notices</U>. Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be delivered
as set forth in the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
<U>Successors and Assigns</U>. This Agreement shall inure to the benefit of and be binding upon the successors and permitted assigns
of each of the parties and shall inure to the benefit of each Holder. The Company may not assign (except by merger) its rights or obligations
hereunder without the prior written consent of all of the Holders of the then outstanding Registrable Securities. Each Holder may assign
their respective rights hereunder in the manner and to the Persons as permitted under Section 5.7 of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
<U>No Inconsistent Agreements</U>. Neither the Company nor any of its Subsidiaries has entered, as of the date hereof, nor shall the
Company or any of its Subsidiaries, on or after the date of this Agreement, enter into any agreement with respect to its securities,
that would have the effect of impairing the rights granted to the Holders in this Agreement or otherwise conflicts with the provisions
hereof. Neither the Company nor any of its Subsidiaries has previously entered into any agreement granting any registration rights with
respect to any of its securities to any Person that have not been satisfied in full.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
<U>Execution and Counterparts</U>. This Agreement may be executed in two or more counterparts, all of which when taken together shall
be considered one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to
the other party, it being understood that both parties need not sign the same counterpart. In the event that any signature is delivered
by e-mail delivery of a &ldquo;.pdf&rdquo; format data file or any electronic signature complying with the U.S. federal ESIGN Act of
2000 (e.g., www.docusign.com), such signature shall create a valid and binding obligation of the party executing (or on whose behalf
such signature is executed) with the same force and effect as if such &ldquo;.pdf&rdquo; signature page were an original thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)
<U>Governing Law</U>. All questions concerning the construction, validity, enforcement and interpretation of this Agreement shall be
determined in accordance with the provisions of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)
<U>Cumulative Remedies</U>. The remedies provided herein are cumulative and not exclusive of any other remedies provided by law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)
<U>Severability</U>. If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to
be invalid, illegal, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall
remain in full force and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their commercially
reasonable efforts to find and employ an alternative means to achieve the same or substantially the same result as that contemplated
by such term, provision, covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that they would
have executed the remaining terms, provisions, covenants and restrictions without including any of such that may be hereafter declared
invalid, illegal, void or unenforceable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)
<U>Headings</U>. The headings in this Agreement are for convenience only, do not constitute a part of the Agreement and shall not be
deemed to limit or affect any of the provisions hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n)
<U>Independent Nature of Holders&rsquo; Obligations and Rights</U>. The obligations of each Holder hereunder are several and not joint
with the obligations of any other Holder hereunder, and no Holder shall be responsible in any way for the performance of the obligations
of any other Holder hereunder. Nothing contained herein or in any other agreement or document delivered at any closing, and no action
taken by any Holder pursuant hereto or thereto, shall be deemed to constitute the Holders as a partnership, an association, a joint venture
or any other kind of group or entity, or create a presumption that the Holders are in any way acting in concert or as a group or entity
with respect to such obligations or the transactions contemplated by this Agreement or any other matters, and the Company acknowledges
that the Holders are not acting in concert or as a group, and the Company shall not assert any such claim, with respect to such obligations
or transactions. Each Holder shall be entitled to protect and enforce its rights, including without limitation the rights arising out
of this Agreement, and it shall not be necessary for any other Holder to be joined as an additional party in any proceeding for such
purpose. The use of a single agreement with respect to the obligations of the Company contained was solely in the control of the Company,
not the action or decision of any Holder, and was done solely for the convenience of the Company and not because it was required or requested
to do so by any Holder. It is expressly understood and agreed that each provision contained in this Agreement is between the Company
and a Holder, solely, and not between the Company and the Holders collectively and not between and among Holders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">********************</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal"><I>(Signature
Pages Follow)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: normal; font-weight: normal"><I>&nbsp;</I></FONT></P>


<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the parties have executed this Registration Rights Agreement as of the date first written above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>wrap technologies,
  Inc.</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
  <TD STYLE="border-bottom: Black 1pt solid"></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Scot Cohen</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Chief Executive Officer and Chairman of the Board</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[SIGNATURE
PAGE OF HOLDERS FOLLOWS]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">[SIGNATURE
PAGE OF HOLDERS TO WRAP RRA]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Holder: __________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Signature
of Authorized Signatory of Holder</I>: __________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Authorized Signatory: _________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
of Authorized Signatory: __________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[SIGNATURE
PAGES CONTINUE]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Annex
A</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Plan
of Distribution</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
Selling Stockholder (the &ldquo;<U>Selling Stockholders</U>&rdquo;) of the securities and any of their pledgees, assignees and successors-in-interest
may, from time to time, sell any or all of their securities covered hereby on the principal Trading Market or any other stock exchange,
market or trading facility on which the securities are traded or in private transactions. These sales may be at fixed or negotiated prices.
A Selling Stockholder may use any one or more of the following methods when selling securities:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ordinary
                                            brokerage transactions and transactions in which the broker-dealer solicits purchasers;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">block
                                            trades in which the broker-dealer will attempt to sell the securities as agent but may position
                                            and resell a portion of the block as principal to facilitate the transaction;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">purchases
                                            by a broker-dealer as principal and resale by the broker-dealer for its account;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
                                            exchange distribution in accordance with the rules of the applicable exchange;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">privately
                                            negotiated transactions;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">settlement
                                            of short sales;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
                                            transactions through broker-dealers that agree with the Selling Stockholders to sell a specified
                                            number of such securities at a stipulated price per security;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">through
                                            the writing or settlement of options or other hedging transactions, whether through an options
                                            exchange or otherwise;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                            combination of any such methods of sale; or</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                            other method permitted pursuant to applicable law.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Selling Stockholders may also sell securities under Rule 144 or any other exemption from registration under the Securities Act of 1933,
as amended (the &ldquo;<U>Securities Act</U>&rdquo;), if available, rather than under this prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Broker-dealers
engaged by the Selling Stockholders may arrange for other brokers-dealers to participate in sales. Broker-dealers may receive commissions
or discounts from the Selling Stockholders (or, if any broker-dealer acts as agent for the purchaser of securities, from the purchaser)
in amounts to be negotiated, but, except as set forth in a supplement to this Prospectus, in the case of an agency transaction not in
excess of a customary brokerage commission in compliance with FINRA Rule 2121; and in the case of a principal transaction a markup or
markdown in compliance with FINRA Rule 2121.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the sale of the securities or interests therein, the Selling Stockholders may enter into hedging transactions with broker-dealers
or other financial institutions, which may in turn engage in short sales of the securities in the course of hedging the positions they
assume. The Selling Stockholders may also sell securities short and deliver these securities to close out their short positions, or loan
or pledge the securities to broker-dealers that in turn may sell these securities. The Selling Stockholders may also enter into option
or other transactions with broker-dealers or other financial institutions or create one or more derivative securities which require the
delivery to such broker-dealer or other financial institution of securities offered by this prospectus, which securities such broker-dealer
or other financial institution may resell pursuant to this prospectus (as supplemented or amended to reflect such transaction).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Selling Stockholders and any broker-dealers or agents that are involved in selling the securities may be deemed to be &ldquo;underwriters&rdquo;
within the meaning of the Securities Act in connection with such sales. In such event, any commissions received by such broker-dealers
or agents and any profit on the resale of the securities purchased by them may be deemed to be underwriting commissions or discounts
under the Securities Act. Each Selling Stockholder has informed the Company that it does not have any written or oral agreement or understanding,
directly or indirectly, with any person to distribute the securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is required to pay certain fees and expenses incurred by the Company incident to the registration of the securities. The Company
has agreed to indemnify the Selling Stockholders against certain losses, claims, damages and liabilities, including liabilities under
the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
agreed to keep this prospectus effective until the earlier of (i) the date on which the securities may be resold by the Selling Stockholders
without registration and without regard to any volume or manner-of-sale limitations by reason of Rule 144, without the requirement for
the Company to be in compliance with the current public information under Rule 144 under the Securities Act or any other rule of similar
effect or (ii) all of the securities have been sold pursuant to this prospectus or Rule 144 under the Securities Act or any other rule
of similar effect. The resale securities will be sold only through registered or licensed brokers or dealers if required under applicable
state securities laws. In addition, in certain states, the resale securities covered hereby may not be sold unless they have been registered
or qualified for sale in the applicable state or an exemption from the registration or qualification requirement is available and is
complied with.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
applicable rules and regulations under the Exchange Act, any person engaged in the distribution of the resale securities may not simultaneously
engage in market making activities with respect to the common stock for the applicable restricted period, as defined in Regulation M,
prior to the commencement of the distribution. In addition, the Selling Stockholders will be subject to applicable provisions of the
Exchange Act and the rules and regulations thereunder, including Regulation M, which may limit the timing of purchases and sales of the
common stock by the Selling Stockholders or any other person. We will make copies of this prospectus available to the Selling Stockholders
and have informed them of the need to deliver a copy of this prospectus to each purchaser at or prior to the time of the sale (including
by compliance with Rule 172 under the Securities Act).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 20; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Annex
B</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SELLING
STOCKHOLDERS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
common stock being offered by the selling stockholders are those previously issued to the selling stockholders, and those issuable to
the selling stockholders, upon exercise of the warrants. For additional information regarding the issuances of those shares of common
stock and warrants, see &ldquo;Private Placement of Shares of Common Stock and Warrants&rdquo; above. We are registering the shares of
common stock in order to permit the selling stockholders to offer the shares for resale from time to time. Except for the ownership of
the shares of common stock and the warrants, the selling stockholders have not had any material relationship with us within the past
three years.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
table below lists the selling stockholders and other information regarding the beneficial ownership of the shares of common stock by
each of the selling stockholders. The second column lists the number of shares of common stock beneficially owned by each selling stockholder,
based on its ownership of the shares of common stock and warrants, as of ________, 2026, assuming exercise of the warrants held by the
selling stockholders on that date, without regard to any limitations on exercises.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
third column lists the shares of common stock being offered by this prospectus by the selling stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with the terms of a registration rights agreement with the selling stockholders, this prospectus generally covers the resale
of the sum of (i) the number of shares of common stock issued to the selling stockholders in the &ldquo;Private Placement of Shares of
Common Stock and Warrants&rdquo; described above and (ii) the maximum number of shares of common stock issuable upon exercise of the
related warrants, determined as if the outstanding warrants were exercised in full as of the trading day immediately preceding the date
this registration statement was initially filed with the SEC, each as of the trading day immediately preceding the applicable date of
determination and all subject to adjustment as provided in the registration rights agreement, without regard to any limitations on the
exercise of the warrants. The fourth column assumes the sale of all of the shares offered by the selling stockholders pursuant to this
prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the terms of the warrants [and other warrants held by selling stockholders], a selling stockholder may not exercise [the] [any such]
warrants to the extent such exercise would cause such selling stockholder, together with its affiliates and attribution parties, to beneficially
own a number of shares of common stock which would exceed 4.99% or 9.99%, as applicable, of our then outstanding common stock following
such exercise, excluding for purposes of such determination shares of common stock issuable upon exercise of such warrants which have
not been exercised. The number of shares in the second and fourth columns do not reflect this limitation. The selling stockholders may
sell all, some or none of their shares in this offering. See &ldquo;Plan of Distribution.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left; width: 34%; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U><BR STYLE="clear: both">
    </U></B><U><BR>
    <B><BR>
    </B></U><B>Name of Selling stockholder</B></FONT></TD>
    <TD STYLE="padding-bottom: 1pt; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 20%; text-align: center"><P STYLE="margin-top: 0; margin-bottom: 0"><B>Number of shares of</B></P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Common Stock Owned</B></FONT></P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Prior to Offering</B></FONT></P></TD>
    <TD STYLE="padding-bottom: 1pt; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 20%; text-align: center"><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-size: 10pt"><B>Maximum
Number of</B></FONT></P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>shares of Common</B></FONT></P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Stock to be Sold</B></FONT></P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Pursuant to this</B></FONT></P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Prospectus</B></FONT></P></TD>
    <TD STYLE="padding-bottom: 1pt; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 20%; text-align: center"><P STYLE="margin-top: 0; margin-bottom: 0"><B>Number of shares of</B></P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Common Stock Owned</B></FONT></P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>After Offering</B></FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Annex
C</U></B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">WRAP
TECHNOLOGIES, Inc.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Selling
Stockholder Notice and Questionnaire</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned beneficial owner of common stock (the &ldquo;<U>Registrable Securities</U>&rdquo;) of Wrap Technologies, Inc., a Delaware
corporation (the &ldquo;<U>Company</U>&rdquo;), understands that the Company has filed or intends to file with the Securities and Exchange
Commission (the &ldquo;<U>Commission</U>&rdquo;) a registration statement (the &ldquo;<U>Registration Statement</U>&rdquo;) for the registration
and resale under Rule 415 of the Securities Act of 1933, as amended (the &ldquo;<U>Securities Act</U>&rdquo;), of the Registrable Securities,
in accordance with the terms of the Registration Rights Agreement (the &ldquo;<U>Registration Rights Agreement</U>&rdquo;) to which this
document is annexed. A copy of the Registration Rights Agreement is available from the Company upon request at the address set forth
below. All capitalized terms not otherwise defined herein shall have the meanings ascribed thereto in the Registration Rights Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
legal consequences arise from being named as a selling stockholder in the Registration Statement and the related prospectus. Accordingly,
holders and beneficial owners of Registrable Securities are advised to consult their own securities law counsel regarding the consequences
of being named or not being named as a selling stockholder in the Registration Statement and the related prospectus.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTICE</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned beneficial owner (the &ldquo;<U>Selling Stockholder</U>&rdquo;) of Registrable Securities hereby elects to include the Registrable
Securities owned by it in the Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 23 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned hereby provides the following information to the Company and represents and warrants that such information is accurate:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">QUESTIONNAIRE</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1.</B></FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Name.</B></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-indent: -1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: justify; width: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Full Legal Name of Selling
  Stockholder</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="border-bottom: Black 1pt solid; text-align: justify"></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: justify; width: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Full Legal Name of Registered
  Holder (if not the same as (a) above) through which Registrable Securities are held:</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="border-bottom: Black 1pt solid; text-align: justify"></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -1in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: justify; width: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Full Legal Name of Natural
  Control Person (which means a natural person who directly or indirectly alone or with others has power to vote or dispose of the securities
  covered by this Questionnaire):</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="border-bottom: Black 1pt solid; text-align: justify"></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -1in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.</B></FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Address
  for Notices to Selling Stockholder:</B></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-indent: -1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 100%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Telephone:
    ______________________________________________________________________________________</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">E-Mail:
    _________________________________________________________________________________________</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contact
    Person: ___________________________________________________________________________________</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.</B></FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Broker-Dealer
  Status:</B></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: justify; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Are
  you a broker-dealer?</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes
&#9744; &nbsp;&nbsp;&nbsp;&nbsp;No &#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: justify; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If &ldquo;yes&rdquo; to Section
  3(a), did you receive your Registrable Securities as compensation for investment banking services to the Company?</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes
 &#9744; &nbsp;&nbsp;&nbsp;&nbsp;No &#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: justify; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note:</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If &ldquo;no&rdquo; to Section
  3(b), the Commission&rsquo;s staff has indicated that you should be identified as an underwriter in the Registration Statement.</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -1in"></P>

<!-- Field: Page; Sequence: 24; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: justify; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Are
  you an affiliate of a broker-dealer?</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes
 &#9744; &nbsp;&nbsp;&nbsp;&nbsp;No &#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: justify; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If you are an affiliate of
  a broker-dealer, do you certify that you purchased the Registrable Securities in the ordinary course of business, and at the time of
  the purchase of the Registrable Securities to be resold, you had no agreements or understandings, directly or indirectly, with any
  person to distribute the Registrable Securities?</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes
&#9744; &nbsp;&nbsp;&nbsp;&nbsp;No &#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: justify; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note:</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If &ldquo;no&rdquo; to Section
  3(d), the Commission&rsquo;s staff has indicated that you should be identified as an underwriter in the Registration Statement.</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.</B></FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Beneficial
  Ownership of Securities of the Company Owned by the Selling Stockholder.</B></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-indent: -1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Except
as set forth below in this Item 4, the undersigned is not the beneficial or registered owner of any securities of the Company other than
the securities issuable pursuant to the Purchase Agreement.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: justify; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Type
  and Amount of other securities beneficially owned by the Selling Stockholder:</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="border-bottom: Black 1pt solid; text-align: justify"></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="border-bottom: Black 1pt solid; text-align: justify"></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -1in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-indent: -1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 25; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-indent: -1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.</B></FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Relationships
  with the Company:</B></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Except
as set forth below, neither the undersigned nor any of its affiliates, officers, directors or principal equity holders (owners of 5%
or more of the equity securities of the undersigned) has held any position or office or has had any other material relationship with
the Company (or its predecessors or affiliates) during the past three years.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-indent: -1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">State
any exceptions here:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-indent: -1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned agrees to promptly notify the Company of any material inaccuracies or changes in the information provided herein that may
occur subsequent to the date hereof at any time while the Registration Statement remains effective; provided, that the undersigned shall
not be required to notify the Company of any changes to the number of securities held or owned by the undersigned or its affiliates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
signing below, the undersigned consents to the disclosure of the information contained herein in its answers to Items 1 through 5 and
the inclusion of such information in the Registration Statement and the related prospectus and any amendments or supplements thereto.
The undersigned understands that such information will be relied upon by the Company in connection with the preparation or amendment
of the Registration Statement and the related prospectus and any amendments or supplements thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF the undersigned, by authority duly given, has caused this Notice and Questionnaire to be executed and delivered either
in person or by its duly authorized agent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 4%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 44%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="width: 14%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Beneficial Owner:</FONT></TD>
  <TD STYLE="border-bottom: Black 1pt solid; width: 36%"></TD></TR>
</TABLE>

<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 48%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
  <TD STYLE="border-bottom: Black 1pt solid; width: 45%"></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PLEASE
EMAIL A .PDF COPY OF THE COMPLETED AND EXECUTED NOTICE AND QUESTIONNAIRE TO:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 26; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>6
<FILENAME>ex99-1.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
99.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Wrap
Raises $5 Million to Restart Manufacturing</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investing
in R&amp;D and Quality Controls, Rehiring Key Talent, and Advancing Non-Lethal Sight, Sound, and Drone Capabilities</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>MIAMI,
Feb. 02, 2026 -- </B>Wrap Technologies, Inc. (NASDAQ: WRAP) (&ldquo;Wrap&rdquo; or, the &ldquo;Company&rdquo;), a global leader in non-lethal
response solutions, today announced that it entered into a securities purchase agreement for a $5 million private placement. The capital
raise is expected to enable the Company to restart domestic manufacturing, advance validated R&amp;D programs into commercialization,
and responsibly accelerate early growth initiatives aligned with rising demand for non-lethal response capabilities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Market
Opportunity</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Wrap&rsquo;s
market opportunity extends beyond a single-device business model to an integrated response platform that combines technology, training,
and policy. This is expected to expand the Company&rsquo;s addressable market by positioning Wrap as a Non-Lethal Response provider,
delivering system-level capabilities rather than standalone tools across state, local, and federal agencies, as well as select private-sector
and commercial security environments where non-lethal, low-risk response solutions are increasingly required.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
part of this transition, the Company is reengaging select manufacturers and key suppliers to support resumed production, future innovation,
and supporting management&rsquo;s outlook.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Manufacturing
Restart and Quality Controls</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Wrap
is restarting domestic manufacturing with a renewed focus on rigorous quality control standards for its Non-Lethal Response technologies.
This is expected to include the return of experienced quality and production personnel who were integral to earlier high-reliability
manufacturing runs, as well as the reimplementation of proven inspection, testing, and process controls. These efforts reflect the Company&rsquo;s
emphasis on precision, durability, and consistency as it prepares for expanded deployments across domestic and federal markets.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Training
Expansion and Operational Readiness</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
parallel, Wrap is increasing domestic training capacity to support broader adoption of Non-Lethal Response programs. Training is expected
to be delivered through a tiered model that includes lead instructors, train-the-trainer certification, and hybrid delivery combining
in-person and digital instruction for all operators of its expanded Non-Lethal Response technologies. The training expansion is expected
to focus on operational integration, lawful control, and scenario-based readiness, ensuring appropriate government agencies may have
the opportunity to deploy non-lethal tools effectively and safely in real-world conditions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Research
and Development and Product Commercialization</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Many
of Wrap&rsquo;s recent R&amp;D initiatives have progressed through testing and are now entering final validation stages. Additional capital
is required to bring these capabilities to market, including next-generation multi-shot systems, drone-enabled non-lethal delivery concepts,
and other supporting technologies designed to provide low-collateral, non-lethal options across a wider range of operational environments.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Federal
and International Expansion</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
investments are expected to support the continued expansion of Wrap Federal, the Company&rsquo;s federal and international business segment
focused on U.S. government agencies and allied operations requiring non-lethal, low-collateral solutions. Wrap sees growing opportunity
across federal, defense-adjacent, and international use cases where early, non-lethal intervention may improve outcomes while preserving
mission readiness.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Leadership
Commentary</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Our
focus is on adding the resources required to accelerate growth, particularly across manufacturing, quality control, marketing, and R&amp;D,&rdquo;
said Scot Cohen, CEO of Wrap. &ldquo;This capital may allow us to take proven concepts, finalize validation, and responsibly bring them
to market, while restoring manufacturing excellence and expanding training to meet real operational demand.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Private
Placement</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the terms of the securities purchase agreement, the Company agreed to issue 2,500,000 shares of common stock at a purchase price of $2.00
per share of common stock (or per pre-funded warrant in lieu thereof) and warrants to purchase up to an aggregate amount of 2,500,000
shares of common stock in a private placement. The common warrants issued in private placement will be immediately exercisable at an
initial exercise price of $2.30 per share and will expire five years from the date of issuance. The private placement is expected to
close on or about February 3, 2026, subject to the satisfaction of customary closing conditions. The gross proceeds from the offering
are expected to be $5 million, prior to deducting offering expenses payable by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
a full description of the terms of the financing, please see the Company&rsquo;s Current Report on Form 8-K that is expected to be filed
with the U.S. Securities and Exchange Commission (&ldquo;SEC&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
securities in the offering were offered and sold in transactions exempt from the registration requirements of the Securities Act of 1933,
as amended (the &ldquo;Securities Act&rdquo;), pursuant to the exemption for transactions by an issuer not involving any public offering
under Section 4(a)(2) of the Securities Act and Rule 506 of Regulation D of the Securities Act and in reliance on similar exemptions
under applicable state laws. Accordingly, the securities issued in the private placement and shares of common stock underlying the warrants
may not be offered or sold in the United States except pursuant to an effective registration statement or an applicable exemption from
the registration requirements of the Securities Act and such applicable state securities laws. Pursuant to a registration rights agreement,
the Company has agreed to file one or more registration statements with the SEC covering the resale of the shares of common stock and
the shares of common stock issuable upon exercise of the pre-funded warrants and common warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
press release is not an offer to sell, or a solicitation of an offer to buy, nor shall there be any sale of these securities in any state
or jurisdiction in which such an offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities
laws of any such state or jurisdiction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>About
Wrap Technologies, Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Wrap
Technologies, Inc. (Nasdaq: WRAP) a global leader in innovative public safety technologies and non-lethal tools, delivering cutting-edge
technology with exceptional people to address the complex, modern day challenges facing public safety organizations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Wrap&rsquo;s
complete public safety portfolio includes the non-lethal BolaWrap<SUP>&reg;</SUP> 150 device, WrapReality&trade; immersive training platform,
WrapVision&trade; body-worn camera system, WrapTactics&trade; training programs, and next-generation CUAS solutions like PAN-DA and the
1KC Kinetic Anti-Drone Cassette, all of which supports the Company&rsquo;s mission to provide safer, scalable, and cost-effective technologies
for public safety, defense, and critical infrastructure markets. Wrap&rsquo;s BolaWrap<SUP>&reg;</SUP> 150 solution leads in pre-escalation
intended to provide law enforcement with a safer choice for nearly every phase of a critical incident. This innovative, patented device
deploys a multi-sensory, cognitive disruption that leverages sight, sound and sensation to expand the pre-escalation period and gives
officers the advantage and critical time to manage non-compliant subjects before resorting to higher-force options. The BolaWrap<SUP>&reg;</SUP>
150 is not pain-based compliance. It does not shoot, strike, shock, or incapacitate, instead, it helps officers strategically operate
pre-escalation on the force continuum, reducing the risk of injury to both officers and subjects. Used by over 1,000 agencies across
the U.S. and in 60 countries, BolaWrap<SUP>&reg;</SUP> is backed by training certified by the International Association of Directors
of Law Enforcement Standards and Training (IADLEST), reinforcing Wrap&rsquo;s commitment to public safety through cutting-edge technology
and expert training.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WrapReality&trade;
VR is a fully immersive training simulator to enhance decision-making under pressure.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a comprehensive public safety training platform, it provides first responders with realistic, interactive scenarios that reflect the
evolving challenges of modern law enforcement. By offering a growing library of real-world situations, WrapReality&trade; is intended
to equip officers with the skills and confidence to navigate high-stakes encounters effectively, which we believe leads to safer outcomes
for both responders and the communities they serve.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WrapVision
is an all-new body-worn camera and evidence management system built for efficiency.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Designed
for efficiency, security, and transparency to meet the rigorous demands of modern law enforcement, WrapVision captures, stores, and helps
manage digital evidence, ensuring operational security, regulatory compliance, and enhanced video picture quality and field of view.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
WrapVision camera, powered by IONODES, boasts streamlined cloud integration and final North American assembly, with country-of-origin
(COO) United States. This track helps ensure data integrity and helps eliminate critical concerns over unauthorized access or foreign
surveillance risks.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Trademark
Information</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Wrap,
the Wrap logo, BolaWrap<SUP>&reg;</SUP>, WrapReality&trade; and Wrap Training Academy are trademarks of Wrap Technologies, Inc., some
of which are registered in the U.S. and abroad. All other trade names used herein are either trademarks or registered trademarks of the
respective holders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Cautionary
Note on Forward-Looking Statements - Safe Harbor Statement</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
release contains &ldquo;forward-looking statements&rdquo; within the meaning of the &ldquo;safe harbor&rdquo; provisions of the Private
Securities Litigation Reform Act of 1995. Words such as &ldquo;expect,&rdquo; &ldquo;anticipate,&rdquo; &ldquo;should&rdquo;, &ldquo;believe&rdquo;,
&ldquo;target&rdquo;, &ldquo;project&rdquo;, &ldquo;goals&rdquo;, &ldquo;estimate&rdquo;, &ldquo;potential&rdquo;, &ldquo;predict&rdquo;,
&ldquo;may&rdquo;, &ldquo;will&rdquo;, &ldquo;could&rdquo;, &ldquo;intend&rdquo;, and variations of these terms or the negative of these
terms and similar expressions are intended to identify these forward-looking statements. Moreover, forward-looking statements are subject
to a number of risks and uncertainties, many of which involve factors or circumstances that are beyond the Company&rsquo;s control and
include, but are not limited to, statements relating to the completion of the offering, the satisfaction of customary closing conditions
related to the offering and the intended use of proceeds therefrom, Wrap&rsquo;s planned future products, technologies, integration,
intended product designs and expected benefits therefrom, expected market opportunities and outcomes related to Wrap&rsquo;s products
to increase officer and public safety. The Company&rsquo;s actual results could differ materially from those stated or implied in forward-looking
statements due to a number of factors, including but not limited to: the Company&rsquo;s ability to maintain compliance with the Nasdaq
Capital Market&rsquo;s listing standards; the Company&rsquo;s ability to successfully implement training programs for the use of its
products; the Company&rsquo;s ability to manufacture and produce products for its customers; the Company&rsquo;s ability to develop sales
for its products; the market acceptance of existing and future products; the availability of funding to continue to finance operations;
the complexity, expense and time associated with sales to law enforcement and government entities; the lengthy evaluation and sales cycle
for the Company&rsquo;s product solutions; product defects; litigation risks from alleged product-related injuries; risks of government
regulations; the impact resulting from geopolitical conflicts and any resulting sanctions; the ability to obtain export licenses for
counties outside of the United States; the ability to obtain patents and defend intellectual property against competitors; the impact
of competitive products and solutions; and the Company&rsquo;s ability to maintain and enhance its brand, as well as other risk factors
mentioned in the Company&rsquo;s most recent annual report on Form 10-K, subsequent quarterly reports on Form 10-Q, and other Securities
and Exchange Commission filings. These forward-looking statements are made as of the date of this release and were based on current expectations,
estimates, forecasts, and projections as well as the beliefs and assumptions of management. Except as required by law, the Company undertakes
no duty or obligation to update any forward-looking statements contained in this release as a result of new information, future events
or changes in its expectations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investor
Relations Contact:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(800)
583-2652</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>ir@wrap.com</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 5; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>7
<FILENAME>wrap-20260202.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.3a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 96Mps7xRiXgen8uDanwsWa6MmbP9z5Z8SekhvWBybenK3y8p7rQUeyjdamJ2kfIM -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:srt-types="http://fasb.org/srt-types/2025" xmlns:WRAP="http://wrap.com/20260202" elementFormDefault="qualified" targetNamespace="http://wrap.com/20260202">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://wrap.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="wrap-20260202_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="wrap-20260202_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd" />
    <import namespace="http://fasb.org/us-gaap/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd" />
    <import namespace="http://fasb.org/us-types/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2024-01-31" schemaLocation="https://www.xbrl.org/dtr/type/2024-01-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2025" schemaLocation="https://xbrl.sec.gov/country/2025/country-2025.xsd" />
    <import namespace="http://fasb.org/srt/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd" />
    <import namespace="http://fasb.org/srt-types/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>8
<FILENAME>wrap-20260202_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.3a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>9
<FILENAME>wrap-20260202_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.3a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="wrap-20260202.xsd#Cover" roleURI="http://wrap.com/role/Cover" />
    <link:presentationLink xlink:type="extended" xlink:role="http://wrap.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Feb. 02, 2026</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Feb.  02,  2026<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-38750<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">WRAP
TECHNOLOGIES, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001702924<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">98-0551945<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">3480
Main Hwy<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 202<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Miami<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">FL<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">33133<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(800)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">583-2652<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.0001 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">WRAP<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="form8-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://wrap.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="form8-k.htm">form8-k.htm</File>
    <File>wrap-20260202.xsd</File>
    <File>wrap-20260202_lab.xml</File>
    <File>wrap-20260202_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>17
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "form8-k.htm": {
   "nsprefix": "WRAP",
   "nsuri": "http://wrap.com/20260202",
   "dts": {
    "inline": {
     "local": [
      "form8-k.htm"
     ]
    },
    "schema": {
     "local": [
      "wrap-20260202.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "wrap-20260202_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "wrap-20260202_pre.xml"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 59,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2025": 23
   },
   "report": {
    "R1": {
     "role": "http://wrap.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2026-02-02",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form8-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2026-02-02",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form8-k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://wrap.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://wrap.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://wrap.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://wrap.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://wrap.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CountryRegion",
     "presentation": [
      "http://wrap.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://wrap.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://wrap.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://wrap.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://wrap.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://wrap.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://wrap.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://wrap.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://wrap.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://wrap.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://wrap.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://wrap.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://wrap.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://wrap.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://wrap.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://wrap.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://wrap.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://wrap.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://wrap.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://wrap.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://wrap.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://wrap.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://wrap.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://wrap.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://wrap.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://wrap.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://wrap.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://wrap.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://wrap.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://wrap.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://wrap.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://wrap.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://wrap.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://wrap.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://wrap.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://wrap.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://wrap.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://wrap.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://wrap.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://wrap.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Extension",
     "presentation": [
      "http://wrap.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://wrap.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://wrap.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://wrap.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://wrap.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://wrap.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://wrap.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12gTitle",
     "presentation": [
      "http://wrap.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://wrap.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://wrap.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://wrap.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://wrap.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://wrap.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>18
<FILENAME>0001493152-26-005110-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001493152-26-005110-xbrl.zip
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M0%"3P5$!<K*,RR.T8R9]AO)+@MI%81+%MG?VAHP4/:!3TIODO2F\C!K/";B
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M8PTH90RLS31Q0%]%!ZVHUZ4.(161%N_W;%4563T7G)3K!Y=OF#!*5/VD$D:
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MJ(Z2J[]];L4V;-)J',^MC+'^=_4C">V@IIU&Z"H_<FH['%&$3B,$QS(K;"
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M-RA]ND2,"S/1A_QO*,%\SECEW[Z*[B0ZV51N-UP7]GM,T R%9VZ2G(%/M?E
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M1I8A&CH8C39X6#CGQ763-XA8@A2CM<,LLP/^RS53^WHVC5A;M((VU7F3*A.
M[']C-;$V#-B*LYD5?H**G.)1Q$GPH%@*#*'>1OUR!#="94^N('AM^21/JYP+
MYMQ#\DJ5^465=)Q(#G[S5&S -MF]SV)/W/N65%/75(0SBW2BXH0/=&6P9%AO
M,A\=I#X,>Q(Y4>:[]R5['.&\9FX4<:VEH_(90"TCGIJ!'ICQT;/F,LN\A/!
M38*Y#-4LW'H2:-R#R7!"1>+Q@.=^1H+*Q22^5C"^X[T[\ACL(CV(%C"0^>2%
MT,*>X.5F/-<ID=2 ,4%Z*31W_B'@<M]6:7::H\8950&E$9L9.6YF2X77L5H'
M-COFZD+PW BD CJ%XH)"/"A"C#8!91IF7*&"GZ!AR2FH)> ++(J!QF:(2HS5
MLUPG[C"@5A0*$2+-*WBRPL8)1I0C05XC\$O.<F,1V*47A'"EMCKTB>8";MPZ
M<V5,=C6'?6MU7ZP6%?<JJ_8;$O4"?^@C*E'1E_C-0F==GNFL7269BY%>>/19
M-D-F*0R=95C5!'RZMBS5R79I.LY^SQQ?QAG#,!Z_+F6E-/X&+ >B/.(8H!1T
M6R)@NZ_H8]A1&@Z1&YIV3%$9*! 9^_X:-9!V3)*TD8(+"#]7I.<=$T>7\A6?
M0FE[Q"_3^1R[BVV0&FU;J'&#LVR,IZYOW0XB*T6.6;5B0DTCFL%^#R)VJ4^A
M&J>OCMU>B,6G9L;JT6-7V94,21P)E#"0N[^ IVW68>#$AD\"BA9+V^ B[UZK
M"2U5-;S]'GL/RK^(K>0@B*W6K;(TNI>M:LX<;@LL%G"%R.98F2&$':.%/JGU
MN"0!;^$?]Z,H3FXK>,]#<"I6)"7_<IV2_[(I^9?KE/S#]G6_+:_^!7KU+LQC
MV>;?S5+65S0+UYS8^;F%\J***=CX!9K[+;A662EOO,N&#"62!XEUS[19H2E+
M34N'8[C<X J@;^GJ=>>FP2U=E3,*7QE_T'RG9I_R1/(MQI Z 4<&?SLO<\B<
MSZ&#&SZF6D.2^SU^A^7X=T2(RG>$4II'C;&VL>R#L,V5)C[5A>Q5XA*0Z:2<
M-ZWQ'-B88S X8PE!3J 1!-XS#3MUM287K&:LD\61]F!B^2*OF@7>XJ[\)R;.
M$+=9T)MT,\!9<LM\&W&*;>[?&14/X1Y?'R,?<XS\%8Z1_;)X1#' ?B\$/D.H
M#?RKF%OL*YY+:("B0$ZNO=-WOBJB-$ V.R)!H</+Q=QT)MLEL9]W(7!#>FCQ
MTG,45HQHOJ<4CR!N%.,Y9J8)4SI$Q:;V/7KPM/!0(>AI96F%K:R.C@9B(YQB
M8ST0[AL7EU1.[RS/+E@'TWW!#GP\X#B0- !G#RC2>D5ND\]Z @0IS15"4YE#
M96X=-_ 875_LV'K?;-?8E,D?63:G%NCOZT#>S6).B0TYJ9*@SQ)S\ORWL*YO
M0%BG.XG77A<JY'!RG1"Y3SOX[,]14%\L+GI'(IV7@K^9*,IUQ9Z*+2TDO:;U
MA??Q@MBDP]AM*%5TU\/8[W6,(Q?Q8KMNV(A/GTJ\;M5<(JP=04%@FM&B/4EK
M2-5-&95Q77IA(*?2Q*W*<&=4&10A*.R\6:X.Y#]++Z/KFZFB($9@7^$K?RWC
M0KSAZ<9<I^KDZEZNOC9WD _Q5T0[YF$LN<7,'!I9N:AU.:#F&:+:7>H6)K;4
M+UA9+ CA^%5SW5FPVYY@5P3-S3JYZQ/L*[)<OBT;[0>PT=X#DYV9T7=5.3;7
M;=V5JEU(4#AK8-/B9Q4F.XZ-<'1J@&^X+*L_B.AVGG-9/^(=UBOHB_4TVECN
MU.<@U_IQ'7W\LM''']?1QQ7=9@_S0/G$*^DE@18GV7E!5?DYES9X,:'WOX#!
MIJLU_=!6 $-_&=&SR?D=%'6"4&=H.<'OP4YW5C<T1&QQ!80#ZS,#QA;S V1P
MB\P'QY!/@R[\A@5?J+A +8224X3>&@\=&"@@:7<!$/0FJ4JA Z(O]'OP8IOV
M0AP^6OQ>XC=-\!@4PQ0_E7AA"?S5YH [3C&*R[-2HJ5UZ'UM*/04,(,*9-"6
M%+_H(%^&7EO$Y^-8#>VFJ_Q17D[7<(OW(\/>[\FX8Q3:COS=#'=R\]%V",K.
MX;83PJ.,Z=\YMVP#I@+0VAS@=F/_#J !MD#I+*W.,1!#G%H*P30KZQKECXP?
MB'4^Y.(Z\-* 8O?PWQ*)+J"\#C[#B';X?<V>N.(M<B%P\Y+_6TQ.F32$*H5J
MB[-W]+#XI$750(A)'NC$HI+4G/)5D2UKCA D4]DK]''PDE&&C!ON/,=@5>+(
M()U/O1"4+99<4*F4\:0!JP.5'E@,!6EN"D(A+ !XRRK"\$PU+,IB^&34+JF,
M)J<1DGA%J6+:->5!@MR'L(4H $!IJ]YH8<1S_I0-7R;\!Q%O VS@*?B\H4/^
MCD3.$@9>&",[!>AE$-\XYZ!@7@'ZV089=/0"^+1AF!74U_?X\)#@TOE07CLV
M.7%\$#VSW_NX.&ZR(8ADE'0;2]&4L?B@_(2X#1$EF+JHIIOI6#-=2=\5DT]1
M!YG^:W(@,O1JB4A21 Z.UB%KE[,YY2'$94.]A*'6DT(/O\A+@8:WZ>C>B=8:
M*;=#_5!<N%V>!G%VX".+$&_1LRAZ#IQ^.9V<0J</Z*&,T("4>G+!&G-,I8O)
M(#FMS.D$!0/F-$(SLR1*I.EBEISG-;^;E Y "Z<-QQ$]M;@8O+]**;2$I<.E
MIQ?!ZTIA5Z(*$D+WC(: ^1&/+5Q2HM& Q[WZ8GVEH1'8%[PUV("!^B0H>>(P
MF</)G'@L3@@UFUI8,AT$-"C!#6"/>7NN>S<"';(;UY0-77=>;_K7!!;U2;F;
MN1N8ZA^>:@8J/'X96&6NCVHA(I;9*4*#\#?>Q*I=##2,$OFC_  +$6J)]-JQ
M3O%:$/8K7N@0&(0'^W_APQ/5\01AIY3Z)./A/CF',BD P%;Z)73H4O?-(HGV
M'\] C87CWKO?M7L=<*-@)R?4*BKV-7O%'(K0&"G<P^B,#(; X\V'-_@*&BMT
MIC\6[7X/Y-Z:8;V:%$KFE3GOX$ ;V[0PG1(-\GV!N@O<C)LD%I#7LPS19Q!!
MIQR@!V&#E#Q$/V?+\/<N(Q"N$&QOZ7@8JXQO +X.<-?&@\$!\R2?F%-B<HHF
MKKKY3NF[3(<_PS4F<3.B*Y,">N_<5I/?[[G?AAB*.-];:$C+\J;SWC_DK2D
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MU;A7QIV=L#ZZZUS$9G$3/%DP1@(]>*)OD-%T:V8,6@20V,5/X1\D'Z>XSE0
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M#$#4U5G@.V=Y-J46,K^B<=<.B&D<LQP[9VD.$&QQU+;+M)JL]CYHV_%ND7)
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M"92.F(!%[_0RM^'F!+Z)(S*XRQ5BS$NP=IX\?GB(KUZ6\5DHMGDA<$H=)NZ
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M^#3^E2XONI'55Y5-HYRN/;K>Y-<YO!X>7-(]F#AP).\9!%KK-Y#"0A@WK9"
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M; X1>E-S]5CO)0%>I&7MCO#Z$L_?J#7NCM%^<%H[]H6*U6J1)FC4Q&MM-?L
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MZXF*TPNPX@1_T")(8!NQ(=9^="<J 1N8(K7N]@PZ=N<$K70TG(P3L-XV>^;
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M=^0]!K![.-A?A8,]^58XV'4#MKYI\_S]]<>W_Z0;Z]?3W]Z_^K]02P,$%
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MT2B9UKBIU1;2QQ<4A-&GO+C,DOB,+_P('7UBU,.[O.>U;H)&?\41#]F,H&;
M*]'T//1N)ZW'M&U'?W]X/OHE]BD>5/T)2V2POG,&4Y]S7$5T)+E%(A']O.<J
MO&E B$BH9QR-N*UB?*-(B%O31;\*LN761C?T-&U2:%C)QB-B:0UX]*8LXJX9
MIH$9_(L3@%)A*)S1*^)/_9ZGDS9[JO71>[<X]]2Z&_&>VU.JJ6.>!P=C%$AT
M_U*(U]+56<QPX(,=IG+#H@,65/.TJB4T2D**=A+_F.[>,& ]'44R*K;UK$*[
MBNXX<LJRUJ<\L8[8Q-?02,B2#EV,S$QUIY!$SIMV9Y15!04NE2YF+%"R-&T3
ME&XLFH+AG()4%=\*<A0:BKT< Z/3-;0Y_+#$ZO&X"0H FNS601P% YJO4YS3
M8BA3AG9L>I'2G?O/C9U'NYO!QF^;_\*?;^QLAM 1F-+G]VX#7P6C6^2BW3TZ
MWA\<V]Y:\9'^_/2O2R(YKPT,15>MG@;LZ2(OKP+DM?IU]01+IQ]O/5GQW,*^
M60BQ6N!EALY\D3_TO_P/+YZ$E3J\*DM]?TX>%#QQOWY$R&D0B*YEJ[=6. CD
M&1SEV'=Q7.UP4 &H=C,+%6K8=^?:$84]0777V%^@3%8SL0B- R':5)*:/!1Q
M--?ALD:("T7RQA/O0U=_!;O2^)#=K$;ZD+TU33#$CP,4Z0FWPBR+2G2UT"OG
M!7Q#2= -%SJ"0=+@Q\>/-X;D63BF5VFHA^].L"-PG4QFV1F%]94>!+=& G\"
MX5D9[$ 6758$+J)9=P)]Y!>3>Z^8VFJ_NE&2E-P?&W.S-;Q]@7U9U=; 9?F#
MO[2;QN+G,@@?H_A)%V"^\U$ZA?%:G7D7E9^2FMT :,SPC;&;%07>-V?!VZWW
M6\&&T>WT;QQ<451I@UP4 C,MVB_&6\>:-C,\[,FU-[_>BO&,S/9E]DUC$^(V
MMOT5V!.Q6.O+@O8]-6 !Q6 CY*-L1DV(7\AYTOB?1UG!AN)UNR;;9//JTXN]
M2=/F?KN6A&EX /@Q$FONG#<G;\$"75-@. /S)E&ZLN0\^F?W10NT=A5W[.H"
M>\M=HRO_WE<<GDS[+4YZFR:S>UU-YF[J+DWPI7&9!8%QFE5BX$NXB6[*%WAR
MUP=H?8!:#]!O#^< =7EOL2>D/%\6LRQ&$SZMX&[#ZY;0]HD3";?<#1@G&*';
MGGS8J'58R/S&PW(UZ]8NT<-B^1U(]:=@HGFFC#@>A_[AJ!EHW&K;7SKA9)6.
M@.W'3[=^Z   >JZ 1T^W\=$[XZ3[4T-; J_V9 U-^V)HVI.'"4W[BJ?MGGK
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MEX>Y_N_5=?FM:0%+.(Z>KAU'7^PX>OHP'4=?Z91]:X?JYE7K@W$C\R@J.5#
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M(F#B2'(7[9]M?[_]^'%]SD*&+FQ5<:K?LTI.75&;Z^F2N6%.";D./2 2B<<
M8X;*=^'85D)8W-Z/!W)J[_ZPSOC$'.JZ26RLK>M\WZ&J]%+HV]1BP'5T3666
M@A_/07FXD("L9TN#/-*9A+[MV<0^>*)+YYYH+0;,:] 0VB%EH PCVC0#,24U
MF)HE\?SD/T-$;GD%5"HK9YN2^-._U#J1D7*>LX+#ZO:'07\#S6]LJ:LB*1$D
MHPJOZD0W\ZU;KQ5TST_*$G'B[<?K0/$7!XJW'S_,2/$W=LZ^B;-VYZ<VE6O1
MJ#8[&$8P-PM<0Y:R@Y%KKPRM1_IJ6$TU,U(+W2M9TG!]X+6'@,I-C=!UO<:8
M'+3H6QAA04!27N0E&L/,_X!9((9P-F=7;)G$Z,ZV(-W>IS@'ALJHV-GV"GI%
MKU!L6F(*Q.-A_"=^BRK<B F/$HUD#.ZP&L$\:)>FX7ZQ21C1,O)0UQ:#?:G]
M1T)'CNDI$G0!+23*--[4+JCA^5.TP:-+I3<]ADSHT59[ICF!*K'1XM4J%;.,
MS]WC,&<5S/U[8KF5B.\I(J[+.;4,2A,QG)=. DH;Y94"-1JVX+#),A1X)$.*
MMJ:QB$0[9=,)-<NRM] '4?V>0=O6=;?319'-\EKJ.Z:Y^2L<%IA'(6'-4E@?
M,Z67J02XF'F'EGT\CM+&"ONDO(:/MRW;17&PJB*?6O_TTC!JFEG8#S7_'N,H
M<8GN*6+@-"058/V;$(/2*H_)X=D M1*R!9G0ZN#)8_1!P,F%UXDAP$$@.G%#
M8IC%2($)4%-$F\-ZH@VCA!BGF,UN%.F:O94;G^VLH=8R 5R(7E/D6HX\[1C7
M+,Z.B N10D-)G+!%&- F0?^ ]3E*$S*?7%!&8)'@00<C-XG;U0,L+.@R83(6
M=;F=JQ?W^KQM(A5EL,L4Q@FS6D@H\BF%_C''N_0/*:6O2)8H]<*K\8,!C8SB
M=PH3W9@ZYOU1K>"- _MNN;ELA0"WD\>U-<2ANJ;,$)(O36HB!] $Z-IG,?B3
MD_C""Q^PW99FLY*SAI0M:M?^%>G)Q7 #%>,GB<6SS.]HU)KE1X_&ZAU,WP#I
M;N(ZAM5<O.OZ&I)=JT^N3COE_FP%ITTJ9^R@=%</4-6W5;*':@^G]:R6"FN"
M Z@0A ^[&6Z/D**PDJ694JEA%=@AV+9"5WC /9W49<=%FG+6P\N,$;YGS[.=
M'#"!"X B?;:3 703YE,!,8K0 #QJKS$=Y>^/_L<N\QTX1;[<_2IJG3,Q,=/^
MDW#C)'$,38-18\5,%52(N0C<"N)>%2V9#N:E >ER=I88?X"\B<3+4\+_H_/7
MX 7Q?'V>XG6"J3=)+3X'@>M_*Z;VW? @W'XIU&>Z%.JII;7)MEN70KTC#F$I
MA:J6,!H280(O[8G!AA$]:VH2ABDD:]0U*SB:19>5OJ-'F'G*X29SWBT.N6>8
M-<,7BR0[L=!Q,VWTTUO;6APO0J&$02,[C40FZSPZ4[.-9[/?\PN#.%%\;F*3
M=24]97@KD]%;9%),GHR;4-WQ9:FH<KV.U3)8Z$<Z)<-NS-@/!_T02.XMUH@_
MRXDW(#KC819G#,WE-3%9V9IFN/%-UYRR>7ZBN@9#0H!S"&$A'!5<*J.9Q7LK
MEY!TB?I!-V5=%V6><""?20*L%">J;#!G2+&2%77TV:I!JVV)">?%*OU;/;[5
M[WW0"I.9T0C5W'2LU0O)7!4"A+9[6L9#_53Z$-@.<%XTQU:I_EBI^<$L,]EY
ML$UI<A-6G>3/51/,;RBD=%%2L?'LOU<MFI"5%XYFL$49K5$24H9/&T[T3.&/
M1/+.]?7?02J&NEQ5J+'$2L-N5"S5,8TA5M$$49"!X@$+T\EJIP"C'KE=.R+2
M]E7@?CF?5^@/1DU!+[?3*1<@@FA=@45;I6 J/2KW74SUG659:% ?'?5LEOJV
M8;PH$>^'O#(6SXO%*60;4-:G9!]6@J111Y=.I0^#H5_SBC;'PWJB8AB#33(6
MMT4V-Q/ATC\8^)'P0AD2.D)LX7Z2K ++1E9$X'Y 227KGT<73(P#KVLN4 F4
MKX.JMYY2N+V]#A5]>:AH^V&&BM;G[&:*^QZ:FUL@6Z>VB!?QS-Z]V !\$^$L
M8<^UUEQ(H4);&Y._Z=H7_XTJ*HX[KJ*$EU:ELUNY5'Y6TEOF2KE %:D2K<I6
M;_0%:RDFMJ^1[P30V_AR&LZY%U>HF0MM$V-<1)NAD/TZJB=W2":4//,7EOJE
M:H(++EN#J%>B36J?HKI,VYX3+RROM-6-QN5M<MB4]PQ1?N9[#$Q#S5J&7MEY
M=E;^4ZP*ZMF8=T]/9 --OX*J)8EAY=JR]JIQ %V%0-'Y"L87QN;'6DNX(\.2
MRJ-^#$A),/_$E"I&Y)+ADKAB9[S:_^C?E%0NKX(,GQT09"I:LT&&F4EN:NN,
MJ?+0-.I4&$#9#2PIF0^2"J$7]']W/"@_$(_*YA(26+)]J$:8Z/8:=C];*=&0
MPH )0^GU5YN1*(=[7!Y3?GNO6I^1G9+(03Q@&#0E4:X N"%^G/!CHWH698'K
M\E66VOH,WI%AQ:X3#_8]I[X8]+>4ZJ+$G]3L^V[?5$N"D7.'>L_SY:A^:P@$
M70^"JGB9TF9$?ASKL+B02RONT)%'H_#KCC-P9\3^/J%BLUV4^**7J#5$TK'J
MTYR=EHH^!^[QLU3EI:&2E"7:L,4H_D2J'V-IA4?%^!$]4%I33LJ9!',XWH14
MJ#K@I/P<G(-L#UNE(;FJ!@H:>87=3,:M*C@)J_: J2KFE]%%6BOUVZ2ECHU(
M)0NT'[)J-6_CB+3]LC]L_;247W8M3^[(L(3FY#AQ# C' VSN=Y7.+K_F0FG:
MMU10U6MIAPT$@Y@B@@2*VIL"/PV5,VPIP*%:)A9;54+<5J=]];)90HF+,5&N
MY&6N*1BQ?ZK. 1RTBQ3FC'!![/XRURWZJ$DZ)%FF#Y_W=;FC,1:@P^<@5R_2
M(G.@5I[\DM<6R*Y^#P16J-1LAP42>6ALJ4KZ/L(^DKA38J[/Y1V(/]JAUQ]T
MZ/5=6J$?GG$'ZZ#K'=F>D4HY"HXY)@EW[XE!<P8?J!"V@NF^".#!DZ2N,YU
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M?-Y9=,D>]K.94I:LU&@[@E:XI17?1>6G1%1S)R_9[$;I889.\KA#P9?\P<@
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M":[U\R!']K7LNU<[)VCGOAL<PDJ]/CI^=\7@AD46?ZLCO%&WXQ6T#]LKYGW
M?/U39M6#[ZK8/-<0,V1%DA/*,7C"]!"%!MCVV=QPW*8Y4>VAVVHKV"^8?+ZR
MWW+C^8F=>:K0;%2D'1FXOB)=0(<'Z_'6#ZM$=-)DJYVSZJ'=SNZ!@]SO_;KS
M]L,@.![L#0Y^'>R'[7N(-@R&]H32SE#8U8KSL4PT_6,EWM.ZN ^S])#2A?]T
MAY\]^>M7\3(L3K>2SCRYX5S9525'FMG[^\W/WO*IQG]?[?1]C63LY=N[O5G^
M1M*W;W@"-ABKQ1U\7Z9YO7GCLW%_=]A#VU!?;;SW=\NTG,F=. :5O&J_.^_(
M37D_Y/;]W78/35*MK[ZE)_B^;X6U]+B)T_3^O,CE+/D@X0=^?:WWV]V9PH<V
MWON[95I$U& 2I1EW;ZUBKS?<79W"AS;>^[ME.J! \7/NGP?C@;^'@8OHN>][
M;&WYW^%S^]#&>W^W3,LQ="N!<S\U4+P;>OI0-MU:<-WA@_S0QGM_M\R2@LNS
M!H,O0KNOY=XMR[VOQ*)[GVI$+5<_=A%F_J<7P=&4ZJ4^#]Y&5;V&T"^&T'_E
M8C.WNF>_WSW:_P>>Q^_?G+Y[^^K_ U!+ P04    " #.@T1<AQ#B)'=$  "W
MM@$ "0   &5X-"TR+FAT;>U]:U/;:+;N=U?Y/^CTF9F"4PH)2;IG.LFDBHO3
M8>\$V$ Z/34UM4NV9%!'ECR2#/'\^K-N[U62,6F3!'"JN@%;E_>ZWG5YUK->
MO3U[_^YUO_?J[6!G'WX&^._5V<'9N\'K5X_Y)WS[6+Y^M7NT_X_@].P?[P9_
M_V%<Y/6+8/O)M [.TDE2!8?)57!23*(\Y _"X#0IT_$/<"/<>GS3^UX&DZ@\
M3_,7 5ZJ__OA]:LW1X=G]M,>C:-)FLU?7/<\NK9*_Y/PZW]X_9=\6$U?OGJ,
M#X3^'J^\I:M^Y,N@3C[7CZ(L/8>ORO3\HE[E>+S:?3WX?)$.T[K?>[[U]-7C
MW=>W-3AN3WZ?574ZGM^=N;WUYA\.#L[>#D[ZO;.W!Z?!Z6#OP\G!V3^"PZ.3
M #Y7'QP,3H,W\-''MP=[;P/W4OA]\-O@9._@=&?WW2!XN_/K(-@=# Z#D\$O
M!Z=G@Y/!?O 17N(_;^=P'V[<>[MS^,L@V#MZ__[@]/3@Z+#?:[[:?!L<O8$;
M43;LG V" WS)NX.=P[U!\.$8OMTYQ+:\/S[#2]^<'+V71ISLT"<?#O<'C8?O
M[)WA4[=_?O8L#';@[_<#N&R_W]O "_^2Q?^>%2_=Z_]2TH>;(78"_K>W=W2R
M?W#XR[M_A,'['1R],Q@">.H;ZCUTZ/3H'?5V<'P6''\X.?VP _-W=D0-AJOV
MS@Y@U)RV4@^A*6?]7G>S3_R'[?RZ<_".YL$=AQ"OA>':">#YAZ=P,WZ#[3S]
ML/M?\'ZX/Z17.(TX&?S/AX,3:L8I3,R;MD;@/.*3:1!H*FBV=XZ/WQWL45-X
MLJS;WNU\/-WREA$^QGLZ3/D'>@#-K2RR@;3#OA?'',;[^-U@_Y<!M6;OZ/!P
MP)WDU@2[1X<[P9N#_0%<??*+-/C#(0WB$6Z!X-T1#" ]$YZQ"VOL ZQUTYRM
M.[O'OZ:(&B5YG90K/BR.3P:/WGS@78FR@+;'T=Y_X^H' 7(*2V[G!-;UV=<[
M26ZEGVJB[FHGY.EU&>75N"@G+X+9=)J4HZA*J'\?3W:.X:09[+T]/'IW] ML
MJC XR$=;][?'W3-Z1I)M;_#NW>GQSAX<'G__X<D/]/?QSOZ^^OO&8W"5QO4%
M7OKDSR^#85'&2?EH5&19-*V@R>JW'T@'?W5V<O,77"9EG8ZB3(UH74Q_$(W^
MU=G^%S?XKS_^>96;Z6-4PI34W*[3BZA,JA?!__(_/1-G^RMH^-/5-OR@JF8)
MMVH_JA/5Z#!X^N3I3W;+X7\GW\LLWN)A]4?FZ':;M9Z K]JL@SRMTRCCM@P^
M@XQ-J\39(PLWR6.2MZ_OCMJV\&3Y!D:G?)CF<4(/3_-5SB[J\_V>T?."A6I>
ML%%?),HT>_5!2?M7CS^\5J89G/2PP<8IM**^B.H07ED&EU$V2X(R&27I91*'
M:MWPOP N2.NJWXNJ"CI>^2]Y6V1PF#KO2*L !B.M,WS8;%KD =X""L:D"J(\
M#JK9\/=D5,/FIB^R=)+649T6\'"X-E&+&"_%[T=%'J?\]452)FD>C>%9_5Z5
MU-C\^B(,HAJNG@<UC"8^ II,U]#M,>R%0%\;1,/B,O$[(;O(W4!.G[ Q,^A4
M!L^$_LG00E?[/=7@.$CS8#S+,O_I9]!S:#5VH?G@X:P.\J+&II8)M3K$@8$Q
MJD9E.DQHAO#MTUDYNH!E'HS+8A)\+*-I<):,+O(B*\YA/L-^#W5&&(M@/\FB
M*SC;8>3*:5'RB[TV[163*0R9W12<*WRUS'M%ZD&P$57VA$4Q+OP)S"]-Q@S6
M/3:X;=WU>ZQA.-TMQG2QO/XO984?5_CW!!IY6A>C3V "PQ6ZN],R'25X7Y$G
MW"C\P[XAH%:X$P,7PD3 \"7_GJ%XE+6F)_@8GPJ#505Q,DYSGKQ3Z"2.U=.-
MX>;7M6MO5XQ\>[GX9.O'U78)EIG,5K^WC2ML*X"/]G$N65;P9WO1%&1+!C?&
M(H!FN%%Q/^&F*W#77>%Z4*N )8PLGXL(1 4NFTD2Y6E^7EER),U)@I) C5)H
M!31G5L*[H1O':NWNG)=)0IO%VW[-*]R=B$(K#MXDPW(6E?/@*9_AL%YAT9_;
M.TA+2;5?2I!(**BCNH ;2:K4Q3==S"N?^];E#)WZ/X\>!6_2)(M?!,?1>?(2
M'O#O69*/\,:7P=&4UL4+?)$LG9?!KWCTP=?!HT=*G]L_^%6UDKO\:%C4=0&:
MQD^H?HCQJ#[;S2(00-LP%E61I3%TTUBPML7J6[3RADY3U#-9F^O?:-<M.K,[
M+5DRICNTHMHT_9W7P;764*I!?!F<S:?P_ITR&J:CE\%A-$EXH \+'+YM^Z;'
MZB[\QNB<2M]\]1A&N67 AW $?GHT3&"+P;.G-(DR"= KF@%HW+$[/[0DS:HX
M=I]N-PH;RS-]+[? W>Z2+=&?:HFN#FSZX%[U]W:G$%O[3;H5;=K3UN^!KF;9
M(5M& Q--4.MY%$ZMP R9@LZ(0BD.AG-7J9M$<U3I)E$,JAL<P%<719:0@9*#
ML"AKSQ HZ2<:%= ,VR1H5??I)&7C@0407>KK[MBF.,G 4,+3M7".8NA1%,2S
M;(XVS&B&/3C>?P,B?3I'%1JL'/BHWX,G)(\F$9@2&_ N^36JZVAT@8J UI$/
MBUHT7]W.E$TI-'RAN3F\AC46:(BG8#1OMA6,K7[O8PI#RX]+HC)+86C@XHUT
M,ZBOX&E/-X.S,HI!Z8%NS]ENVTCQ6[@AGTV&?+USS0C&H4RK5#24TQINBLH8
MEDH-MB"I0<>P:HJ8C K1N/H]1_&.-[$)K(5M0D>SK+A2#R1+#EYJ+$1H%\Y4
M%:4Q&R%LC8KZ)O-$7T3GH&B=XP-<$X#,*[@ !D06&1LM035-1F@HQVK0H^DT
M@V-VF+7.#$SJ58IKAAP3.#AE,(JJ"QA7;>2,+A+0%>(RNLIQH47!!UB'\ (8
MJ!K>.(SR3_W>+,^2JF+#%^ZG/W2'IV4Q2N(9O,=IGAF^$1B4"0P9VN WZ\$6
M? 87?GI4P$:$%0\V4TLWM5E5POD._85ASPLUWK@')DD,OV)CSD%SA?%,$EKF
MI&D'-6@0^#SS'7P%BGA4IO^A/4:+'Y^CW]WOF3$VK\76UE>PA"M<9+A X"9<
MT.=*@Y>].0+Y5((*W;(\T "P'HEW3"_F%:I2&6[8LDRT76F6A[?GE4] /QMD
MF99I8&C >V0[>^LKNH1M3W.A[6BMRZM+\5G#)#$^$=XMZ&,0^9>.+G"9)"W=
M<SL0=+1_3.L4%#50.VD-H;E?\$]0QJHBAS;.8>%%HUK6CMZ48%7K7:D:0^()
MET^K^*K4GN3AMAJR!9ID24)9];7B@;.:#L,VRVJ<8Y3W,L85'3%1, 6K#-LO
MHUW#HLHL0;7$Z'LV7S(>H\\#[H7>@M@2(53,:KWF&H]7+@_5.N\-T.PH1QL.
M5@T[)M0H6%NSL\UZ5;&#1"9;K1DUH=2+?@\.E1SM4G3K@8T!DWIA!.GUK]"/
M53*WFL'DZC'G%CBOU-*63D+R%Y$JASXC>S^;U7#%)Q"Z=3:VG>,&+R-WY+36
M[\[I : 3[K[V>D]6,#DG$]@'((BCT2B9UKBHU1+2VQ<TA-&GO+C*DOB<3_P(
M#7!QAL*]O.:U<E(6EW"@D6=2%B/H&7!+-+T(O=-)*S)MR]%?'Y[O;(EUBAM5
MO\(2&:SPG,/0YZSVB)(DIT@DHI_77(4G#0@1<<F.HQ$_JQC?:K#YFRFC7P4\
M\,UZ-_14;5)H6,L^<U0>2W](S:8(])Y(/N.&84\S;+0)R>_F37]ZLO7DR9/M
M8 KKSEFG87"%IUZ9/!KCJHRUNU5KQJ16PX-0V2H6Z^ AGMD5N0_J;([Z11#%
M' " R_&[%!:^.+5%K5#+W&][OW=]XS>;2@VV$?Z<@EK)-HB6-R+-0(U%*0%_
MR2F!'R:.96/&%Y3MLP[=0X5)U*" )C\K::S*!(>29 D>]@7+59$JH9'(,.;4
MS,[)5IK%O-\;I>5H-JE$,I826= R[PID8%4DERB4TGR4S6(Y:NDTO$3UO<7%
MCCVA,]-55-S)MJRH?@\GFE=HF> QA6^9Y=0+K^U3'J\;>OQEIL/KPA;]GF<S
MN9:!8R_=.]GQ!3[4IVMWZ0K=I4\?J+OTABO>-/-^[+L1G=E[8MD;XU8=VYZW
M*\HJ.HJT7.WV>]%Y0!K@<$X!JXHU49%O#6>"R+8 8U?&=G-.*>^$$H0 Z@A=
M^JICU,#CZQ1%;C%$4X0=>G%ZF=+!\L^-G4>[F\'&;YO_PL\W=C9#; A(YQ</
M0]HN*?IVCT[V!R>V%'1$G;W?"1_C26'Z[";)0HM%90L:2S7'WJX"C^H0HGK4
MIZC9Y>>/4.0Z^!XU$X_X,WG%DZVG*YX86'4+(5WZQ=OTXK\OV;-5-I&\G-H]
M\()=M+"[?OVX<QR((6?;SNEDDL0IZ%C9'-5?V+.Q[T"]WIV9BG[9[L1!<QW6
MUX7Q<Z,E;5P[8*=6,W$VF9C.1K0IQB9[/^-HSB%T>")JD9'K BC)"7W#UP2-
MM]C/))U4&R?%-"'=$ZX4&0D:]"R+2G3BTCT7!;Q!R<D-%RMR,H.1^^G)DXTA
M^2Q/Z%9JPN'[4W0<3&;9.47QE:X*]G:"EDL65!HJT.]ET56UB4VE\;9:&[*_
M/:JEL;8[@:4T&&XIV3\;\Z671-"Z(MB3MWA)X(3\A]^S"ZKZL3$E$U<WEP;
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MRQ9;8.:EQI>I'TD&.*4'+Q=(-#A1T)!9MY=WJ=IO7.]9V:"=W'6-@!X_F>.
M8#^QRAZS568ANPE8Z^*A++,$:81U&XG6S=ADS9'AP",1O5$F\EA5%&C$%RR
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M*&<(ACNN-WO199##@X&%?!,/=MW>RV-74],8=W%*M'0?VBEN@,YVYG0X8/%
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M%78[?H8%*_PN=>+PZ.Q@;]#O';T)!K\-3O8.3@=WO$=?>UI6+CX7VA5GQ8L
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M\R)X%U7U&A&U&!'UE8FDODK&MA]!?;Q[M/\/W V/WYZ]?_?Z_P-02P,$%
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M+,$@ZYO@Y0[FI;C( ODEU+"?,5!Z^OWSY_!H$WE02R"Q1TF%PVK[OM"!0!B
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MVFMA)S62$.C#I+C-VZ;5X6:E378-WT7$L)A3T."^KGK4TOF#_:4MBNB.+:>
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MDHQA+!QL&^KL77>'BB37E])G=X?)GMBX(:F0'9:A2%-8&#DU.F1<Q+_;P M
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M1?-P'#A'YY_?O5,4*78]:XK_#H*A4_]_4$L#!!0    ( ,Z#1%QBYO;P)0,
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M'&PN7^3J7"R3!C:VH?<)CV&[BY]:'"Q"NL.!%!5A2,9Y(JEQ&Z*'(4/IFA[
MJLZ-)@N*&+LWD)52C@J]?T@N:3P(D5KG!Q#-IAV/2A0@'&UG?6@(M4\PKI(L
MPFGIY4ILRSJ:9]&Z!@2TJT-B"(,"!7('PE(&*&:*$*_ _(M@/@R7AM(/+(95
M.RJU+$!0=&]]F$B]%TAF6\Y;KN$9!Y8ZNRG;8[:^/POH@@"EQYQQU[:4MT#Q
M- -=TCS)]_)QNIOM9D6XI7&FQ!4;D#G%A%X>! N *9V!4H:D#I5"+SVO[A+0
M7#[$"#9'E[DEP&ZR34%;$Q )5F, #0=M\4RI%R)F8F3B.)W3F.Q^(7NP78;.
M+1. S384FB@@*NS. "PJ,2K42,B]@'''DPWF^T42]4P5IM M&I#1-ANZ*B X
M &L '94:+>8SGS/)$N_FL0 U>4C*Y\%[* 'U;F'IL=UF!A 'A$ZW0X @$83:
M43Y!FM.(\6?6>-QAQK9B -S/6 RO4'JBW$(UJ EMM#I# @)LB$\ LU;HA_*9
M%,3D:SQ%!4C6X(6XBS@6!RJK_KE.*#D&VV_5NJ6KPVZ;*8LP())@=P _E?*#
M^H!D#+JEH4 S?4-3I_ZAF0Z%9AHT--/W0+-\98% <_*&II[XA^9D*#0G04-S
M\BYH1,=['6MFXN,M7[)7V\/9H-(+,J95*S '67BX&-[Z8)$!<CTC0WQB4BRL
M;OD=9R\)C> E,R3W @Q@VDJ-I@T/';O!/G[J!;&*\SK6E(ORWB^)DOD99=HF
M[4-,J0D/DK:QWL&E5/M$XHYE.4[_G3QWGHC;Q5[PL!JV0M)2AH>*S5X?,&4,
M$D$^3JPK7.4-#>NK9%JYNU> +;8.KP W"H. P.;(? 6XO'I2BEQWLV24$PR,
M".UB9YUL,57W<:,LC"XV#1D]7'ROA<;'%UEF=TGO'AF%'Q P):YZ&C*G>ELO
M#Z+' 5-ZKQ<R5.@\78V7&28R^_#=*',VL^MVZHE<%031N[H;8YI6Y8Y[\S>>
MY&+/,[;9;&EUE\?VW""@<]7+G395CUM%0?1^ES.=A$J+VF+'6"Q8FD1)GM#U
MK^+DDR?8UBJ;R!40L$%%@ZD( @70EL[!08B4TC$$=YQ("(GHB.(E0)E8B-\^
M/%AG^RZQ*RCZ#2LX8&40D/3:TV$1 >.H$8'*$%3$^,5FGF5;PM\$CR7$$T*@
M>0 D0Q\B3I#)7JC*0)]L+4BT%?/C_GBZ6B9Y:CNY-"7.YB3 7#TC:>5!L &8
MTEDHRA![0,?3OZW^CE24X^Z_84N.9>[8Q7ZS8BF0?<JJ<@5!AT7%@442! JP
M+YV&&X8J*2JU/K)3M<Q:FJ.5NP+ :DMU?:LPB$ZW.3*^_*V^]C3D7^ZB1V&*
M "\DV&6NAWZ;27WX;VJ"0*##F'%24DF1TOIX(>$P9:W[%P%K;XN =<\B8!WB
M(F ]=!&P]K8(4+LM4X2(<>EVE29K#"0G[%2[AJ+#LLZ'11H4*K _<,RH0] A
MQG5&RR+%F4S/SS?%_J_$!TLK 9VSG)9=-NNDEC91$(QT.3/26I9)YQIB)-6N
MN=C&24[BTLQ50C&-$IS6Z1%M5\3[0YS1,M!\#4Z//@R&AIDT<"K#5"[#.O"0
MZM+UI?3R 8S?2)K^0MDK71"<,4KB\EJ*[4Y1M][M$S,]MML/S0#B(' :XA!X
M=$8&C9]D%%)AU94P+R1]8^F6YI@7[Y)SV\@$Z-R2 ]AL$Z.) B+%[@P@I!:C
M4NWG!>TR>T2]R"I_=PAL("1W_+IVIVGMK6VK-B!F.@U"[W!7.3\.:^,RRM,K
MECF1OQ>1O) O.,>5-["]D-SU2Y5=IO6W*6W:@!#J- B^/UG'R%0Q6#'E+64,
MGXFEUIIU/"6NJ=PGCC$LFKEC:DE >-A\=620X4AIO;"PV. T_;S-$DHR>"+2
M5&Y9L%ILL]"2!,2"S1? 0B%%2NN%A<L-X6LQO?W,V6O^6.5G!=L&J-VRT6FY
MS8A5&A K7?X 9E0(*F-42ET_\.P."<7++(MP2RU2Q]B 9C5F#%U(P$#F#%I2
M$LGK+3<L1TN&OF8$Y8\$758_0]?,!%_6X^N71J)(OA!1KLIIC+D-H2ZQ\U\=
M 0T;OSUB*(, J=<>_#LD=012(8ZIN14,\^9Y7&%BGI,-^+9#?X@K@H::5QSU
MZ8.@::!)G:DBK'UR700B&>DSFU$SN3V\Q&N)'*^,+0:UA7%#$00CH"UH6=S\
MK0 _N?.VJS2)KE*&X:LL+8WCC'FF/2U9WD$0$ &F*RA%7B%$A=)+_W_&](EO
MG_-H?\=91(A\RBJK1ZN^ZV\#H]TR\Z8FM6D:%!H09V_Q"Q!XJ (UZOC0F+%\
M7LR3#XW+;&XL>EH\8G$ ;[=Y)F=080R^"MX9Y/CVPH &:#<9.B("0F^ 3>B&
M0Q&)BM /J Q&C6A/YV?9(0L@B3_O[\D#X?*]@R79Y9_%CIXZSC &Q+H^>QO<
M'/UDKC<P" C?ZA8ZU<M0LP*TDL^(556@WV4EJ*C%]OOES4W7XI/8K#:)OU8X
M(V++?P%02P,$%     @ SH-$7!/88?16!P  S%<  !4   !W<F%P+3(P,C8P
M,C R7W!R92YX;6S-G%USXC84AN\[T__@TFM"(-UMPR;M9-FPPVQVDX;L;MN;
M'6$+T$26&$D.\.\KV9CP8<DG-S[)14+,JX_W.;;L8TN^^&N5\NB)*LVDN&QU
M3TY;$16Q3)B87;:^CMM7X\%HU(JT(2(A7 IZV1*R]=>?/_\4V9^+7]KM:,@H
M3_K1!QFW1V(JWT5?2$K[T4<JJ")&JG?1-\(SMT4.&:<J&LATP:FA]HNBX7[T
M]N2,1.TVH-IO5"12?;T?;:N=&[/0_4YGN5R>"/E$EE(]ZI-8IK *QX:83&]K
M.UV=;GZ*XA><B<>^^S4AFD86E]#]E6:7+=?NIMGEV8E4LT[O]+3;^>?SS3B>
MTY2TF7#88MHJ2[E:JLIUS\_/._FWI?1(N9HH7K9QUBF[LZW9?LL"^IV>:-;7
M>?=N9$Q,'O7:9B*OPOW7+F5MMZG=[;7/NB<KG;1*^#E!)3F]I],HM]DWZX7=
MDS1S.T)KLVVNZ/2RM51D82OJO3VUOUPUOPZDW3];D:O AOVYNU;HHMQQ7W0V
MHLY>FPM%-14FMWEC-^PU3E?&[DHT*9MWU80KWY1FQ@DW.TDW:KL]*DMM._9C
MH=QTHNP&E_%>R]R1EVK?=[D7YWPUC4]F\JF34&8Y]]ZX#P[*FQR(_>='WM#5
M1!M%8E/6Q,F$\KS^'U9S(.DTT*N2Q(.ML;I3^XK#/NT&[$K%D50)599U61=1
M\7Z8CG;(C:*S(,I6U([GC&\C/%4R]='9D)">CNZ"LDTT0_/*MI^X/@PYF57C
M/)  >78Q@%:ZP2+Z@>I8L87C4@-V3PGDVT/E6^&M8<SEL7-/9\SUUW7%G6:I
MVQ@>%SQ%@.#/,$>*H%ND"%P)D1%^3Q=2U8#?5P)Y_X;)N\H;$N:_,Z(,57P-
M(7TD!L)^@PG;XQ")]X,B0C/'!P+\6 TD_A;UPL/C$0GY>$XY=YD;$:"]O$H/
MQ/X[)G:_SU< _OK)G=_MJ07.?J<($/\?KP7_D5ND"-Q1Q61B3^D*P/Y(#*1^
MCDG=XQ"5][5(H+2W4G#^@P_[P!X2ZB'3,>%%CX9VFP[CKI!#D:/DG+4V4;'_
M2XD"0]\10Y&CI*$U%AL&/LB4VNM,<%3QJZ'(41+0.I,-,[\6AIFUN]7_)4LG
MSS=.]UD?JZ",49).GRD4MN6=!F'<(XP0WT,EE#%*KADRA\)Y8/THPD<BH:M/
M=!T"?22%DD;),8/V4%#?*982M1ZSN'[0.-9"8:-DEF&#*+0?R&J46%=LRHJ'
M@/70O46@[%'22I!=E!",1"S50N[<+A[(S!Z/ZX%,@D-Z34%H.%#RS1=81PG*
M59)87'KSYX8)V@V%HE(.?D:$%X" S5>"O?<R[#TX=I0\M-;F*\%^]C+L9W#L
M*+EHK4U,[ /[\58]R*7G";17#$6.DHO66,0$GI]I;M6=DD^LF M51_VH!!0]
M8HH:-HNZPQ<G><C>7BJAO!'3U6ISF)SOI#:$_\<6=5>2U7HH<\3$-62TZ1N,
M1=S=30O?5*(#"90O2JY:::=II"["BA+_[KNO@ )%24"KS#3,\T:Z9Q]S*8+W
M8X]54*XHF:3/5-,#KYM$K+V'_L[7X!EL*,/JH8V&,7Y7S-@>#&2:9F)SC\;S
M5,PCA>)%2?^"]AI&/9:<Q<PP,?MLKQ 5([R:<Y4."ADEV?,;:YCPG:(NTM1>
M=N?SN-PJ W4[G?I&WI >2APEUZLWBDM^I'5&U4OY5Y2"1@$E[8.:;GJ<H7%F
MA[UUMS=Y<"MF/*/,D0K*&B7E\YEJF.T7^:"(6Z(W7J<3R?W+0RJ%4,(H"5[
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M2P$"% ,4    " #.@T1<WP4/SV*G  #[#00 "@              @ $
M97@Q,"TQ+FAT;5!+ 0(4 Q0    ( ,Z#1%SYQBOUZ%L  *K1 @ *
M      "  8JG  !E>#$P+3(N:'1M4$L! A0#%     @ SH-$7$ZN[SVH30
MNO,!  D              ( !F@,! &5X-"TQ+FAT;5!+ 0(4 Q0    ( ,Z#
M1%R'$.(D=T0  +>V 0 )              "  6E1 0!E>#0M,BYH=&U02P$"
M% ,4    " #.@T1<;#5VZ?07   T=@  "@              @ $'E@$ 97@Y
M.2TQ+FAT;5!+ 0(4 Q0    ( ,Z#1%R30#7S(!H  (FV   +
M  "  2.N 0!F;W)M."UK+FAT;5!+ 0(4 Q0    ( ,Z#1%QBYO;P)0,  -8+
M   1              "  6S( 0!W<F%P+3(P,C8P,C R+GAS9%!+ 0(4 Q0
M   ( ,Z#1%R89#;N_0H  '^&   5              "  <#+ 0!W<F%P+3(P
M,C8P,C R7VQA8BYX;6Q02P$"% ,4    " #.@T1<$]AA]%8'  #,5P  %0
M            @ 'PU@$ =W)A<"TR,#(V,#(P,E]P<F4N>&UL4$L%!@     )
-  D % (  'G> 0    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>form8-k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="wrap-20260202.xsd" xlink:type="simple"/>
    <context id="AsOf2026-02-02">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001702924</identifier>
        </entity>
        <period>
            <startDate>2026-02-02</startDate>
            <endDate>2026-02-02</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="AsOf2026-02-02" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2026-02-02" id="Fact000004">0001702924</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="AsOf2026-02-02" id="Fact000009">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2026-02-02" id="Fact000010">2026-02-02</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2026-02-02" id="Fact000011">WRAP TECHNOLOGIES, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2026-02-02" id="Fact000012">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2026-02-02" id="Fact000013">001-38750</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2026-02-02" id="Fact000014">98-0551945</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2026-02-02" id="Fact000015">3480 Main Hwy</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="AsOf2026-02-02" id="Fact000016">Suite 202</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="AsOf2026-02-02" id="Fact000017">Miami</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2026-02-02" id="Fact000018">FL</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2026-02-02" id="Fact000019">33133</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2026-02-02" id="Fact000020">(800)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2026-02-02" id="Fact000021">583-2652</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2026-02-02" id="Fact000022">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2026-02-02" id="Fact000023">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2026-02-02" id="Fact000024">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2026-02-02" id="Fact000025">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="AsOf2026-02-02" id="Fact000026">Common Stock, par value $0.0001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="AsOf2026-02-02" id="Fact000027">WRAP</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="AsOf2026-02-02" id="Fact000028">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2026-02-02" id="Fact000029">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
